<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d234627dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXECUTION VERSION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSET
PURCHASE AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BETWEEN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MOLINA HEALTHCARE, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AETNA INC.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dated as of August 2, 2016<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> </B></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"></TD></TR></TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Schedule A, attaching the form of Administrative Services Agreement, Schedule B, attaching the form of Transitional Trademark License Agreement, Schedule C, attaching the form of Assignment and Assumption Agreement, and
the Disclosure Schedules to this agreement have been omitted in accordance with Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule will be furnished to the Securities and Exchange Commission upon request. </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 1 DEFINITIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Defined Terms.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Definitional and Interpretative Provisions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 2 PURCHASE AND SALE OF ASSETS; ASSUMPTION OF CERTAIN LIABILITIES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sale and Purchase of Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchaser&#146;s Right to Assignment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payments Intended for Other Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Deliveries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase Price Adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Adjustment to Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Allocation of Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reduction in Applicable Service Area</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regional PPO</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 3 REPRESENTATIONS AND WARRANTIES OF SELLER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Existence and Power</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Authorization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Authorization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-Contravention</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Absence of Certain Changes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title to Purchased Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Books and Records</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compliance with Applicable Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conveyed Medicare Advantage Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Provider Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller Enrollees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreements with Brokers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NDAs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Finders&#146; Fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Other Seller Representations and Warranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 4 REPRESENTATIONS AND WARRANTIES OF PURCHASER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Existence and Power</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Authorization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Authorization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-i- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-Contravention</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compliance with Applicable Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Finders&#146; Fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Other Purchaser Representations and Warranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 5 COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conduct of Business</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preparation for Transfer and Transition</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Best Efforts; Novation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enrollee Non-Solicitation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing Covenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public Announcements; Confidentiality</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Further Assurances</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice to Enrollees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preauthorizations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Access to Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Broker Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2017 Calendar Year True-Ups</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mail and Communications</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notices of Certain Events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller Marks</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2016 Marketing Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2017 Marketing Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exclusivity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase Option</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.21</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Humana Purchase Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.22</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2018 Bids</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;6&nbsp;CONDITIONS TO CLOSING</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conditions to Purchaser&#146;s and Seller&#146;s Obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conditions to Purchaser&#146;s Obligation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conditions to Seller&#146;s Obligation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Frustration of Conditions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 7 INDEMNIFICATION AND REMEDIES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Survival</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification by Seller</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification by Purchaser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third-Party Claim Procedures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Direct Claim Procedures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Calculation of Damages</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assignment of Claims</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exclusive Remedy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-ii- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase Price Adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Indemnity Provisions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE 8 TERMINATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Grounds for Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Applicable Termination Fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;9&nbsp;MISCELLANEOUS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notices</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendments and Waivers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disclosure Schedule References</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Binding Effect; Benefit; Assignment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governing Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jurisdiction/Venue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WAIVER OF JURY TRIAL</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Counterparts; Effectiveness</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entire Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Specific Performance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waiver of Claims</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>Schedules</U></P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Schedule&nbsp;A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Administrative Services Agreement</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Schedule&nbsp;B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Transitional Trademark License Agreement</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Schedule&nbsp;C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Assignment and Assumption Agreement</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iii- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSET PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ASSET PURCHASE AGREEMENT (this &#147;<B>Agreement</B>&#148;) dated as of August 2, 2016 between Molina Healthcare, Inc., a Delaware
corporation (&#147;<B>Purchaser</B>&#148;), and Aetna Inc., a Pennsylvania corporation (&#147;<B>Seller</B>&#148;; each of Seller and Purchaser, a &#147;<B>party</B>&#148; and together, the &#147;<B>parties</B>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>W I T N E S S E T H : </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to the Agreement and Plan of Merger (the &#147;<B>Merger Agreement</B>&#148;) dated as of July 2, 2015 among Seller, Echo
Merger Sub, Inc., a Delaware corporation, Echo Merger Sub, LLC, a Delaware limited liability company, and Humana Inc., a Delaware corporation (&#147;<B>Humana</B>&#148;), Seller has agreed to acquire Humana (the &#147;<B>Humana
Acquisition</B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Seller owns and, in connection with the Humana Acquisition Litigation (as defined below) desires to
divest, the Purchased Assets (as defined below); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, accordingly, upon the terms and conditions set forth herein, Seller desires
to sell and transfer to Purchaser, and Purchaser desires to purchase and assume from Seller, all of the Purchased Assets and the Assumed Liabilities, on the terms and subject to the conditions set forth herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing and the representations, warranties, covenants and agreements contained in this Agreement,
and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 1 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DEFINITIONS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 1.01 <I>Defined Terms.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) The following terms shall have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>1934 Act</B>&#148; means the Securities Exchange Act of 1934. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2017 Bid</B>&#148; means each of the bids submitted by Seller or any of its Affiliates to CMS set forth on Section 1.01(a)(i) of the
Seller Disclosure Schedules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2017 Enrollee-Based Payment</B>&#148; means any payment that is determined on an
Enrollee-by-Enrollee basis and is received by a party from CMS (and, in the case of the Part D coverage gap discount program, any payment that is determined on an Enrollee-by-Enrollee basis and is received by a party from CMS or a pharmaceutical
manufacturer under such program) for calendar year 2017 coverage of Enrollees under a 2017 Seller Split Year Medicare Advantage Plan or a Purchaser Medicare Advantage Plan, in each case to the extent such payment is either received during calendar
year 2017, or as an adjustment to or additional payment received after calendar year 2017 with respect to any such payment for calendar year 2017, including risk-adjusted Part C capitation payments, risk-adjusted Part&nbsp;D direct subsidies, Part D
reinsurance, Part D low-income subsidies and Part D coverage gap discount payments (and adjustments or additional payments with respect thereto). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-1- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2017 Plan-Based Adjustment</B>&#148; means any amount, other than any 2017
Enrollee-Based Payment (or any adjustment or additional payment with respect to any 2017 Enrollee-Based Payment), that is (i)&nbsp;received by a party from CMS in respect of all or any portion of calendar year 2017 as an adjustment to or in addition
to the amounts previously paid by CMS to a party for calendar year 2017 coverage of Enrollees or (ii)&nbsp;paid by a party to CMS as an adjustment to an amount previously paid by or to CMS for calendar year 2017 coverage of Enrollees or as an
additional payment required in connection with a Medicare Advantage plan in respect of all or any portion of calendar year 2017, in each case, where the amount paid by CMS or such party relates to coverage of Enrollees under both a 2017 Seller Split
Year Medicare Advantage Plan and a Purchaser Medicare Advantage Plan, including any Part C medical loss ratio (&#147;<B>MLR</B>&#148;) payments, Part D MLR payments and Part D risk corridor payments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2017 Seller Medicare Advantage Contract</B>&#148; means each Contract that (i) covers only calendar year 2017 in its entirety, (ii)
covers individuals who reside (as defined by applicable Law) in the Applicable Service Area and are directly enrolled in a Medicare Advantage plan (but does not necessarily cover only such individuals) and (iii) is entered into by Seller or any of
its Affiliates pursuant to any of the 2017 Bids. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2017 Seller Medicare Advantage Plan</B>&#148; means (i) if the 2017 Split Year
Medicare Advantage Contracts are the Conveyed Medicare Advantage Contracts, any 2017 Seller Split Year Medicare Advantage Plan, and (ii) if the 2018 Medicare Advantage Contracts are the Conveyed Medicare Advantage Contracts, any 2017 Seller Whole
Year Medicare Advantage Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2017 Seller Split Year Medicare Advantage Plan</B>&#148; means any Medicare Advantage plan offered
by Seller or any of its Affiliates from and after January&nbsp;1, 2017 and prior to the Closing Date directly to individuals in the Applicable Service Area pursuant to a 2017 Seller Medicare Advantage Contract (and, for the avoidance of doubt, the
term &#147;2017 Seller Split Year Medicare Advantage Plan&#148; shall in all events refer to such plan solely to the extent owned by Seller or any of its Affiliates during the period from and after January&nbsp;1, 2017 and prior to the Closing
Date).&nbsp;For the avoidance of doubt, in no event shall (i) any Medicare Advantage or other plan offered by Seller or any of its Affiliates to groups or solely to individuals who are part of a group or (ii) any Special Needs Plan be deemed to be a
&#147;2017 Seller Split Year Medicare Advantage Plan&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2017 Seller Whole Year Medicare Advantage Plan</B>&#148; means any
Medicare Advantage plan offered by Seller or any of its Affiliates during calendar year 2017 directly to individuals in the Applicable Service Area pursuant to a 2017 Seller Medicare Advantage Contract (and, for the avoidance of doubt, the term
&#147;2017 Seller Whole Year Medicare Advantage Plan&#148; shall in all events refer to such plan solely to the extent owned by Seller or any of its Affiliates during calendar year 2017).&nbsp;For the avoidance of doubt, in no event shall (i) any
Medicare Advantage or other plan offered by Seller or any of its Affiliates to groups or solely to individuals who are part of a group or (ii) any Special Needs Plan be deemed to be a &#147;2017 Seller Whole Year Medicare Advantage Plan&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2017 Split Year Medicare Advantage Contract</B>&#148; means each Contract that (i) is
split from a 2017 Seller Medicare Advantage Contract at or prior to the Closing, covers only calendar year 2017 in its entirety or the portion of calendar year 2017 from and after the Closing and is of the same Series as such 2017 Seller Medicare
Advantage Contract, (ii)&nbsp;covers only individuals who reside (as defined by applicable Law) in the Applicable Service Area and are directly enrolled in a Medicare Advantage plan and (iii) in all material respects, is on terms substantially
similar to the terms of the Existing Medicare Advantage Contract that currently covers such individuals, except for (A)&nbsp;any changes to the payment rates or other terms thereof required by a Governmental Authority relating to or arising out of
(1) differences in the risk profiles of the Seller Enrollees as compared to all persons enrolled in a Medicare Advantage plan under the applicable Existing Medicare Advantage Contract wherever resident, (2) changes to reimbursement or payment rates
or in methods or procedures for determining such rates, any changes to eligibility requirements or any other programmatic changes or (3) changes in regulatory, legislative or political conditions, including the adoption, implementation,
promulgation, repeal, modification, amendment, authoritative interpretation, change or proposed change of any Law, or (B)&nbsp;any changes to the payment rates or other terms thereof relating to or arising out of (1) the 2017 Bids, (2) changes
resulting from the removal of certain products (e.g., group Medicare Advantage), geographies or plans that were offered under or covered by the applicable Existing Medicare Advantage Contract, (3) the matters set forth on Section 1.01(a)(ii) of the
Seller Disclosure Schedules or (4) changes after the date hereof to which Purchaser has consented, such consent not to be unreasonably withheld, conditioned or delayed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2017 Whole Year Medicare Advantage Contract</B>&#148; means each Contract that (i) is split from an Existing Medicare Advantage
Contract on or prior to January&nbsp;1, 2017, covers only calendar year 2017 in its entirety and is of the same Series as such Existing Medicare Advantage Contract, (ii) covers only individuals who reside (as defined by applicable Law) in the
Applicable Service Area and are directly enrolled in a Medicare Advantage plan and (iii)&nbsp;in all material respects, is on terms substantially similar to the terms of the Existing Medicare Advantage Contract from which such Contract is split,
except for (A)&nbsp;any changes to the payment rates or other terms thereof required by a Governmental Authority relating to or arising out of (1) differences in the risk profiles of the Seller Enrollees as compared to all persons enrolled in a
Medicare Advantage plan under the applicable Existing Medicare Advantage Contract wherever resident, (2) changes to reimbursement or payment rates or in methods or procedures for determining such rates, any changes to eligibility requirements or any
other programmatic changes or&nbsp;(3) changes in regulatory, legislative or political conditions, including the adoption, implementation, promulgation, repeal, modification, amendment, authoritative interpretation, change or proposed change of any
Law, or (B)&nbsp;any changes to the payment rates or other terms thereof relating to or arising out of (1) the 2017 Bids, (2) changes resulting from the removal of certain products (e.g., group Medicare Advantage), geographies or plans from the
applicable Existing Medicare Advantage Contract, (3)&nbsp;the matters set forth on Section 1.01(a)(ii) of the Seller Disclosure Schedules or (4)&nbsp;changes after the date hereof to which Purchaser has consented, such consent not to be unreasonably
withheld, conditioned or delayed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2018 Medicare Advantage Contract</B>&#148; means each Contract that (i) is split from a 2017
Seller Medicare Advantage Contract at or prior to the Closing, covers only calendar year 2018 and is of the same Series as such 2017 Seller Medicare Advantage Contract, (ii) covers only individuals who reside (as defined by applicable Law) in the
Applicable Service Area and are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
directly enrolled in a Medicare Advantage plan and (iii) in all material respects, is on terms substantially similar to the terms of the Existing Medicare Advantage Contract that currently covers
such individuals, except for (A)&nbsp;any changes to the payment rates or other terms thereof required by a Governmental Authority relating to or arising out of (1)&nbsp;differences in the risk profiles of the Seller Enrollees as compared to all
persons enrolled in a Medicare Advantage plan under the applicable Existing Medicare Advantage Contract wherever resident, (2) changes to reimbursement or payment rates or in methods or procedures for determining such rates, any changes to
eligibility requirements or any other programmatic changes or&nbsp;(3) changes in regulatory, legislative or political conditions, including the adoption, implementation, promulgation, repeal, modification, amendment, authoritative interpretation,
change or proposed change of any Law, or (B)&nbsp;any changes to the payment rates or other terms thereof relating to or arising out of (1) the 2017 Bids, (2) Seller&#146;s and its Affiliates&#146; respective 2018 Bids prepared in accordance with
Section 5.22(d), (3) changes resulting from the removal of certain products (e.g., group Medicare Advantage), geographies or plans that were offered under or covered by the applicable Existing Medicare Advantage Contract, (4) the matters set forth
on Section 1.01(a)(iii) of the Seller Disclosure Schedules or (5) changes after the date hereof to which Purchaser has consented, such consent not to be unreasonably withheld, conditioned or delayed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2018 Medicare Advantage Contract Entry Date</B>&#148; means the date during calendar year 2017 (expected to be on or about
August&nbsp;31, 2017) on which Seller and its Affiliates execute the 2018 Medicare Advantage Contracts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Action</B>&#148; means
any action, controversy, complaint, inquiry, grievance, hearing, mediation, demand, notice of proceeding, administrative proceeding, suit (whether in contract or tort or otherwise), arbitration, litigation, or proceeding (whether at law or in
equity, whether civil or criminal) before any arbitrator, Governmental Authority, or intermediary contractor of a Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Additional Seller Enrollees</B>&#148; means the Seller Enrollees who reside (as defined by applicable Laws) within the Additional
Service Area as of the most recent date that is shown on the monthly membership roster issued by CMS in the month immediately preceding the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Affiliate</B>&#148; means, with respect to any Person, any other Person directly or indirectly controlling, controlled by, or under
common control with such Person.&nbsp;The term &#147;control&#148; (including, with correlative meaning, the terms &#147;controlled by&#148; and &#147;under common control with&#148;), as used with respect to any Person, means the possession,
directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by representation on the board of directors, management committee or similar
governing body, by contract or otherwise; <I>provided </I>that any joint venture or similar arrangement between Seller or any of its Affiliates and any Provider shall not be deemed an Affiliate of Seller for purposes of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Portion</B>&#148; means, with respect to any amount payable under Section 8.03 pursuant to an Applicable Termination, such
amount multiplied by a fraction the numerator of which is (i) the number of Seller Enrollees as of the most recent date that is shown on the monthly membership roster issued by CMS in the month immediately preceding the date of such
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Applicable Termination, and the denominator of which is (ii) the sum of (A) the number of Seller Enrollees referred to in clause (i) of this definition, plus (B) the number of &#147;Seller
Enrollees&#148; (as defined in the Humana APA) referred to in clause (i) of the definition of &#147;Applicable Portion&#148; in the Humana APA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Seller Enrollees</B>&#148; means the Seller Enrollees who reside (as defined by applicable Law) within the Divested
Service Area as of the most recent date that is shown on the monthly membership roster issued by CMS in the month immediately preceding the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Service Area</B>&#148; means, with respect to any H-series contract, the counties in the states set forth on Section
1.01(a)(iv)&nbsp;of the Seller Disclosure Schedules and, with respect to any R-series contract, the counties in the states set forth in Section 1.01(a)(v) of the Seller Disclosure Schedules, in each case, under the heading &#147;Applicable Service
Area&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Broker</B>&#148; means any Person that has entered into a contract with Seller or any of its Affiliates with respect
to an Existing Medicare Advantage Plan or a 2017 Seller Medicare Advantage Plan and is licensed by a state to sell, or to solicit individuals resident (as defined by applicable Law) in all or any portion of the Applicable Service Area to enroll in,
an Existing Medicare Advantage Plan or a 2017 Seller Medicare Advantage Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Day</B>&#148; means a day, other than
Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or required by applicable Law to close. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>CMS</B>&#148; means the Centers for Medicare &amp; Medicaid Services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>CMS Report</B>&#148; means each written report or other written communication issued by CMS after December&nbsp;31, 2017 and on or
before December&nbsp;31, 2018 that contains a determination by CMS of (i)&nbsp;any adjustment to or additional payment with respect to any 2017 Enrollee-Based Payment or (ii)&nbsp;any 2017 Plan-Based Adjustment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Code</B>&#148; means the Internal Revenue Code of 1986. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Commercially Reasonable Efforts</B>&#148; means, where applied to carrying out specific tasks and obligations of a party, expending
reasonable, diligent, good faith efforts and resources to accomplish such task or obligation as such party (on its own and/or acting through any of its Affiliates, agents or subcontractors) would normally use to accomplish a similar task or
obligation under similar circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Competing Transaction</B>&#148; means a transaction (other than the transactions
contemplated by this Agreement) involving (i)&nbsp;any sale, lease, exchange, mortgage, pledge, transfer or other disposition of any of the Purchased Assets in a single transaction or a series of related transactions, (ii)&nbsp;any joint venture
agreement to which Seller or any of its Affiliates is a party pursuant to which any other Person would acquire an interest in any of the Purchased Assets or (iii)&nbsp;any agreement by Seller or any of its Affiliates to, or public announcement by
Seller or any of its Affiliates of a proposal, plan or intention to, do any of the foregoing or (iv) any other transaction which would preclude the sale or transfer of the Purchased Assets to Purchaser or any of its Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Consent</B>&#148; means any consent, approval, permission, license, permit, variance,
franchise, exemption, clearance, authorization, acknowledgment, Order, ratification or waiver from, notice to, or filing with, any Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Contract</B>&#148; means any H-series or R-series contract between a Person and CMS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Conveyed Medicare Advantage Contract</B>&#148; means (i) if the Closing occurs on or prior to January&nbsp;1, 2017, each 2017 Whole
Year Medicare Advantage Contract; (ii) if the Closing occurs after January&nbsp;1, 2017 and before the 2018 Medicare Advantage Contract Entry Date, each 2017 Split Year Medicare Advantage Contract; and (iii) if the Closing occurs on or after the
2018 Medicare Advantage Contract Entry Date, each 2018 Medicare Advantage Contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>DHHS</B>&#148; means the United States
Department of Health and Human Services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Divested Service Area</B>&#148; means such counties that are included in the Original
Service Area in which Seller is required to divest individual Medicare Advantage plan Contracts in accordance with the Final Resolution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>DOJ</B>&#148; means the United States Department of Justice, Antitrust Division. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Enrollees</B>&#148; means the Seller Enrollees and the Purchaser Enrollees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Enrollee Measurement Date</B>&#148; means, (i) if Seller and its Affiliates submit the 2018 Bids to CMS pursuant to Section 5.22(c),
or if the 2018 Medicare Advantage Contracts are the Conveyed Medicare Advantage Contracts, January&nbsp;1, 2018, and (ii) otherwise, the date that is the later of (A)&nbsp;January&nbsp;1, 2017 and (B)&nbsp;the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Existing Medicare Advantage Contract</B>&#148; means each of the Contracts set forth on Section 1.01(a)(vi)&nbsp;of the Seller
Disclosure Schedules, including the R-series Contract set forth thereon (the &#147;<B>Applicable RPPO Contract</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Existing Medicare Advantage Plan</B>&#148; means any Medicare Advantage plan offered prior to January&nbsp;1, 2017 by Seller or any
of its Affiliates directly to individuals in an Applicable Service Area pursuant to an Existing Medicare Advantage Contract.&nbsp;For the avoidance of doubt, in no event shall (i)&nbsp;any Medicare Advantage or other plan offered by Seller or any of
its Affiliates to groups or solely to individuals who are part of a group or (ii)&nbsp;any Special Needs Plan be deemed to be an &#147;Existing Medicare Advantage Plan&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Filing</B>&#148; means any registration, petition, statement, application, schedule, form, declaration, notice, notification, report,
submission or other filing with a Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Final Determination</B>&#148; means (i)&nbsp;any final determination
of liability in respect of a Tax that, under applicable Law, is not subject to further appeal, review or modification through proceedings or otherwise (including the expiration of a statute of limitations or a period for the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
filing of claims for refunds, amended returns or appeals from adverse determinations) or (ii)&nbsp;the payment of Tax by Seller, Purchaser or any of their Affiliates, whichever is responsible for
payment of such Tax under applicable Law, with respect to any item disallowed or adjusted by a Taxing Authority, provided that such responsible party determines that no action should be taken to recoup such payment and the other party agrees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Financing Source</B>&#148; means Barclays Bank PLC (collectively with any of its Affiliates and any of its officers, directors,
employees, agents or representatives and each of their respective successors and assigns), any other Person that has committed to provide or arrange the debt financing contemplated by the Debt Commitment Letter in connection with the transactions
contemplated hereby, or any Affiliates of such Person or any of their respective officers, directors, employees, agents or representatives and each of their respective successors and assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>FIRPTA Certificate</B>&#148; means a certificate pursuant to Treasury Regulations Section 1.1445-2(b)&nbsp;that Seller is not a
&#147;foreign person&#148; within the meaning of Section 1445 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Authority</B>&#148; means any
transnational, territorial, domestic or foreign federal, state or local governmental, legislative, regulatory or administrative authority, department, court, tribunal, board, bureau, agency or instrumentality, commission or official, including any
political or other subdivision thereof, department or branch of any of the foregoing, or any government authorized non-governmental self-regulatory agency, commission or authority, including the DHHS, CMS and the OIG. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Government Sponsored Health Care Programs</B>&#148; means (i)&nbsp;the Medicare program established under and governed by the
applicable provisions of Title XVIII of the Social Security Act, the regulations promulgated thereunder and any sub-regulatory guidance issued thereunder and (ii)&nbsp;any other state or federal health care program or plan applicable to the Medicare
program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Health Care Laws</B>&#148; means all Laws relating to: (i)&nbsp;the licensure, certification, qualification or
authority to transact business in connection with the payment for, or arrangement of, health care services, health benefits or health insurance, including: (A)&nbsp;Laws that regulate managed care and health insurance plans, including Medicare
Advantage plans, third-party payors and Persons bearing the financial risk for, or providing administrative or other functions in connection with, the provision of, payment for or arrangement of health care services, (B)&nbsp;Laws relating to
Government Sponsored Health Care Programs pursuant to which any regulated Subsidiary of Purchaser or Seller, as applicable, is required to be licensed or authorized to transact business, and (C) Laws relating to health care or insurance fraud, waste
or abuse, including the solicitation or acceptance of improper incentives involving persons operating in the health care industry, patient referrals or Provider incentives generally, including the following statutes: the Federal Anti-kickback
Statute (42 U.S.C. &#167;&nbsp;1320a-7b), the Stark laws (42 U.S.C. &#167;&nbsp;1395nn), the Federal Civil False Claims Act (31 U.S.C. &#167;&#167;&nbsp;3729, et seq.), the Federal Civil Monetary Penalties Law (42 U.S.C. &#167;&nbsp;1320a-7a), the
Federal Program Fraud Civil Remedies Act (31 U.S.C. &#167;&nbsp;3801 et seq.) and the Federal Health Care Fraud Law (18 U.S.C. &#167;&nbsp;1347); (ii)&nbsp;the provision of administrative, management or other services related to any Government
Sponsored Health Care Programs, including the administration of health care claims or benefits or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
processing or payment for health care services, treatment or supplies furnished by Providers, including the provision of the services of third party administrators, utilization review agents and
Persons performing quality assurance, credentialing or coordination of benefits; (iii)&nbsp;the licensure, certification, qualification or authority to transact business in connection with the&nbsp;payment for pharmacy services, along with the
requirements of the U.S. Drug Enforcement Administration in connection therewith; (iv)&nbsp;the Consolidated Omnibus Budget Reconciliation Act of 1985; (v)&nbsp;the Medicare Prescription Drug, Improvement, and Modernization Act of 2003;
(vi)&nbsp;the Medicare Improvements for Patients and Providers Act of 2008; (vii) the privacy, security, integrity, accuracy, transmission, storage or other protection of information about or belonging to actual or prospective participants in
Government Sponsored Health Care Programs or other lines of business, including the Health Insurance Portability and Accountability Act of 1996 (Pub. L. No. 104-191), as amended by the Health Information Technology for Economic and Clinical Health
Act (Pub. L. No. 111-5), including any other Laws relating to medical information; and (viii) the Patient Protection and Affordable Care Act (Pub. L. 111-148) as amended by the Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Humana Acquisition Litigation</B>&#148; means the civil antitrust action captioned United States of America et al. v. Aetna Inc.
and Humana Inc., case number 1:16-cv-01494 (D.D.C. July 21, 2016), including any appeals therefrom. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>knowledge of
Purchaser</B>&#148; and &#147;<B>to Purchaser&#146;s knowledge</B>&#148; and words of similar import mean the actual knowledge of those executive officers of Purchaser as set forth in Section 1.01(a)&nbsp;of the Purchaser Disclosure Schedules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>knowledge of Seller</B>&#148; and &#147;<B>to Seller&#146;s knowledge</B>&#148; and words of similar import mean the actual knowledge
of those executive officers of Seller as set forth in Section 1.01(a)(vii)&nbsp;of the Seller Disclosure Schedules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Law</B>&#148; means, with respect to any Person, any federal, state or local law (statutory, common or otherwise), constitution,
treaty, convention, ordinance, code, rule, regulation, Order or other similar requirement (including any federal directive or other requirement that relates to Medicare) enacted, adopted, promulgated or applied by a Governmental Authority that is
binding upon or applicable to such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Liability</B>&#148; means any direct or indirect liability, indebtedness, claim,
loss, damage, deficiency, debt, assessment, penalty, obligation or responsibility of any kind or nature, whether fixed or unfixed, choate or inchoate, liquidated or unliquidated, secured or unsecured, asserted or unasserted, determined,
determinable, due or to become due, accrued, absolute, known or unknown, contingent or otherwise, and whether presently in existence or arising hereafter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Lien</B>&#148; means, with respect to any Purchased Asset, any mortgage, lien, license, pledge, charge, claim, guaranty, option,
restriction on transfer (including any buy-sell agreement or right of first refusal or offer), forfeiture, penalty, security interest or encumbrance of any kind in respect of such Purchased Asset. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Neutral Arbitrator</B>&#148; means a nationally recognized independent accounting firm or actuarial consulting firm that is mutually
acceptable to Seller and Purchaser; <I>provided, however</I>, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that if Seller and Purchaser are unable to agree on such a firm, each of Seller and Purchaser shall select a nationally recognized independent accounting firm or actuarial consulting firm that
has expertise in valuing Medicare Advantage members, which firms shall jointly select a third nationally recognized independent accounting firm or actuarial consulting firm that has expertise in valuing Medicare Advantage members to act as the
Neutral Arbitrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>OIG</B>&#148; means the Office of Inspector General of DHHS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Order</B>&#148; means any order, writ, decree, judgment, award, injunction, ruling, settlement or stipulation issued, promulgated,
made, rendered or entered into by or with any Governmental Authority or arbitrator (in each case, whether temporary, preliminary or permanent). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Liens</B>&#148; means any of the following: (i)&nbsp;Liens for Taxes, assessments, charges, levies or other claims not yet
delinquent, or the validity of which are being contested in good faith; (ii)&nbsp;Liens imposed by Law, such as materialmen&#146;s, mechanics&#146;, carriers&#146;, warehousemen&#146;s, workmen&#146;s and repairmen&#146;s liens and other such liens
for amounts not yet delinquent, or the validity of which are being contested in good faith; (iii)&nbsp;pledges or deposits to secure obligations under workers&#146; compensation Laws or similar legislation or to secure public or statutory
obligations and (iv)&nbsp;Liens arising pursuant to the terms of the Conveyed Medicare Advantage Contracts to the extent consistent with the definition of &#147;Conveyed Medicare Advantage Contracts.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Person</B>&#148; means any natural person, corporation, partnership, limited liability company, trust, association or other entity or
organization, including any Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Post-Closing Tax Period</B>&#148; means (i)&nbsp;any tax period beginning on
or after the Closing Date and (ii)&nbsp;with respect to a tax period that begins before but ends on or after the Closing Date, the portion of such period from and after the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Pre-Closing Tax Period</B>&#148; means (i)&nbsp;any tax period ending before the Closing Date and (ii)&nbsp;with respect to a tax
period that begins before but ends on or after the Closing Date, the portion of such period up to but excluding the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Providers</B>&#148; means those Persons who render or arrange for health care services to individuals and includes primary care
physicians and physician groups, independent practice associations, specialist physicians, mental health professionals, community health centers, clinics, surgicenters, physical therapists, hospitals and skilled nursing facilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchaser Enrollees</B>&#148; means all natural persons who reside (as defined by applicable Law) in the Applicable Service Area and
are enrolled in a Purchaser Medicare Advantage Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchaser Fundamental Representations</B>&#148; means the representations
and warranties of Purchaser contained in Sections&nbsp;4.01(a) (Corporate Existence and Power), 4.02 (Corporate Authorization), 4.04(a) (Non-Contravention) and 4.09 (No Finders&#146; Fee). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchaser Medicare Advantage Plan</B>&#148; means any Medicare Advantage plan offered by Purchaser or any of its Affiliates in all or
any portion of the Applicable Service Area pursuant to a Conveyed Medicare Advantage Contract (and, for the avoidance of doubt, the term&nbsp;&#147;Purchaser Medicare Advantage Plan&#148; shall in all events refer to such plan solely to the extent
owned by Purchaser or any of its Affiliates during the period from and after the Closing Date). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-9- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchaser&#146;s Transaction Costs</B>&#148; means the amount of reasonable and
documented out-of-pocket expenses incurred by Purchaser and its Affiliates in connection with this Agreement, the Humana APA and the transactions contemplated hereby and thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Region</B>&#148; means the geographic region consisting of the counties set forth under the name of such region on Section
1.01(a)(viii)&nbsp;of the Seller Disclosure Schedules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Representatives</B>&#148; means, with respect to any Person, the
officers, directors, employees, investment bankers, attorneys, accountants, consultants and other agents, advisors and representatives of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Restricted Period</B>&#148; means from the Closing until the later of (i)&nbsp;December&nbsp;31, 2018, (ii)&nbsp;the second (2<SUP
STYLE="font-size:85%; vertical-align:top">nd</SUP>) anniversary of the Closing Date and (iii) 11:59 pm Pacific Standard Time on the last day of the second Medicare annual open enrollment period after the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Seller Disclosure Schedules</B>&#148; means the schedules delivered by Seller to Purchaser on the date hereof setting forth, among
other things, items the disclosure of which is necessary or appropriate either in response to an express disclosure requirement contained in a provision hereof or as an exception to one or more of the representations and warranties contained in
Article 3 or to one or more of the covenants contained in Article 5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Seller Enrollees</B>&#148; means (i)&nbsp;if the Closing
occurs on or prior to January&nbsp;1, 2017, all natural persons who reside (as defined by applicable Law) in the Applicable Service Area and are enrolled in an Existing Medicare Advantage Plan and (ii)&nbsp;if the Closing occurs after
January&nbsp;1, 2017, all natural persons who reside (as defined by applicable Law) in the Applicable Service Area and are enrolled in a 2017 Seller Medicare Advantage Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Seller Fundamental Representations</B>&#148; means the representations and warranties of Seller contained in Sections 3.01(a)
(Corporate Existence and Power), 3.02 (Corporate Authorization), 3.04(a) (Non-Contravention) and 3.15 (No Finders&#146; Fee). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series</B>&#148; means, with respect to any Contract, the CMS-designated series thereof (i.e., for purposes hereof, either the
H-series or the R-series). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Special Needs Plan</B>&#148; means a Medicare Advantage coordinated care plan specifically designed
to provide targeted care and limit enrollment to special needs individuals, including institutionalized individuals, dual-eligibles and individuals with a severe or disabling chronic condition, as specified by CMS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Special Opt Out Period</B>&#148; means any special enrollment period or opt-out period mandated by CMS relating to the transactions
contemplated hereby during which any Enrollee is entitled to opt out of a Purchaser Medicare Advantage Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Subsidiary</B>&#148; means, with respect to any Person, any entity of which securities or other equity ownership interests having
ordinary voting power to elect a majority of the board of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
directors or other persons performing similar functions are directly or indirectly owned by such Person; <I>provided </I>that any joint venture or similar arrangement between Seller or any of its
Affiliates and any Provider shall not be deemed a Subsidiary of Seller for purposes of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax</B>&#148; or
&#147;<B>Taxes</B>&#148; means any tax of any kind or nature (or assessment in the nature of a tax) imposed by any Governmental Authority responsible for the imposition of any tax (or assessment in the nature of a tax) (each, a &#147;<B>Taxing
Authority</B>&#148;), including any federal, state, local or foreign income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation, premium, windfall profits, environmental, capital stock, franchise, profits,
withholding, social security (or similar), unemployment, disability, real property, personal property, sales, use, transfer, registration, value added, alternative or add-on minimum, estimated or other tax of any kind whatsoever, and including the
health insurance providers fee under the Patient Protection and Affordable Care Act (PPACA)&nbsp;section 9010, as amended, whether computed on a separate or consolidated, unitary or combined basis or in any other manner, including any interest,
penalty, deficiency or addition thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax Return</B>&#148; means any Tax return, statement, report, election, declaration,
disclosure, schedule or form (including any estimated tax or information return or report) filed or required to be filed with any Taxing Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transaction Documents</B>&#148; means this Agreement, the Assignment and Assumption Agreement, the Novation Agreement, the
Administrative Services Agreement and the Transitional Trademark License Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Willful Breach</B>&#148; means a material
breach of this Agreement that is the consequence of an act or omission by a party with the actual knowledge that the taking of such act or failure to take such action would be a material breach of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Each of the following terms is defined in the Section set forth opposite such term: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="87%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:19.10pt; font-size:8pt; font-family:Times New Roman"><B>Term</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Section</B></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">2017 Enrollee-Based Payment Entitlement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.12(a)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">2017 Plan-Based Adjustment Portion</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.12(a)(ii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">2017 Lead Generation Budget</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.18(a)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">2018 Bid</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.22(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">2018 Bid Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.22(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Accounting Referee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.12(b)(v)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Additional Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.20(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Additional Service Area</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.12(a)(ii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Adjusted Purchase Price</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.09(f)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Administrative Services Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.08(b)(ii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Aggregate Cap</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.02(c)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Aggregate Enrollees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.12(a)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Preamble</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Allocation Statement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.11(a)</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-11- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="87%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:19.10pt; font-size:8pt; font-family:Times New Roman"><B>Term</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Section</B></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Alternative Financing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.05(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Applicable RPPO Contract</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">1.01(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Applicable Service Area Reduction Option</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.12</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Applicable Termination Fee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">8.03(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Applicable Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">8.03(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Apportioned Obligations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.16(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Approved Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.05</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Assumed Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.03</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Assignment and Assumption Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.08(b)(iv)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Bankruptcy and Equity Exceptions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">3.02</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Cap</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.02(b)(iii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.07</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Closing Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.07(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Closing Payment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.08(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">CMS Sanction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">6.02(d)(iii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Confidentiality Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.06(b)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Damages</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.02(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">De Minimis Amount</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.02(b)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Debt Commitment Letter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">4.08(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Debt Financing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">4.08(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Direct Claim</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.05</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Disclosure Schedules</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Article&nbsp;4</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">e-mail</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">9.01</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">End Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">8.01(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Excluded Assets</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.02</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Excluded Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.04(h)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Extended Representations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.01</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Final Resolution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.12(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Final Service Area</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.12(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Humana</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Recitals</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Humana Acquisition</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Recitals</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Humana APA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">6.01(d)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Indemnified Party</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.04(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Indemnifying Party</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.04(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Lead Generation Budget</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.17(a)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Material Providers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">3.11(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Material Provider Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">3.11(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Medicare Advantage Contract Novations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.03(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Merger Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Recitals</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">MLR</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">1.01(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Monthly Membership Report</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.09(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">NDAs</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.01(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Notice of Disagreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.09(c)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Notice of True-Up Disagreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.12(b)(iii)</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-12- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="87%"></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:19.10pt; font-size:8pt; font-family:Times New Roman"><B>Term</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Section</B></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Novation Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.08(b)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Option</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.20(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Option Exercise Period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.20(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Original Service Area</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.12(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Overseeing Court</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.12(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Preamble</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">party</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Preamble</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Post-Closing 2017 Lead Generation Budget</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.18(a)(iii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Post-Closing Lead Generation Budget</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.17(a)(iii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Post-Closing Statement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.09(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Pre-Closing 2017 Lead Generation Budget</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.18(a)(ii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Pre-Closing Lead Generation Budget</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.17(a)(ii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Preferred Service Area List</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.12(a)(ii)(A)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Prepayment Amounts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.01(c)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Proposed Transaction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.03(d)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Purchase Price</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.09(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Purchase Price Calculation Period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.09(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Purchased Assets</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.01</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Purchaser</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Preamble</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Purchaser&#146;s Damages</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.10(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Purchaser Disclosure Schedules</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Article 4</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Purchaser Indemnified Persons</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.02(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Purchase Price Calculation Period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.09(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Purchaser&#146;s Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.10(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Purchaser True-Up Statement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.12(b)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Purchaser Warranty Breaches</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.03(a)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Qualifying Purchaser Warranty Breach</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.03(b)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Qualifying Seller Warranty Breach</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.02(b)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Regional Purchase Price</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.09(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Required Divestiture Enrollees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.12(a)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Required Regulatory Approval</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">6.01(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Required Period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.10(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Required Purchaser Permits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">4.06</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Respective Indemnified Persons</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.08</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Reviewing Consultant</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.22(a)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Seller</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Preamble</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Seller&#146;s CMS Sanction Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.10(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Seller Indemnified Persons</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.03(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Seller Marks</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.15(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Seller&#146;s Response Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.10(b)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Seller True-Up Statement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.12(b)(ii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Seller Warranty Breaches</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.02(a)(i)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Sensitive 2018 Bid Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.22(a)(iii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Tax Representations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.01</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-13- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="90%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:19.10pt; font-size:8pt; font-family:Times New Roman"><B>Term</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Section</B></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Taxing Authority</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">1.01(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Third-Party Claim</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.04(a)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Threshold</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7.02(b)(ii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Transfer Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.16(c)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Transitional Trademark License Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.08(b)(iii)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">True-Up Amount</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5.12(b)(i)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 1.02 <I>Other Definitional and Interpretative Provisions</I>.&nbsp;The following rules of
interpretation shall apply to this Agreement: (i)&nbsp;the words &#147;hereof&#148;, &#147;hereby&#148;, &#147;herein&#148; and &#147;hereunder&#148; and words of like import used in this Agreement shall refer to this Agreement as a whole and not to
any particular provision of this Agreement; (ii)&nbsp;the table of contents and captions in this Agreement are included for convenience of reference only and shall be ignored in the construction or interpretation hereof; (iii)&nbsp;references to
Articles, Sections, Schedules and Exhibits are to Articles, Sections, Schedules and Exhibits of this Agreement unless otherwise specified; (iv)&nbsp;all Exhibits and Schedules annexed to this Agreement or referred to in this Agreement, including the
Disclosure Schedules, are incorporated in and made a part of this Agreement as if set forth in full in this Agreement; (v)&nbsp;any capitalized term used in any Exhibit or the Disclosure Schedules but not otherwise defined therein shall have the
meaning set forth in this Agreement; (vi)&nbsp;any singular term in this Agreement shall be deemed to include the plural, and any plural term the singular, and references to any gender shall include all genders; (vii) whenever the words
&#147;include&#148;, &#147;includes&#148; or &#147;including&#148; are used in this Agreement, they shall be deemed to be followed by the words &#147;without limitation&#148;, whether or not they are in fact followed by those words or words of like
import; (viii) &#147;writing&#148;, &#147;written&#148; and comparable terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form; (ix)&nbsp;references to any applicable Law shall be deemed to
refer to such applicable Law as amended from time to time and to any rules or regulations promulgated thereunder; (x)&nbsp;references to any contract are to that contract as amended, modified or supplemented from time to time in accordance with the
terms thereof, and references to the portion of any contract that is split off or assigned in part hereunder are, after such split or assignment, solely to that portion of such contract, and not to the contract in its entirety prior to such split or
assignment in part thereof; (xi) references to any Person include the successors and permitted assigns of that Person; (xii) references &#147;from&#148; or &#147;through&#148; any date mean, unless otherwise specified, &#147;from and including&#148;
or &#147;through and including&#148;, respectively; (xiii) references to a &#147;day&#148; or &#147;days&#148; mean, unless otherwise specified, a calendar day or calendar days, respectively; (xiv)&nbsp;references to &#147;dollars&#148; and
&#147;$&#148; means U.S. dollars, and all payments to be made by either party hereunder shall be made in U.S. dollars, (xv) the term &#147;made available&#148; and words of similar import mean that the relevant documents, instruments or materials
were (A)&nbsp;posted and made available to the other party on the electronic data site maintained by the disclosing party in connection with the transactions contemplated hereby; or (B)&nbsp;provided by the disclosing party via e-mail or in person;
(xvi) the word &#147;extent&#148; in the phrase &#147;to the extent&#148; shall mean the degree to which a subject or other theory extends and such phrase shall not mean &#147;if&#148;; and (xvii) the parties have participated jointly in the
negotiation and drafting of this Agreement and, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the parties and no presumption or burden of proof shall arise favoring
or disfavoring any party by virtue of the authorship of any provision of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-14- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 2 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PURCHASE AND SALE OF ASSETS; ASSUMPTION OF CERTAIN LIABILITIES </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 2.01 <I>Sale and Purchase of Assets</I><I>.</I>&nbsp;Upon the terms and subject to the conditions set forth in this Agreement, on the
Closing Date and effective as of the Closing, Seller shall transfer, sell, convey, assign and deliver, or cause to be transferred, sold, conveyed, assigned and delivered, to Purchaser, and Purchaser shall purchase, acquire, assume and accept, or
cause one or more of its Subsidiaries to purchase, acquire, assume and accept, from Seller, free and clear of all Liens (other than Permitted Liens), all of Seller&#146;s and its Affiliates&#146; right, title and interest in and to only the
following assets and properties (collectively, the &#147;<B>Purchased Assets</B>&#148;): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <I><U>Contract Rights</U></I>.&nbsp;All
rights and interests under each Conveyed Medicare Advantage Contract to the extent arising or accruing from and after the Closing Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <I><U>Nondisclosure Agreements</U></I>. All rights and interests under each nondisclosure agreement that Seller has entered into prior to
the date hereof with a potential bidder relating to the Conveyed Medicare Advantage Contracts or the Existing Medicare Advantage Contracts (collectively, the &#147;<B>NDAs</B>&#148;) in each case in connection with the process for the sale of the
Conveyed Medicare Advantage Contracts; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <I><U>Prepayment and Other Amounts</U></I>.&nbsp;All premium receivables and rights to payment
of premiums from CMS or any other third parties arising or accruing under each Conveyed Medicare Advantage Contract to the extent relating to the period from and after the Closing Date, whether such amounts are paid before, on or after the Closing
Date (&#147;<B>Prepayment Amounts</B>&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <I><U>Books and Records</U></I>.&nbsp;Copies of all business and financial books,
records and data maintained by or on behalf of Seller and its Affiliates required or reasonably necessary to perform each Conveyed Medicare Advantage Contract, including (i)&nbsp;all such books and records reasonably required for Purchaser to
operate the Purchaser Medicare Advantage Plans in accordance with the Conveyed Medicare Advantage Contracts, applicable Laws, the requirements set forth in this Agreement and the requirements set forth in the Novation Agreement or any other
requirements imposed by any Governmental Authority in connection therewith, (ii)&nbsp;all such data reasonably required for Purchaser&#146;s Medicare star ratings filings or performance quality filings after the Closing Date, (iii)&nbsp;copies of
the applicable formulary if Seller&#146;s formulary will be utilized pursuant to the Administrative Services Agreement, (iv)&nbsp;a copy of the bid submitted by Seller to CMS for each Conveyed Medicare Advantage Contract, (v)&nbsp;copies of any
other material materials submitted by Seller to CMS in connection with any Conveyed Medicare Advantage Contract, (vi)&nbsp;lists of all the names, addresses, identification numbers, medical, claims and customer service history and care or chronic
disease management plans (to the maximum extent permissible under applicable Law) of Seller Enrollees who become Purchaser Enrollees; <I>provided</I> that (A)&nbsp;such books, records and data shall be provided to Purchaser only as permitted by
applicable Law and shall not include (1) any personally identifiable health records relating to former members or other natural persons who do not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-15- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
become Purchaser Enrollees except to the extent required in connection with clause (i)&nbsp;above and permitted by Law; or (2) any materials relating to proprietary policies or procedures of
Seller or any of its Affiliates; (B)&nbsp;Seller shall be permitted to retain copies of all such books, records and data, subject to Seller&#146;s confidentiality obligations and compliance with applicable Laws; and (C) Purchaser shall not be
entitled to have access to or copies of (1) any rebate or discount agreement or other contract or related documents relating to the provision of pharmaceutical coverage or products that are applicable to any Conveyed Medicare Advantage Contract or
(2) any broker or vendor agreements or compensation information related to unassigned Provider, Broker or vendor contracts and rates.&nbsp;To the extent that any books, records and data relate to one or more Conveyed Medicare Advantage Contracts,
Prepayment Amounts and/or NDAs but do not solely relate to the Conveyed Medicare Advantage Contracts,&nbsp;Prepayment Amounts and/or NDAs, Seller shall make available to Purchaser excerpts comprised of such sections of such books, records and data
that relate to the Conveyed Medicare Advantage Contracts, Prepayment Amounts and/or NDAs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 2.02 <I>Excluded
Assets</I><I>.</I>&nbsp;Notwithstanding anything herein to the contrary, Seller and its Affiliates shall retain, and there shall be excluded from the sale, transfer, conveyance, assignment and delivery of the Purchased Assets to Purchaser hereunder,
and the Purchased Assets shall not include, any assets of Seller or any of its Affiliates other than the Purchased Assets (collectively, the &#147;<B>Excluded Assets</B>&#148;).&nbsp;The Excluded Assets include (a)&nbsp;any contract between Seller
(or any of its Affiliates) and CMS other than the Conveyed Medicare Advantage Contracts (including, for the avoidance of doubt, (i) the split portion of each Existing Medicare Advantage Contract that is not a Conveyed Medicare Advantage Contract and
(ii) if applicable, the split portion of each 2017 Seller Medicare Advantage Contract that is not a Conveyed Medicare Advantage Contract) and (b)&nbsp;other than Prepayment Amounts, all rights arising under each Conveyed Medicare Advantage Contract
prior to the Closing Date, including any rights to payments of premiums or other amounts thereunder relating to the period prior to the Closing Date, whether such amounts are paid before, on or after the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 2.03 <I>Assumed Liabilities</I><I>.</I>&nbsp;Upon the terms and subject to the conditions set forth in this Agreement, on the Closing
Date and effective as of the Closing, Purchaser shall assume and discharge and perform, or cause one or more of its Subsidiaries to assume, discharge and perform, when due all Liabilities arising from or relating to (a)&nbsp;the Purchaser Medicare
Advantage Plans, including the provision of coverage or services to Purchaser Enrollees thereunder from and after the Closing Date, and any filings or reports submitted to CMS by Purchaser or any of its Affiliates from and after the Closing Date,
regardless of whether the data used to prepare such filings or reports include data provided by Seller or any of its Affiliates, (b)&nbsp;the performance of the Conveyed Medicare Advantage Contracts and NDAs from and after the Closing Date and
(c)&nbsp;Taxes in Post-Closing Tax Periods with respect to the Purchased Assets; <I>provided</I> that Liabilities for Transfer Taxes and Apportioned Obligations shall be allocated in the manner set forth in Section 5.16 (collectively, the
&#147;<B>Assumed Liabilities</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 2.04<I> Excluded Liabilities</I><I>.</I>&nbsp;Notwithstanding anything to the contrary
in this Agreement, except for the Assumed Liabilities, neither Purchaser nor any of its Affiliates shall assume hereunder, and in no event be deemed to have assumed, and Seller and its Affiliates shall retain, any and all Liabilities of Seller
and/or its Affiliates, including any Liabilities of Seller and/or its Affiliates arising from or relating to (a) the Existing Medicare Advantage Plans, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-16- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
including the provision of coverage or services to Seller Enrollees thereunder prior to the Closing Date, and any filings or reports submitted to CMS by Seller or any of its Affiliates prior to
the Closing Date, (b)&nbsp;the performance of the Existing Medicare Advantage Contracts, (c)&nbsp;if the Closing occurs after January&nbsp;1, 2017, (i)&nbsp;the 2017 Seller Medicare Advantage Plans, including the provision of coverage or services to
Seller Enrollees thereunder prior to the Closing Date, and any filings or reports submitted to CMS by Seller or any of its Affiliates prior to the Closing Date, (ii)&nbsp;if applicable, the performance by Seller of the 2017 Split Year Medicare
Advantage Contracts prior to the Closing Date and (iii) if the Closing occurs on or after the 2018 Medicare Advantage Contract Entry Date, the performance of the 2017 Seller Medicare Advantage Contracts, (d)&nbsp;all Taxes of Seller, including Taxes
resulting from the sale of Purchased Assets pursuant to this Agreement and Taxes of Seller in Pre-Closing Tax Periods with respect to the Purchased Assets; <I>provided</I> that Liabilities for Transfer Taxes and Apportioned Obligations shall be
allocated in the manner set forth in Section 5.16, (e)&nbsp;any breach by Seller of any of its obligations under the Existing Medicare Advantage Contracts, the 2017 Seller Medicare Advantage Contracts or the Conveyed Medicare Advantage Contracts
occurring prior to the Closing Date, or (f) a breach of any change of control provision set forth in any contract between Humana or any of its Subsidiaries and any material Provider that occurs as a result of the closing of the Humana Acquisition,
(g) relating to any Action filed with a Governmental Authority with respect to the Purchased Assets prior to the Closing Date, or&nbsp;(h)&nbsp;relating to the Excluded Assets (collectively, the &#147;<B>Excluded Liabilities</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 2.05 P<I>urchaser&#146;s Right to Assignment</I><I>.</I>&nbsp;For the avoidance of doubt, Purchaser shall have the right under this
Agreement to (a)&nbsp;purchase, acquire, take assignment and delivery of any and all of the Purchased Assets and assume, discharge and perform any of the Assumed Liabilities directly, or (b)&nbsp;cause one or more of its Subsidiaries, including the
Subsidiaries set forth on Section 2.05 of the Purchaser Disclosure Schedules (the &#147;<B>Approved Subsidiaries</B>&#148;), to purchase, acquire, take assignment of and receive all or any portion of the Purchased Assets and assume, discharge and
perform any of the Assumed Liabilities; <I>provided</I> that in no event shall Purchaser&#146;s election to cause one or more of its Subsidiaries to take any of the foregoing actions (i) relieve Purchaser of any of its obligations hereunder or
enlarge, alter or change any obligation of Seller to Purchaser under this Agreement or any other agreement executed in connection herewith or (ii) delay or prevent the Closing or consummation of the transactions contemplated by this Agreement or any
other agreement executed in connection herewith; <I>provided, however</I>, that it is acknowledged and agreed that Purchaser may cause one or more of the Approved Subsidiaries to purchase, acquire, take assignment of and receive all or any portion
of the Purchased Assets and assume, discharge and perform any of the Assumed Liabilities notwithstanding the restrictions set forth in clause (ii) above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 2.06 <I>Payments</I><B> </B><I>Intended for Other Party</I><I>.</I><B>&nbsp;</B>To the extent that, on or after the Closing Date,
Purchaser receives any payment constituting an Excluded Asset, Purchaser shall pay such amount to Seller. To the extent that, on or after the Closing Date, Seller receives any payment constituting a Purchased Asset, Seller shall pay such amount to
Purchaser. Any payment to be made pursuant to this Section 2.06 shall be made promptly and, if so requested by a receiving party, by wire transfer of immediately available funds to the account designated in writing by the receiving party to the
paying party. Each paying party shall provide written notice to the other party of any payment made pursuant to this Section 2.06 when such payment is made. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-17- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 2.07 <I>Closing</I>.&nbsp;The closing of the purchase and sale of the Purchased Assets
and the assumption of the Assumed Liabilities hereunder (the &#147;<B>Closing</B>&#148;) shall take place at the offices of Davis Polk &amp; Wardwell LLP, 450 Lexington Avenue, New York, New York 10017, (a)&nbsp;as soon as possible, but in no event
later than three Business Days, following satisfaction or, to the extent permissible, waiver of the conditions set forth in Article 6 by the party or parties entitled to the benefit thereof (other than those conditions that by their nature are to be
satisfied at the Closing, but subject to the satisfaction or, to the extent permissible, waiver of those conditions at the Closing) or (b)&nbsp;at such other time and/or place as may be mutually agreed upon by the parties (the date on which the
Closing occurs, the &#147;<B>Closing Date</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 2.08<I></I> <I>Closing Deliveries</I><I>.</I>&nbsp;At the Closing,
(a)&nbsp;Purchaser shall pay $7,549,105.70 (the &#147;<B>Closing Payment</B>&#148;) to Seller by wire transfer of immediately available funds to an account of Seller designated by Seller prior to Closing and (b)&nbsp;the parties or their respective
Affiliates, as applicable, shall enter into (i)&nbsp;unless Purchaser is entering into the Conveyed Medicare Advantage Contracts directly with CMS, a CMS Novation Agreement in the form required by CMS for the novation or assignment of the Conveyed
Medicare Advantage Contracts to Purchaser (the &#147;<B>Novation Agreement</B>&#148;), (ii)&nbsp;an Administrative Services Agreement substantially in the form attached hereto as <U>Schedule A</U> (the &#147;<B>Administrative Services
Agreement</B>&#148;), (iii)&nbsp;a Transitional Trademark License Agreement substantially in the form attached hereto as <U>Schedule B</U> (the &#147;<B>Transitional Trademark License Agreement</B>&#148;) and (iv) an Assignment and Assumption
Agreement substantially in the form attached hereto as <U>Schedule C</U> (the &#147;<B>Assignment and Assumption Agreement</B>&#148;).&nbsp;Notwithstanding the foregoing, the parties acknowledge and agree that if the form of Novation Agreement
required by CMS for the novation or assignment of the Conveyed Medicare Advantage Contracts contains terms and conditions that are not customarily found in a CMS novation agreement and such terms and conditions would result in any of the Conveyed
Medicare Advantage Contracts no longer constituting a &#147;Conveyed Medicare Advantage Contract&#148; as defined herein, the form of such Novation Agreement shall be subject to the prior approval of Seller and Purchaser, such approval not to be
unreasonably withheld, conditioned or delayed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 2.09<I></I> <I>Purchase Price Adjustment</I><I>.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Within 30 calendar days after Purchaser&#146;s receipt of the monthly membership roster issued by CMS in the second (2<SUP
STYLE="font-size:85%; vertical-align:top">nd</SUP>) month following the later of (x) the Enrollee Measurement Date and (y) the end of any Special Opt Out Period<B> </B>(such 30-calendar day period, the &#147;<B>Purchase Price Calculation
Period</B>&#148; and such<B> </B>monthly<B> </B>CMS membership roster, the &#147;<B>Monthly Membership Report</B>&#148;, which Purchase Price Calculation Period shall be extended for up to an additional 30 calendar days if Purchaser makes a written
request of Seller prior to the expiration of the initial Purchase Price Calculation Period reasonably documenting the reason for such extension), Purchaser shall deliver to Seller (i)&nbsp;a written statement (the &#147;<B>Post-Closing
Statement</B>&#148;) setting forth Purchaser&#146;s calculation of the Purchase Price, which shall be calculated based solely on the number of Purchaser Enrollees as of the first date that is on or after the later of the Enrollee Measurement Date
and the end of any Special Opt Out Period as shown on the Monthly Membership Report (and, for the avoidance of doubt, will not be based, in whole or in part, on any other information including any records of Seller, Purchaser or any other Person,
including CMS) and (ii)&nbsp;a copy of the Monthly Membership Report.&nbsp;For purposes of this Agreement, the following terms have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchase Price</B>&#148; means an amount in cash equal to the sum of all Regional Purchase Prices. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-18- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;<B>Regional Purchase Price</B>&#148; means, for each Region, an amount in cash equal to
the product of (i)&nbsp;the number of Purchaser Enrollees as of the first date that is on or after the later of the Enrollee Measurement Date and the end of any Special Opt Out Period as shown on the Monthly Membership Report who reside in such
Region as set forth on the Monthly Membership Report and (ii)&nbsp;the dollar amount per Enrollee set forth opposite the name of such Region on Section 2.09(a)&nbsp;of the Seller Disclosure Schedules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) If Purchaser fails to deliver the Post-Closing Statement and the Monthly Membership Report during the Purchase Price Calculation Period
(including any extension of the Purchase Price Calculation Period in accordance with Section 2.09(a)), Purchaser shall still be required to deliver to Seller the Monthly Membership Report in accordance with Section 2.09(a)&nbsp;and if such report is
not delivered, Purchaser authorizes Seller to request such report directly from CMS, and authorizes CMS to deliver such report directly to Seller, and, in such event, upon receipt of the Monthly Membership Report from Purchaser or CMS, as
applicable, Seller shall be entitled to calculate the Purchase Price based solely on the Monthly Membership Report, and such amount, as calculated by Seller, shall be final and binding upon Purchaser and Seller for all purposes of this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) If Purchaser delivers the Post-Closing Statement and the Monthly Membership Report during the Purchase Price Calculation Period
(including any extension of the Purchase Price Calculation Period in accordance with Section 2.09(a)) and Seller disagrees with Purchaser&#146;s calculation of the Purchase Price set forth on the Post-Closing Statement, Seller may, within 30
calendar days after receipt of the Post-Closing Statement, deliver a notice (a &#147;<B>Notice of Disagreement</B>&#148;) to Purchaser which notice shall describe the nature of any such disagreement in reasonable detail, identify the specific items
involved, and specify Seller&#146;s calculation of the Purchase Price.&nbsp;If Seller delivers to Purchaser a notice accepting the Post-Closing Statement, or does not timely deliver any Notice of Disagreement, Seller shall be deemed to have agreed
with all items and amounts contained in the Post-Closing Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) If Seller timely delivers a Notice of Disagreement, Purchaser and
Seller shall, during the 30 calendar days after delivery thereof, use their respective Commercially Reasonable Efforts to reach agreement on the disputed matters in order to determine the Purchase Price.&nbsp;If Purchaser and Seller are unable to
reach agreement as to the Purchase Price during such 30-calendar day period, then either party may bring an Action to determine the Purchase Price in the courts provided for by Section 9.07. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) If the Adjusted Purchase Price is greater than the Closing Payment, then Purchaser shall pay the amount of such difference to Seller, by
wire transfer of immediately available funds to an account specified by Seller prior to such payment.&nbsp;If the Adjusted Purchase Price is less than the Closing Payment, Seller shall pay the amount of such difference to Purchaser, by wire transfer
of immediately available funds to an account specified by Purchaser.&nbsp;The payment required to be made by Purchaser or Seller, as applicable, pursuant to the immediately preceding sentences will be made within three Business Days of the
determination of the Adjusted Purchase Price. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-19- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) &#147;<B>Adjusted Purchase Price</B>&#148; means (i)&nbsp;if Purchaser does not deliver the
Post-Closing Statement and the Monthly Membership Report during the Purchase Price Calculation Period (including any extension of the Purchase Price Calculation Period in accordance with Section 2.09(a)), Seller&#146;s calculation of the Purchase
Price pursuant to Section 2.09(b); (ii)&nbsp;if Purchaser delivers the Post-Closing Statement and the Monthly Membership Report during the Purchase Price Calculation Period (including any extension of the Purchase Price Calculation Period in
accordance with Section 2.09(a)), and Seller does not deliver any Notice of Disagreement within 30 calendar days after receipt of the Post-Closing Statement or Seller delivers a notice accepting the Post-Closing Statement, Purchaser&#146;s
calculation of the Purchase Price set forth on the Post-Closing Statement; or (iii)&nbsp;if Seller does deliver a Notice of Disagreement within 30 calendar days after receipt of the Post-Closing Statement, (A)&nbsp;the Purchase Price as agreed by
Purchaser and Seller pursuant to Section 2.09(d)&nbsp;or (B)&nbsp;in the absence of such agreement, the Purchase Price as determined in any Action brought by either party pursuant to Section 2.09(d)&nbsp;and Section 9.07; <I>provided</I> that in no
event shall the Adjusted Purchase Price be more than Seller&#146;s calculation of the Purchase Price set forth in the Notice of Disagreement or less than Purchaser&#146;s calculation of the Purchase Price set forth in the Post-Closing Statement.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 2.10 <I>Additional Adjustment to Purchase Price</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Between the date hereof until the Closing Date, in the event that a CMS Sanction is imposed on Seller that individually or in the aggregate
with any and all other CMS Sanctions imposed on Seller between the date hereof and the Closing Date has a material adverse effect on Seller&#146;s ability to provide the services under the Administrative Services Agreement, Seller shall provide
prompt written notice to Purchaser of such CMS Sanction along with a reasonably detailed explanation of the impact that the CMS Sanction will have on Seller&#146;s ability to provide the services under the Administrative Services Agreement
(&#147;<B>Seller</B><B>&#146;</B><B>s CMS Sanction Notice</B>&#148;).</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) During the 30 calendar days after the delivery of Seller&#146;s
CMS Sanction Notice, Purchaser and Seller shall use their respective Commercially Reasonable Efforts to reach agreement on the Damages that the CMS Sanction will have on Purchaser&#146;s performance and operation of the Conveyed Medicare Advantage
Contracts after the Closing (it being understood and agreed that, among other things, the impact (and the reasonably expected impact) of any remediation or other offsetting actions that Seller or any of its Affiliates undertakes or has taken shall
be taken into account in determining the Damages that the CMS Sanction will have on Purchaser&#146;s performance and operation of the Conveyed Medicare Advantage Contracts after the Closing; <I>provided, however</I>, that in the event Seller and/or
any of its Affiliates has determined to undertake any remediation or other offsetting actions pursuant to this Section 2.10(b), then Seller shall covenant and agree in writing to Purchaser to promptly perform or cause to be performed such actions;
and <I>provided, further</I>, that in no event shall such Damages be deemed to be greater than the Adjusted Purchase Price for purposes of this Section 2.10) (such Damages, the &#147;<B>Purchaser</B><B>&#146;</B><B>s
Damages</B>&#148;).&nbsp;Purchaser shall, within such 30-calendar day period, deliver written notice to Seller, specifying Purchaser&#146;s reasonable good faith determination of the Purchaser&#146;s Damages (the
&#147;<B>Purchaser</B><B>&#146;</B><B>s Notice</B>&#148;) along with reasonable detail supporting such determination.&nbsp;If Purchaser timely delivers the Purchaser&#146;s Notice within such 30-day period and Seller disagrees with Purchaser&#146;s
determination of the Purchaser&#146;s Damages, Seller may, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-20- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
within 10 calendar days after receiving the Purchaser&#146;s Notice, deliver a notice (the &#147;<B>Seller&#146;s Response Notice</B>&#148;) to Purchaser, which notice shall describe the nature
of such disagreement in reasonable detail, specifying Seller&#146;s reasonable good faith determination of the Purchaser&#146;s Damages and identifying any specific item(s) of dispute. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) If the greater of the two calculations of the Purchaser&#146;s Damages set forth in each of the Purchaser&#146;s Notice and the
Seller&#146;s Response Notice is less than twenty percent (20%) greater than the lesser of such two calculations, then the Purchaser&#146;s Damages shall be the average of the two calculations of the Purchaser&#146;s Damages set forth in the
Purchaser&#146;s Notice and the Seller&#146;s Response Notice.&nbsp;If the greater of the two calculations of the Purchaser&#146;s Damages set forth in the Purchaser&#146;s Notice and the Seller&#146;s Response Notice is equal to or more than twenty
percent (20%) greater than the lesser of such two calculations, then either party may thereafter upon notice to the other party cause a Neutral Arbitrator to promptly review this Agreement and the disputed matters for purposes of determining the
Purchaser&#146;s Damages. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) If the parties submit the dispute to the Neutral Arbitrator, then in making its calculation of the
Purchaser&#146;s Damages, the Neutral Arbitrator shall (i) be bound by the terms of this Agreement, including the terms of this Section 2.10, (ii) consider only the disputed matters, and (iii) determine the value of the Purchaser&#146;s Damages by
choosing either the calculation of Purchaser&#146;s Damages set forth on the Purchaser&#146;s Notice or the calculation of Purchaser&#146;s Damages set forth on the Seller&#146;s Response Notice. The Neutral Arbitrator&#146;s determination of the
Purchaser&#146;s Damages shall be based solely on written materials, presentations and arguments submitted and/or made by Purchaser and Seller (i.e., shall not be based on an independent review).&nbsp;The Neutral Arbitrator shall deliver to
Purchaser and Seller, as promptly as practicable, a written report setting forth its determination of the Purchaser&#146;s Damages.&nbsp;Such Neutral Arbitrator&#146;s report shall be final and binding upon Purchaser and Seller for all purposes of
this Agreement.&nbsp;The fees and expenses of the Neutral Arbitrator shall be paid by the party whose calculation of the Purchaser&#146;s Damages that the Arbitrator did not choose.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) The parties agree that the Adjusted Purchase Price shall be reduced by the amount of any Purchaser&#146;s Damages as finally determined in
accordance with Section 2.10(c) and Section 2.10(d), but not below zero.&nbsp;Further, in the event that final determination of the Purchaser&#146;s Damages is not made until a date following the determination of the Adjusted Purchase Price, Seller
shall promptly (and in any event not more than 30 days after the date of final determination made in accordance with Section 2.10(c) or Section 2.10(d)) deliver the amount of the Purchaser&#146;s Damages to Purchaser by wire transfer of immediately
available funds to the account designated in writing by Purchaser.&nbsp;Purchaser may also elect in writing to offset the amount of any Purchaser&#146;s Damages as finally determined in accordance with Section 2.10(c) and Section 2.10(d) in whole or
in part against any amounts payable by Purchaser under the Administrative Services Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 2.11 <I>Allocation of Purchase
Price.</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) As promptly as practicable after the Purchase Price (as adjusted pursuant to Section 2.09, Section 2.10 and Section 2.12)
is finally determined, but not later than 45 days thereafter, Purchaser shall deliver to Seller a statement (the &#147;<B>Allocation Statement</B>&#148;), allocating the Purchase Price (plus Assumed Liabilities, to the extent properly taken into
account under </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-21- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Section&nbsp;1060 of the Code) among the Purchased Assets in accordance with Section 1060 of the Code.&nbsp;If, within 10 days after the delivery of the Allocation Statement, Seller notifies
Purchaser in writing that Purchaser objects to the allocation set forth in the Allocation Statement, Purchaser and Seller shall use Commercially Reasonable Efforts to resolve such dispute within 20 days.&nbsp;In the event that Purchaser and Seller
are unable to resolve such dispute within 20 days, Purchaser and Seller shall jointly retain an independent certified public accounting firm of nationally recognized standing (other than any such firm that audited the financial statements of
Purchaser or Seller or any Affiliate of either within the three calendar years before such retention) reasonably satisfactory to Purchaser and Seller to determine the appropriate allocation of the disputed items.&nbsp;Upon allocation of the disputed
items by such independent accounting firm, the allocation reflected on the Allocation Statement shall be adjusted accordingly, and such adjusted Allocation Statement shall be the Allocation Statement for all purposes of this Agreement.&nbsp;The
costs, fees and expenses of the independent accounting firm shall be borne equally by Purchaser and Seller. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Each of Seller and
Purchaser agrees, except as required by a Final Determination, to (i)&nbsp;be bound by the Allocation Statement for Tax purposes and (ii)&nbsp;act in accordance with the Allocation Statement in the preparation, filing and audit of any Tax Return
(including filing Form 8594 with its federal income Tax Return for the taxable year that includes the Closing Date). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Not later than
30 days prior to the filing of their respective Forms 8594 relating to the transactions contemplated hereby, each party shall deliver to the other party a copy of its Form 8594. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 2.12 <I>Reduction in Applicable Service Area</I>.&nbsp;(a)&nbsp;Notwithstanding anything to the contrary contained herein, if the
Humana Acquisition Litigation is finally and non-appealably resolved (including by settlement) prior to the Closing, or is resolved and such resolution has not yet been appealed prior to the Closing, and Seller is required pursuant to or in
connection with such resolution (whether by DOJ, the U.S. District Court overseeing the Humana Acquisition Litigation (the &#147;<B>Overseeing Court</B>&#148;) or otherwise) (such resolution, the &#147;<B>Final Resolution</B>&#148;) to divest to
Purchaser individual Medicare Advantage plan Contracts covering fewer states and/or counties than are included in the Applicable Service Area as of the date hereof (the &#147;<B>Original Service Area</B>&#148;) in order to consummate the Humana
Acquisition, then Seller shall have the option (the &#147;<B>Applicable Service Area Reduction Option</B>&#148;), in Seller&#146;s sole discretion, exercisable by written notice to Purchaser prior to the Closing Date, to amend Sections 1.01(a)(iv)
and 1.01(a)(v) of the Seller Disclosure Schedules to remove certain states and/or counties in which Seller is not required to make divestitures from the Applicable Service Area (such amended Applicable Service Area, the&nbsp;&#148;<B>Final Service
Area</B>&#148;) in accordance with the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Seller shall have the right to remove any and all counties and/or
states in which Seller is not required to make divestitures pursuant to the Final Resolution so long as the total number of all Applicable Seller Enrollees together with any &#147;Applicable Seller Enrollees&#148; as defined in the Humana APA
(collectively, the &#147;<B>Required Divestiture Enrollees</B>&#148;) is at least one hundred seventy five thousand (175,000). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-22- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) In the event that the total number of Required Divestiture Enrollees is less
than one hundred seventy five thousand (175,000), then the Final Service Area shall include the Divested Service Area and additional counties from the Original Service Area (collectively, the &#147;<B>Additional Service Area</B>&#148;) as follows:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(A) Section 2.12(a)(ii) of the Purchaser Disclosure Schedules sets forth the states within the Original Service Area
sequentially arranged in order of Purchaser&#146;s priority (the &#147;<B>Preferred Service Area List</B>&#148;); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(B)
beginning with the first state on the Preferred Service Area List, if the Divested Service Area includes any county within such state, then starting from the largest such county, each county that is (i) closest (and thereafter, next closest) in
proximity to such county within such state and (ii) included in the Original Service Area, shall be included in the Final Service Area until the total number of Required Divestiture Enrollees, together with the total number of all Additional Seller
Enrollees and any &#147;Additional Seller Enrollees&#148; as defined in the Humana APA (collectively, the &#147;<B>Aggregate Enrollees</B>&#148;), is at least one hundred seventy five thousand (175,000); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(C) in the event the Aggregate Enrollees do not equal at least one hundred seventy five thousand (175,000) following the
process set forth in Section 2.12(a)(ii)(B) above, such process shall be repeated for each state in which any county is included in the Divested Service Area and counties within such state in the priority set forth on the Preferred Service Area List
until the total number of Aggregate Enrollees is at least one hundred seventy five thousand (175,000); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(D) in the event
the Aggregate Enrollees do not equal at least one hundred seventy five thousand (175,000) following the process set forth in Section 2.12(a)(ii)(C) above, such process shall be repeated with respect to any states and counties within such states that
are included in the Original Service Area but which are not included in the Divested Services Area in the priority set forth on the Preferred Service Area List and otherwise as reasonably agreed by the parties until the total number of Aggregate
Enrollees is at least one hundred seventy five thousand (175,000); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(E) thereafter, Seller shall have the right, at
its sole discretion, to remove any remaining counties and/or states from the Final Service Area. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) For the avoidance of doubt, no
Seller Enrollees covered by the Applicable RPPO Contract shall be included in the Aggregate Enrollees for purposes of meeting the threshold required in Section 2.12(a)(ii).&nbsp;Additionally, if Seller exercises the Applicable Service Area Reduction
Option, from and after the exercise thereof, among other consequences </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-23- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
hereunder, the Applicable Service Area shall be limited to the smaller number of states and/or counties on Sections 1.01(a)(iv) and 1.01(a)(v) of the Seller Disclosure Schedules as amended
pursuant to the Applicable Service Area Reduction Option, the Conveyed Medicare Advantage Contracts shall be limited to individual Medicare Advantage plan Contracts covering such smaller number of states and/or counties and the Seller Enrollees and
Purchaser Enrollees shall be limited to natural persons who reside in such smaller number of states and/or counties, in each case for all purposes of this Agreement, including the determination of the scope of the Purchased Assets and the amount of
the Purchase Price hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) If Seller exercises the Applicable Service Area Reduction Option, and the Final Service Area includes
any Additional Service Area pursuant to Section 2.12(a)(ii), then, upon the terms and subject to the conditions set forth in this Agreement, each party shall, and shall cause its Affiliates to, use best efforts to consummate the closing of the
purchase and sale of the Purchased Assets and the assumption of the Assumed Liabilities with respect to the Divested Service Area hereunder as promptly as practicable, without delay due to the inclusion of the Additional Service Area in the Final
Service Area pursuant to Section 2.12(a)(ii) (including, if necessary or advisable, by means of an initial closing with respect to the Divested Service Area hereunder and a subsequent closing with respect to the Additional Service Area hereunder).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) If Seller is required pursuant to or in connection with the Final Resolution to divest individual Medicare Advantage plan Contracts
covering states and/or counties outside of the Original Service Area, and Purchaser agrees in writing to purchase such Contracts, Purchaser acknowledges and agrees that natural persons who reside (as defined by applicable Law) in such states and/or
counties and are enrolled in a Medicare Advantage plan offered by Seller or any of its Affiliates directly to individuals in such state and/or counties pursuant to any such Contract shall count towards the threshold required in Section 2.12(a)(ii),
as if such persons were &#147;Aggregate Enrollees&#148; hereunder, and the impact of counting such persons in such manner on the operation of Section 2.12(a)(ii) shall be as reasonably agreed by the parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 2.13 <I>Regional PPO</I>.&nbsp;Notwithstanding anything herein to the contrary, Seller shall have the option, exercisable by written
notice to Purchaser for any reason at any time prior to the Closing, not to sell to Purchaser pursuant hereto the Applicable RPPO Contract (or any portion thereof, including on a county-by-county basis), and if Seller exercises such option, the
Applicable RPPO Contract (or the applicable portion(s) thereof) shall cease to be a &#147;Conveyed Medicare Advantage Contract&#148; for all purposes of this Agreement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 3 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REPRESENTATIONS AND
WARRANTIES OF SELLER </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to Section 9.04, except as set forth in the Seller Disclosure Schedules, Seller represents and warrants to
Purchaser as of the date hereof and as of the Closing Date as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.01 <I>Corporate Existence and
Power</I><I>.</I>&nbsp;(a)&nbsp;Seller has been duly incorporated and remains validly subsisting as a corporation under the laws of the Commonwealth of Pennsylvania.&nbsp;Seller has all corporate powers and authority required to own or lease all of
its properties or assets and to carry on its business as now conducted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-24- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Seller is in good standing in the Commonwealth of Pennsylvania and is duly qualified to do
business and in good standing in each other jurisdiction where such qualification is necessary, except for those jurisdictions where failure to be so qualified would not be material to the Conveyed Medicare Advantage Contracts taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Section 3.01(c) of the Seller Disclosure Schedules sets forth each material joint venture or similar agreement as of the date hereof
between Seller or any of its Affiliates and any Provider that relates to a Conveyed Medicare Advantage Contract and which Provider is (i) directly or indirectly controlling, controlled by, or under common control with Seller, or (ii) for which
securities or other equity ownership interests having ordinary voting power to elect a majority of the board of directors or other persons performing similar functions of such Provider are directly or indirectly owned by Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.02 <I>Corporate Authorization</I>.&nbsp;The execution, delivery and performance by Seller of this Agreement and each of the other
Transaction Documents and the consummation by Seller of the transactions contemplated by this Agreement and each of the other Transaction Documents are within the corporate powers and authority of Seller and have been duly authorized by all
necessary corporate action on the part of Seller.&nbsp;This Agreement has been, and upon its execution and delivery each of the other Transaction Documents will have been, duly executed and delivered by Seller and (assuming due authorization,
execution and delivery by the other parties hereto and thereto) this Agreement constitutes, and upon its execution and delivery each of the other Transaction Documents will constitute, a legal, valid and binding agreement of Seller enforceable
against Seller in accordance with its respective terms (subject to applicable bankruptcy, insolvency, reorganization, moratorium and similar Laws affecting creditors&#146; rights and remedies generally, and subject, as to enforceability, to general
principles of equity (regardless of whether enforcement is sought in a proceeding at law or in equity) (the &#147;<B>Bankruptcy and Equity Exceptions</B>&#148;)). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.03 <I>Governmental Authorization</I>.&nbsp;The execution, delivery and performance by Seller of this Agreement and each of the other
Transaction Documents and the consummation by Seller of the transactions contemplated hereby and thereby require no actions by or in respect of, Consents of, or Filings with, any Governmental Authority, other than (a)&nbsp;compliance with any
applicable requirements of the 1934 Act and any other applicable U.S. state or federal securities Laws or pursuant to the rules of the New York Stock Exchange, (b)&nbsp;the Consents of, and Filings with, the Governmental Authorities listed on
Section 3.03(b) of the Seller Disclosure Schedules, including the Consents of, and Filings with, the state insurance departments, federal and state departments of health and other Consents and Filings required under Health Care Laws or insurance
laws listed thereon and (c)&nbsp;any other such actions, Consents or Filings (i) required solely by reason of the participation of Purchaser or any of its Affiliates in the transactions contemplated hereby or (ii) the absence of which would not be
material to the Conveyed Medicare Advantage Contracts, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.04 <I>Non-Contravention</I>.&nbsp;The execution,
delivery and performance by Seller of this Agreement and the Transaction Documents, and the consummation of the transactions contemplated hereby and thereby, do not and will not (a)&nbsp;contravene, conflict with, or result in any violation or
breach of any provision of Seller&#146;s organizational documents, (b)&nbsp;assuming compliance with the matters referred to in Section 3.03, materially contravene, materially </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-25- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conflict with or result in any material violation or material breach of any provision of any applicable Law, (c)&nbsp;assuming compliance with the matters referred to in Section 3.03, require any
material Consent or other material action by any Person under, constitute a material default, or an event that, with or without notice or lapse of time or both, would constitute a material default, under, or cause or permit the termination,
cancellation, acceleration or other material change of any material right or obligation or the loss of any material benefit to which Seller or any of its Affiliates is entitled under, any provision of the Existing Medicare Advantage Contracts, the
2017 Seller Medicare Advantage Contracts or the Conveyed Medicare Advantage Contracts, or (d)&nbsp;result in the creation or imposition of any Lien (other than Permitted Liens) on any of the Purchased Assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.05 <I>Absence of Certain Changes</I>.&nbsp;Since January&nbsp;1, 2016, (a)&nbsp;the Existing Medicare Advantage Plans have been, and
if the Closing occurs after January&nbsp;1, 2017, the 2017 Seller Medicare Advantage Plans will have been, operated in all material respects in the ordinary course of business consistent with past practices and in compliance with all Laws in all
material respects; and (b)&nbsp;there has not been: (i)&nbsp;any cancellation, termination or, to the knowledge of Seller, threatened in writing cancellation or termination, or receipt of any written notice of termination or cancellation of any
Existing Medicare Advantage Contracts, the 2017 Seller Medicare Advantage Contracts or the Conveyed Medicare Advantage Contracts; (ii) any settlement or agreement to settle any material Action related to the Purchased Assets to which Seller is a
party; (iii)&nbsp;any event, circumstance, development or change which, individually or together with other such events, changes, developments or effects, has had, or would have a material adverse effect on the Conveyed Medicare Advantage Contracts
individually or in the aggregate; and (iv)&nbsp;any material change by Seller of its accounting or actuarial methods, principles or practices solely with respect to the Existing Medicare Advantage Plans, or if the Closing occurs after
January&nbsp;1, 2017, the 2017 Seller Medicare Advantage Plans, in each case, other than as required by changes in applicable Law, United States generally accepted accounting principles and/or applicable statutory accounting principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.06 <I>Litigation</I>.&nbsp;There is no material Action pending or, to the knowledge of Seller, any material investigation pending or
threatened in writing against Seller or its Affiliates with respect to or affecting the Existing Medicare Advantage Plans or the 2017 Seller Medicare Advantage Plans, before (or, in the case of threatened Actions, that would be before) any
arbitrator or Governmental Authority.&nbsp;There is no Action pending, or to the knowledge of Seller, threatened, against Seller or its Affiliates (i)&nbsp;that seeks damages or other relief in connection with the transactions contemplated by this
Agreement, or (ii)&nbsp;that would reasonably be expected to prevent, enjoin, alter, materially delay, make illegal, impose limits or conditions on or otherwise materially interfere with any of the transactions contemplated by this
Agreement.&nbsp;There is no material Order outstanding or threatened in writing against or affecting the Existing Medicare Advantage Plans or the 2017 Seller Medicare Advantage Plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.07 <I>Title to Purchased Assets</I>.&nbsp;Seller or one or more of its Affiliates will at the Closing assign or convey as applicable
to Purchaser or any Affiliates of Purchaser designated by Purchaser, good title to all of the Purchased Assets free and clear of all Liens except Permitted Liens. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-26- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.08 <I>Books and Records</I>.&nbsp;The books and records that constitute Purchased
Assets have been prepared and maintained in good faith and consistently with Seller&#146;s practice for maintaining books and records in its Medicare Advantage business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.09 <I>Compliance with Applicable Laws</I>.&nbsp;(a)&nbsp;The Existing Medicare Advantage Plans are, and since January&nbsp;1, 2014
have been, in compliance with all applicable Laws in all material respects, including applicable Health Care Laws.&nbsp;If the Closing occurs after January&nbsp;1, 2017, the 2017 Seller Medicare Advantage Plans will since January&nbsp;1, 2017 have
been in compliance with all applicable Laws in all material respects, including applicable Health Care Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1,
2014, neither Seller nor any of its Affiliates has entered into any agreement or settlement (including any corrective action plan, corporate integrity agreement or corporate compliance agreement) with any Governmental Authority with respect to any
Existing Medicare Advantage Plan and, if the Closing occurs after January&nbsp;1, 2017, with respect to any 2017 Seller Medicare Advantage Plan, with respect to any actual or alleged violation of any applicable Law, except for agreements and
settlements that would not be material to the Conveyed Medicare Advantage Contracts, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Since January&nbsp;1, 2014,
neither Seller nor any of its Affiliates has been subject to CMS&#146;s imposition of, or has received any written correspondence from CMS threatening the imposition of, sanctions on Seller or any of its Affiliates in relation to any Existing
Medicare Advantage Plans or, if the Closing occurs after January&nbsp;1, 2017, any 2017 Seller Medicare Advantage Plans, as applicable, in each case, except as would not reasonably be expected to be material to the Conveyed Medicare Advantage
Contracts, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) Since January&nbsp;1, 2014, neither Seller nor any of its Affiliates has been subject to any
Governmental Authority&#146;s (other than CMS) imposition of, or has received any written correspondence from any Governmental Authority (other than CMS) threatening the imposition of, sanctions on Seller or any of its Affiliates in relation to the
operation of any Existing Medicare Advantage Plan or, if the Closing occurs after January&nbsp;1, 2017, any 2017 Seller Medicare Advantage Plan, as applicable, in each case except as would not be material to the Conveyed Medicare Advantage
Contracts, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) Since January&nbsp;1, 2014, all material Filings with Governmental Authorities (including Filings with
respect to premium rates, rating plans, policy terms and other terms established or used by the Existing Medicare Advantage Plans) with respect to any Existing Medicare Advantage Plan and, if the Closing occurs after January&nbsp;1, 2017, with
respect to any 2017 Seller Medicare Advantage Plan, together with any material amendments with respect thereto, in each case that were required to be filed with any Governmental Authority, including CMS, state insurance departments, state
departments of health, other applicable state authorities, and any other agencies with jurisdiction over the Existing Medicare Advantage Plans and the 2017 Seller Medicare Advantage Plans, if applicable, and including material Filings that were
required to be filed under the Patient Protection and Affordable Care Act (Pub. L. 111-148) as amended by the Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152), have been made and were true and correct in all material respects
when made. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-27- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) Since January&nbsp;1, 2014, except as would not be material to the Conveyed Medicare
Advantage Contracts, taken as a whole, none of Seller or any of its Affiliates has been or is currently suspended, excluded or debarred from contracting with the federal or any state government or from participating in any state or federally funded
healthcare program nor has Seller or any of its Affiliates received any written notice threatening such suspension, exclusion or debarment.&nbsp;As of the date hereof, to the knowledge of Seller, Seller is not aware of any reason or basis with
respect to Seller or any of its Affiliates on which CMS or any other applicable Governmental Authority reasonably would be expected to refuse to grant any consent or novation with respect to the transfer to Purchaser of the Purchased Assets by
Seller or any of its Affiliates, other than any such reason or basis solely relating to the Humana Acquisition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) Since January&nbsp;1,
2014, except as would not be material to the Conveyed Medicare Advantage Contracts, taken as a whole, Seller has had a program to prevent and detect violations of legal requirements applicable to the Existing Medicare Advantage Plans and, if the
Closing occurs after January&nbsp;1, 2017, the 2017 Seller Medicare Advantage Plans, and such program has, at all times, complied with (i)&nbsp;the provisions of the U.S. Sentencing Guidelines relating to corporate compliance programs, and
(ii)&nbsp;the applicable model compliance plans issued by the U.S. Department of Health and Human Services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.10 <I>Conveyed
Medicare Advantage Contracts</I>.&nbsp;Prior to the date hereof, Seller has delivered to Purchaser a true and correct copy of each Existing Medicare Advantage Contract (<I>provided</I> that such copies may be redacted so as to omit provisions
thereof not related to the Existing Medicare Advantage Plans in the Applicable Service Area).&nbsp;Each of the Existing Medicare Advantage Contracts is, and if the Closing occurs after January&nbsp;1, 2017, each of the 2017 Seller Medicare Advantage
Contracts and the Conveyed Medicare Advantage Contracts will be, a legal, valid and binding obligation of Seller or its applicable Affiliate (as the case may be) and, to the knowledge of Seller, CMS, and is or will be, as applicable, in full force
and effect and enforceable in accordance with its terms against Seller or its applicable Affiliate (as the case may be) and, to the knowledge of Seller, CMS, except where the failure of an Existing Medicare Advantage Contract, 2017 Seller Medicare
Advantage Contract or Conveyed Medicare Advantage Contract, as applicable, to be a valid and binding obligation and in full force and effect and enforceable would not reasonably be expected to be material to the Conveyed Medicare Advantage
Contracts, taken as a whole (provided that, notwithstanding anything to the contrary contained herein, if any or all of the Conveyed Medicare Advantage Contracts are new contracts entered into directly by Purchaser, such Conveyed Medicare Advantage
Contracts will not be a valid and binding obligation of Seller or its applicable Affiliate (as the case may be) and will not be enforceable in accordance with its terms against Seller or its applicable Affiliate (as the case may be)).&nbsp;To the
knowledge of Seller, CMS is not seeking to terminate, cancel or challenging the validity or enforceability of any Existing Medicare Advantage Contract or, if the Closing occurs after January&nbsp;1, 2017, any 2017 Seller Medicare Advantage Contract
or Conveyed Medicare Advantage Contract, and neither Seller nor any of its Affiliates has received any written communication from CMS relating to any such potential termination, cancellation or challenge.&nbsp;Neither Seller nor any of its
Affiliates, nor, to the knowledge of Seller, CMS has materially violated any provision of, or committed or failed to perform any act which (with or without notice, lapse of time or both) would constitute a material default under any provision of any
Existing Medicare Advantage Contract or, if the Closing occurs after January&nbsp;1, 2017, any 2017 Seller Medicare Advantage Contract or Conveyed Medicare Advantage Contract.&nbsp;Neither </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-28- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Seller nor any of its Affiliates has received written notice from CMS that it has violated or defaulted, in each case, in any material respect, under any Existing Medicare Advantage Contract or,
if the Closing occurs after January&nbsp;1, 2017, any 2017 Seller Medicare Advantage Contract or Conveyed Medicare Advantage Contract.&nbsp;Except as would not be material to the Conveyed Medicare Advantage Contracts, taken as a whole, Seller has
maintained all records required to be maintained by applicable Laws with respect to the Conveyed Medicare Advantage Contracts. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section
3.11 <I>Material Provider Contracts</I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Except as would not be material to the Conveyed Medicare Advantage Contracts, taken as a
whole, Section 3.11(a)&nbsp;of the Seller Disclosure Schedules sets forth a true and complete list as of the date hereof of the following Providers (collectively, &#147;<B>Material Providers</B>&#148;, and contracts between Seller or any of its
Affiliates and any of such Material Providers, &#147;<B>Material Provider Contracts</B>&#148;) in each state within the Applicable Service Area:&nbsp;(i)&nbsp;the top 20 hospitals, based on the total of all hospital payments made by Seller and its
Affiliates in respect of Seller Enrollees during the period from January 1, 2015 through May 31, 2016 in such state; (ii)&nbsp;the top 50&nbsp;physician practices (i.e., individual physicians and physician groups) based on the total of all physician
payments made by Seller and its Affiliates in respect of Seller Enrollees during the period from January 1, 2015 through May 31, 2016 in such state; and (iii)&nbsp;the top 20 Providers that (A) are not hospitals or physician practices, based on the
total of all Provider payments made by Seller and its Affiliates in respect of Seller Enrollees during the period from January 1, 2015 through May 31, 2016 in such state and (B) received payments in excess of $100,000 during such
period.&nbsp;Section 3.11(a)&nbsp;of the Seller Disclosure Schedules also identifies any Material Providers that provide services on an exclusive basis as of the date hereof.&nbsp;All Material Provider Contracts comply in all material respects with
the requirements of applicable Law, except as would not be material to the Conveyed Medicare Advantage Contracts, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)
Seller has made available to Purchaser a true and correct copy of the contracts of the top five (5) hospitals and the top five (5) physician practices based on the total of all payments made by Seller and its Affiliates in respect of Seller
Enrollees during 2015 for each state within the Applicable Service Area, including all amendments, modifications, side letters, supplements, renewals, extensions and guarantees currently in effect and related thereto.&nbsp;As of the date hereof,
each of the Material Provider Contracts is a legal, valid and binding obligation of Seller or its applicable Affiliate (as the case may be) and, to the knowledge of Seller, is in full force and effect in all material respects (subject to the
Bankruptcy and Equity Exceptions), except as would not be material to the Conveyed Medicare Advantage Contracts, taken as a whole.&nbsp;To the knowledge of Seller, as of the date hereof, there is no event which with the giving of notice or the
passage of time or both would constitute a material default, or material modification, or acceleration of any material rights or obligations, under any Material Provider Contract; and, to the knowledge of Seller, as of the date hereof, no other
party to any Material Provider Contract has repudiated any material provision of such Material Provider Contract, in each case, except as would not be material to the Conveyed Medicare Advantage Contracts, taken as a whole.&nbsp;As of the date
hereof, Seller has performed its obligations in all material respects under each Material Provider Contract.&nbsp;Except as would not be material to the Conveyed Medicare Advantage Contracts, taken as a whole, Seller has maintained all records
required to be maintained by applicable Laws with respect to the Material Provider Contracts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-29- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Since January&nbsp;1, 2015, each Provider under the Material Provider Contracts has been
compensated and is currently compensated for covered services provided to Seller Enrollees in accordance with the rates and fees set forth in the applicable Material Provider Contracts and Seller&#146;s standard payment policies and procedures,
except as would not be material to the Conveyed Medicare Advantage Contracts, taken as a whole.&nbsp;As of the date hereof, there are no renegotiations, attempts to renegotiate or outstanding rights to negotiate any amount to be paid or payable to
or by Seller under any Material Provider Contract other than in all material respects in the ordinary course of business consistent with the past practices of Seller and its Affiliates.&nbsp;Furthermore, with respect to each Material Provider
Contract, (i)&nbsp;no Affiliate of Seller is a Material Provider and (ii)&nbsp;each Material Provider Contract may be terminated by a party thereto without cause or nonrenewed with advance written notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.12 <I>Seller Enrollees</I>.&nbsp;With respect to all requests for services duly made by or for a Seller Enrollee prior to the
Closing, Seller has complied in all material respects with its internal medical management policies and procedures (including utilization review and pre-authorization procedures) and the use of such policies and procedures complies in all material
respects with the Existing Medicare Advantage Contracts or, if the Closing occurs after January&nbsp;1, 2017, the 2017 Seller Medicare Advantage Contracts and the Conveyed Medicare Advantage Contracts, as applicable, and all applicable
Laws.&nbsp;Seller has adjudicated all requests for preauthorizations, referrals, and admissions in all material respects in the ordinary course of business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.13 <I>Agreements with Brokers</I>.&nbsp;(a)&nbsp;To the knowledge of Seller, each Broker, at the time such Broker wrote, sold, or
produced insurance contracts related to the Existing Medicare Advantage Plans and, if the Closing occurs after January&nbsp;1, 2017, the 2017 Seller Medicare Advantage Plans on behalf of Seller and with respect to Seller Enrollees was duly licensed
for such business and duly appointed by Seller or one or more of its Affiliates in accordance with applicable Laws in all material respects and (b)&nbsp;to the knowledge of Seller, no such Broker has violated in any material respect any term or
provision of any Law applicable to the writing, sale or production of business for Seller related to the Existing Medicare Advantage Plans with respect to the Seller Enrollees or, if the Closing occurs after January&nbsp;1, 2017, the 2017 Seller
Medicare Advantage Plans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.14 <I>NDAs</I>.&nbsp;Seller has provided Purchaser with a true and complete copy of all of the
NDAs.&nbsp;The NDAs are legal, valid, binding, enforceable and in full force and effect.&nbsp;Except as set forth on Section 3.14 of the Seller Disclosure Schedules,&nbsp;as of the date hereof, Seller has not received or given written notice of, and
to the knowledge of Seller, is not aware of, any default or claimed, purported or alleged default, breach or state of facts which, with notice or lapse of time or both, would constitute a material default or breach on the part of any party of the
performance of any obligation to be performed by such party under the NDAs or would permit termination of such NDAs. To the knowledge of Seller, as of the date hereof, no other party has repudiated any provision of the NDAs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.15 <I>No Finders&#146; Fee</I>.&nbsp;Except for Ernst &amp; Young Capital Advisors, LLC, whose fee will be paid by Seller or its
Affiliates, there is no investment banker, broker, finder or other intermediary that has been retained by or is authorized to act on behalf of Seller or any of its Affiliates who might be entitled to any fee or commission in connection with the
transactions contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-30- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.16 <I>Taxes</I><I> (a)</I>&nbsp;Seller has filed or caused to be filed on a timely
basis all material Tax Returns required to be filed pursuant to applicable Laws by Seller with respect to the Purchased Assets.&nbsp;All such Tax Returns, in so far as they relate to the Purchased Assets, are true, correct and complete in all
material respects.&nbsp;Seller has timely paid, or made provision for, all Taxes with respect to the Purchased Assets reflected on such Tax Returns.&nbsp;There is no Lien (other than Permitted Liens) on any of the Purchased Assets that arose in
connection with any failure (or alleged failure) to pay any Tax, and Seller has no Knowledge of any basis for assertion of any claims attributable to Taxes which, if adversely determined, would result in any such Lien (other than Permitted Liens) on
any of the Purchased Assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Section 3.16(b) of the Seller Disclosure Schedules sets forth each state, county, local municipal,
domestic or foreign jurisdiction or Taxing Authority in or with which, with respect to the Purchased Assets, Seller (i)&nbsp;has filed a property or income Tax Return with respect to the Purchased Assets, (ii)&nbsp;has registered for any Tax purpose
in connection with the Purchased Assets, (iii)&nbsp;has paid any property or income Tax on a &#147;nexus&#148; basis at any time in connection with the Purchased Assets or (iv)&nbsp;has received written notification from a Taxing Authority that it
is qualified to do business in connection with the Purchased Assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 3.17 <I>No Other Seller Representations and
Warranties</I>.&nbsp;(a)&nbsp;Except for the representations and warranties made by Seller in this Article 3 (as qualified by the applicable items disclosed in the Seller Disclosure Schedules in accordance with Section 9.04 and the introduction to
this Article 3), neither Seller nor any other Person makes or has made any representation or warranty, expressed or implied, at law or in equity, with respect to or on behalf of Seller or any of its Affiliates, the Purchased Assets, the Existing
Medicare Advantage Plans, the 2017 Seller Medicare Advantage Plans, the Purchaser Medicare Advantage Plans, the Existing Medicare Advantage Contracts, the 2017 Seller Medicare Advantage Contracts, Seller&#146;s or any of its Affiliates&#146; other
businesses, operations, assets, liabilities, financial condition, results of operations, future operating or financial results, estimates, projections, forecasts, plans or prospects (including the reasonableness of the assumptions underlying such
estimates, projections, forecasts, plans or prospects) or the accuracy or completeness of any information regarding the foregoing or any other matter furnished or provided to Purchaser or made available to Purchaser in any &#147;data rooms&#148;,
&#147;virtual data rooms&#148;, management presentations or in any other form in expectation of, or in connection with, this Agreement or the transactions contemplated hereby.&nbsp;Seller and its Affiliates disclaim any other representations or
warranties, whether made by Seller or any of its Affiliates or any of their respective Representatives.&nbsp;Without limiting the generality of the foregoing, except for the representations and warranties made by Seller in this Article 3 (as
qualified by the applicable items disclosed in the Seller Disclosure Schedules in accordance with Section 9.04 and the introduction to this Article 3), neither Seller nor any other Person makes or has made any representation or warranty, expressed
or implied, at law or in equity, with respect to or on behalf of Seller or any of its Affiliates with respect to (i)&nbsp;the number of Seller Enrollees or Purchaser Enrollees, (ii)&nbsp;the claims experience of any Seller Enrollees under any
Existing Medicare Advantage Plan or any 2017 Seller Medicare Advantage Plan, or (iii)&nbsp;any other financial or operating metrics with respect to any Existing Medicare Advantage Plan, any 2017 Seller Medicare Advantage Plan or Seller Enrollees, in
each case whether as of the date hereof, as of the Closing Date or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-31- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Seller acknowledges and agrees that, except for the representations and warranties made by
Purchaser in Article 4 (as qualified by the applicable items disclosed in the Purchaser Disclosure Schedules in accordance with Section 9.04 and the introduction to Article 4), neither Purchaser nor any other Person is making or has made any
representation or warranty, expressed or implied, at law or in equity, with respect to or on behalf of Purchaser or any of its Affiliates or any of their respective businesses, operations, assets, liabilities, financial condition, results of
operations, future operating or financial results, estimates, projections, forecasts, plans or prospects (including the reasonableness of the assumptions underlying such estimates, projections, forecasts, plans or prospects) or the accuracy or
completeness of any information regarding Purchaser or any of its Affiliates or any other matter furnished or provided to Seller or made available to Seller in any &#147;data rooms,&#148; &#147;virtual data rooms,&#148; management presentations or
in any other form in expectation of, or in connection with, this Agreement, or the transactions contemplated hereby.&nbsp;Seller specifically disclaims that it is relying upon or has relied upon any such other representations or warranties that may
have been made by any Person, and acknowledges and agrees that Purchaser and its Affiliates have specifically disclaimed and do hereby specifically disclaim any such other representations and warranties. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 4 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REPRESENTATIONS AND
WARRANTIES OF PURCHASER </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth in the Purchaser Disclosure Schedules delivered by Purchaser to Seller prior to the execution
of this Agreement (the &#147;<B>Purchaser Disclosure Schedules</B>&#148; and together with the Seller Disclosure Schedules, the &#147;<B>Disclosure Schedules</B>&#148;), which schedules shall reference the specific section of this Article 4 to which
such schedules relate, Purchaser represents and warrants to Seller as of the date hereof and as of the Closing Date as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section
4.01 <I>Corporate Existence and Power</I>.&nbsp;(a)&nbsp;Purchaser is a corporation duly incorporated and validly existing under the laws of the State of Delaware.&nbsp;Purchaser has all corporate powers and authority required to own or lease all of
its properties or assets and to carry on its business as now conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Purchaser is in good standing in the State of Delaware and is
duly qualified to do business and in good standing in each other jurisdiction where such qualification is necessary, except for those jurisdictions where failure to be so qualified would not prevent or materially impair or delay Purchaser&#146;s
consummation of any of the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 4.02 <I>Corporate Authorization</I>.&nbsp;The execution,
delivery and performance by Purchaser of this Agreement and each of the other Transaction Documents and the consummation by Purchaser of the transactions contemplated by this Agreement and each of the other Transaction Documents are within the
corporate powers and authority of Purchaser and have been duly authorized by all necessary corporate action on the part of Purchaser.&nbsp;This Agreement has been, and upon its execution and delivery each of the other Transaction Documents will have
been, duly executed and delivered by Purchaser and (assuming due </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-32- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
authorization, execution and delivery by the other parties hereto and thereto) this Agreement constitutes, and upon its execution and delivery each of the other Transaction Documents will
constitute, a legal, valid and binding agreement of Purchaser enforceable against Purchaser in accordance with its respective terms (subject to the Bankruptcy and Equity Exceptions). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 4.03 <I>Governmental Authorization</I>.&nbsp;The execution, delivery and performance by Purchaser of this Agreement and each of the
other Transaction Documents and the consummation by Purchaser of the transactions contemplated hereby and thereby require no actions by or in respect of, Consents of, or Filings with, any Governmental Authority, other than (a)&nbsp;compliance with
any applicable requirements of the 1934 Act and any other applicable U.S. state or federal securities Laws or pursuant to the rules of the New York Stock Exchange, (b)&nbsp;the Consents of, and Filings with, the Governmental Authorities listed on
Section 4.03(b) of the Purchaser Disclosure Schedules, including Consents of, and Filings with, the state insurance departments, federal and state departments of health and other Consents and Filings required under Health Care Laws or insurance laws
and (c)&nbsp;any other such actions, Consents or Filings (i)&nbsp;required solely by reason of the participation of Seller or any of its Affiliates in the transactions contemplated hereby or (ii)&nbsp;the absence of which would not prevent or
materially impair or delay Purchaser&#146;s consummation of any of the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 4.04
<I>Non-Contravention</I>.&nbsp;The execution, delivery and performance by Purchaser of this Agreement and the Transaction Documents, and the consummation of the transactions contemplated hereby and thereby do not and will not (a)&nbsp;contravene,
conflict with, or result in any violation or breach of any provision of Purchaser&#146;s organizational documents, (b)&nbsp;assuming compliance with the matters referred to in Section 4.03, contravene, conflict with or result in any violation or
breach of any provision of any applicable Law, (c)&nbsp;assuming compliance with the matters referred to in Section 4.03, require any material Consent or other material action by any Person under, constitute a material default, or an event that,
with or without notice or lapse of time or both, would constitute a material default, under, or cause or permit the termination, cancellation, acceleration or other material change of any material right or obligation or the loss of any material
benefit to which Purchaser or any of its Affiliates is entitled under, any provision of any contract binding upon Purchaser or any of its Affiliates or any Consent of any Governmental Authority, or (d)&nbsp;result in the creation or imposition of
any Lien (other than Permitted Liens) on any of the Purchased Assets, with such exceptions, in the case of each of clauses (b) and (d), as would not prevent or materially impair or delay Purchaser&#146;s consummation of any of the transactions
contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 4.05 <I>Litigation</I>.&nbsp;There is no Action pending or, to the knowledge of Purchaser, any
investigation pending or threatened in writing or any Action threatened against or affecting Purchaser, before (or, in the case of threatened Actions, that would be before) any arbitrator or Governmental Authority that in any manner challenges or
seeks to prevent, enjoin, alter, materially delay, make illegal, impose conditions or limitations on or otherwise materially interfere with any of the transactions contemplated by this Agreement.&nbsp;As of the date hereof, there is no Order
outstanding or, to the knowledge of Purchaser, threatened in writing against or affecting Purchaser that would prevent, enjoin, alter, materially delay, make illegal, impose conditions or limitations on or otherwise materially interfere with any of
the transactions contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-33- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 4.06 <I>Permits</I>.&nbsp;Except as would not prevent or materially impair or delay
Purchaser&#146;s consummation of any of the transactions contemplated by this Agreement, Purchaser and its Affiliates hold all federal and state governmental licenses and permits necessary for the operation of their respective businesses as they are
now being conducted and, except as set forth on Section 4.06 of the Purchaser Disclosure Schedules (collectively, the &#147;<B>Required Purchaser Permits</B>&#148;), Purchaser&#146;s or its Affiliates&#146; businesses to be performed under the
Conveyed Medicare Advantage Contracts.&nbsp;Purchaser and its Affiliates are in compliance with the terms of such licenses and permits, except for failures to comply that would not prevent or materially impair or delay Purchaser&#146;s consummation
of any of the transactions contemplated by this Agreement.&nbsp;There is no material Action pending, or, to the knowledge of Purchaser, any investigation pending or threatened or any Action threatened that seeks the revocation, cancellation,
termination, non-renewal or adverse modification of any such license or permit, except where such revocation, cancellation, termination, non-renewal or adverse modification would not prevent or materially impair or delay Purchaser&#146;s
consummation of any of the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 4.07 <I>Compliance with Applicable
Laws</I>.&nbsp;(a)&nbsp;Purchaser is in compliance with all applicable Laws, including applicable Health Care Laws, except for failures to comply that would not prevent or materially impair or delay Purchaser&#146;s consummation of any of the
transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1, 2014, except as would not prevent or materially impair or delay
Purchaser&#146;s consummation of any of the transactions contemplated by this Agreement, (i)&nbsp;none of Purchaser or any of its Affiliates has been or is currently suspended, excluded or debarred from contracting with the federal or any state
government or from participating in any state or federally funded healthcare program, (ii)&nbsp;none of Purchaser or any of its Affiliates is party to any contract, arrangement or understanding or subject to any Order that would limit or restrict
Purchaser or any of its Affiliates in any manner from owning, operating or utilizing the Purchased Assets or assuming, performing and discharging the Assumed Liabilities from and after the Closing, (iii)&nbsp;neither Purchaser nor any of its
Affiliates has been subject to any Governmental Authority&#146;s imposition of, or has received any written correspondence from any Governmental Authority threatening the imposition of, sanctions on Purchaser or any of its Affiliates in relation to
its licenses or the operation of&nbsp;its health plans, as applicable and (iv)&nbsp;except as set forth in Section 4.07(b)(iv)&nbsp;of the Purchaser Disclosure Schedules, Purchaser has all licenses and permits necessary to complete the transactions
contemplated by this Agreement.&nbsp;As of the date hereof, Purchaser has no knowledge of any circumstances that would be a reasonable basis for CMS to impose any enrollment sanctions on Purchaser or any of its Affiliates or to exclude Purchaser,
any of its Affiliates or any of their respective directors or officers from participating in the Medicare or Medicaid programs, or any other reason or basis with respect to Purchaser or any of its Affiliates on which CMS or any other Governmental
Authority would refuse to grant the Medicare Advantage Contract Novations or any Required Purchaser Permit in favor of Purchaser.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section
4.08 <I>Financing</I><I>.</I><I>&nbsp;</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Purchaser has sufficient cash, available lines of credit or other sources of immediately
available funds to enable it to consummate the transactions contemplated hereby, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-34- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
including paying in full all amounts required to be paid hereunder by Purchaser, including with respect to any regulatory capital requirements arising out of the transactions contemplated hereby
or the Purchased Assets.&nbsp;Purchaser expressly acknowledges and agrees that its obligations hereunder, including its obligations to consummate the transactions contemplated hereby, are not subject to, or conditioned on, receipt of financing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Without limiting the foregoing, Purchaser has delivered to Seller a complete and correct copy of a fully executed commitment letter from
Barclays Bank PLC (including all exhibits, schedules and annexes to such letter as and to the extent delivered to Seller on or prior to the date of this Agreement, the &#147;<B>Debt Commitment Letter</B>&#148;), pursuant to which Barclays Bank PLC
has committed, upon the terms and subject to the conditions set forth therein, to provide the debt financing described therein in connection with the transactions contemplated hereby.&nbsp;The Debt Commitment Letter and any other debt commitment
letter (including any replacement of the Debt Commitment Letter in connection with any Alternative Financing) executed in accordance with Section 5.05, as replaced, amended, supplemented, modified or waived in accordance with Section 5.05, including
all exhibits, schedules and annexes to such letters, are hereinafter referred to together as the &#147;<B>Debt Commitment Letters</B>.&#148;&nbsp;The financing contemplated pursuant to the Debt Commitment Letters is hereinafter referred to as the
&#147;<B>Debt Financing</B>&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) As of the date of this Agreement, the Debt Commitment Letter is in full force and effect and is a
legal, valid and binding obligation of Purchaser and, to the knowledge of Purchaser, Barclays Bank PLC, and is enforceable in accordance with its terms against Purchaser and, to the knowledge of Purchaser, Barclays Bank PLC (subject to the
Bankruptcy and Equity Exceptions). All commitment fees required to be paid under the Debt Commitment Letter have been paid in full or will be duly paid in full as and when due; and Purchaser shall have otherwise satisfied all of the conditions
required to be satisfied by Purchaser pursuant to the terms of the Debt Commitment Letter on or prior to the date of this Agreement.&nbsp;The Debt Commitment Letter has not been amended, modified or terminated on or prior to the date of this
Agreement, no such amendment, modification or termination is contemplated by Purchaser as of the date of this Agreement, and no Debt Commitment Letter will be amended, modified or terminated by Purchaser, in violation of Section 5.05.&nbsp;As of the
date of this Agreement, no event has occurred which, with or without notice, lapse of time or both, would constitute a breach or default by Purchaser under the Debt Commitment Letter.&nbsp;Purchaser, as of the date of this Agreement, is not aware of
any fact, occurrence or condition that makes any of the assumptions or statements set forth in the Debt Commitment Letter inaccurate (assuming the accuracy of Seller&#146;s representations and warranties set forth in this Agreement) in any material
respect or that would reasonably be expected to cause the commitments provided in the Debt Commitment Letter to be terminated or ineffective or any of the conditions contained therein not to be met.&nbsp;The consummation of the Debt Financing is
subject to no conditions precedent other than those expressly set forth in the copy of the Debt Commitment Letter, and there are no contingencies that would permit Barclays Bank PLC to reduce the total amount of the Debt Financing other than those
expressly set forth in the copy of the Debt Commitment Letter. Except for fee letters relating to fees with respect to the Debt Financing (redacted copies of which, removing only fee amounts, market &#147;flex&#148; provisions and certain other
items (none of which concern or would adversely affect the amounts, availability, timing or conditionality of the Debt Financing), but including all fee amounts payable in connection with a termination of this Agreement, have been
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-35- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provided to Seller on or prior to the date of this Agreement) have been provided to Seller on or prior to the date of this Agreement), there are no side letters or other agreements, contracts, or
arrangements related to the funding of the Debt Financing, other than as expressly set forth in the Debt Commitment Letter.&nbsp;As of the date of this Agreement, assuming no breach by Purchaser of its representations and warranties under this
Agreement (and cooperation and assistance by Seller as required by the terms of this Agreement) and no breach or default by Seller of its obligations under this Agreement (in either case such that the conditions set forth in Section 6.01 or Section
6.02 would fail to be satisfied), and based upon facts and events known by Purchaser as of the date of this Agreement, Purchaser has no reason to believe that any of the conditions to the Debt Financing will not be satisfied or the Debt Financing
will not be consummated as contemplated in the Debt Commitment Letter on or prior to the Closing Date, if required to comply with its obligations under this Agreement (including its obligations under Section 5.03, and including to consummate the
transactions contemplated hereby and satisfy regulatory capital requirements applicable to Purchaser or any of its Affiliates related to or arising out of the consummation of the transactions contemplated hereby or the Purchased Assets).&nbsp;The
aggregate proceeds of the Debt Financing, together with cash or cash equivalents held by Purchaser, as of the Closing Date, will be sufficient to enable Purchaser to pay in cash all amounts required to be paid by it in cash in connection with the
transactions contemplated hereby, including payment of all amounts required to be paid pursuant to Article 2, and to pay all related fees and expenses payable by Purchaser and satisfy all regulatory capital requirements applicable to Purchaser or
any of its Affiliates related to or arising out of the consummation of the transactions contemplated by this Agreement or the Purchased Assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 4.09 <I>No Finders&#146; Fee</I>.&nbsp;Except for Barclays Capital Inc., whose fee will be paid by Purchaser or its Affiliates, there
is no investment banker, broker, finder or other intermediary that has been retained by or is authorized to act on behalf of Purchaser or any of its Affiliates who might be entitled to any fee or commission in connection with the transactions
contemplated by this Agreement.&nbsp;A copy of Barclays Capital Inc.&#146;s financial services advisory agreement with Purchaser as in effect on the date hereof has been made available to Seller&#146;s counsel on the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 4.10 <I>No Other Purchaser Representations and Warranties</I>.&nbsp;(a)&nbsp;Except for the representations and warranties made by
Purchaser in this Article 4, neither Purchaser nor any other Person makes or has made any representation or warranty, expressed or implied, at law or in equity, with respect to or on behalf of Purchaser or any of its Affiliates, their respective
businesses, operations, assets, liabilities, financial condition, results of operations, future operating or financial results, estimates, projections, forecasts, plans or prospects (including the reasonableness of the assumptions underlying such
estimates, projections, forecasts, plans or prospects) or the accuracy or completeness of any information regarding Purchaser or any of its Affiliates or any of their respective businesses or any other matter furnished or provided to Seller or made
available to Seller in any &#147;data rooms&#148;, &#147;virtual data rooms&#148;, management presentations or in any other form in expectation of, or in connection with, this Agreement or the transactions contemplated hereby.&nbsp;Purchaser and its
Affiliates disclaim any other representations or warranties, whether made by Purchaser or any of its Affiliates or any of their respective Representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-36- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Purchaser acknowledges and agrees that, except for the representations and warranties made by
Seller in Article 3 (as qualified by the applicable items disclosed in the Seller Disclosure Schedules in accordance with Section 9.04 and the introduction to Article 3), neither Seller nor any other Person is making or has made any representation
or warranty, expressed or implied, at law or in equity, with respect to or on behalf of Seller or any of its Affiliates, the Existing Medicare Advantage Contracts, the 2017 Seller Medicare Advantage Contracts, the Conveyed Medicare Advantage
Contracts, Seller&#146;s or any of its Affiliates&#146; respective other businesses, operations, assets, liabilities, financial condition, results of operations, future operating or financial results, estimates, projections, forecasts, plans or
prospects (including the reasonableness of the assumptions underlying such estimates, projections, forecasts, plans or prospects) or the accuracy or completeness of any information regarding Seller or any of its Affiliates or any other matter
furnished or provided to Purchaser or made available to Purchaser in any &#147;data rooms,&#148; &#147;virtual data rooms,&#148; management presentations or in any other form in expectation of, or in connection with, this Agreement, or the
transactions contemplated hereby.&nbsp;Purchaser specifically disclaims that it is relying upon or has relied upon any such other representations or warranties that may have been made by any Person, and acknowledges and agrees that Seller and its
Affiliates have specifically disclaimed and do hereby specifically disclaim any such other representations and warranties. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 5 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COVENANTS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.01
<I>Conduct of Business</I>.&nbsp;From and after the date hereof until the Closing, except (i)&nbsp;as required by applicable Law, (ii)&nbsp;as required by any Governmental Authority, (iii)&nbsp;as required or expressly contemplated by this
Agreement, (iv)&nbsp;as disclosed in Section 5.01 of the Seller Disclosure Schedules, or (v)&nbsp;with the prior written consent of Purchaser (which consent shall not be unreasonably withheld, delayed or conditioned), (A)&nbsp;Seller shall, and
shall cause its Affiliates to, operate the Existing Medicare Advantage Plans in the ordinary course of business, (B)&nbsp;if the Closing occurs after January&nbsp;1, 2017, Seller shall, and shall cause its Affiliates to operate the 2017 Seller
Medicare Advantage Plans in the ordinary course of business, (C) if the Closing occurs on or after January 1, 2018, Seller shall, and shall cause its Affiliates to, perform and/or operate the 2018 Medicare Advantage Contract in the ordinary course
of business, and (D)&nbsp;Seller shall not, and shall not permit any of its Affiliates to do any of the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) amend, terminate,
renew, cancel, grant any waiver under or otherwise modify any Existing Medicare Advantage Contract or 2017 Seller Medicare Advantage Contract as it relates to all or any portion of the Applicable Service Area except (A)&nbsp;renewals in accordance
with previously submitted bids to CMS, copies of the applicable portions of which have been made available to Purchaser or a Representative of Purchaser and (B)&nbsp;to enter into the Conveyed Medicare Advantage Contracts to the extent contemplated
by clauses (A)&nbsp;and (B)&nbsp;of the definition of 2017 Whole Year Medicare Advantage Contract, 2017 Split Year Medicare Advantage Contract or 2018 Medicare Advantage Contract, including to remove the Applicable Service Area, products and plans
from the Existing Medicare Advantage Contracts or the 2017 Seller Medicare Advantage Contracts, as applicable; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) submit any bid or file
or submit other material documents, reports or files to CMS with respect to any Existing Medicare Advantage Plan or if the Closing occurs after January&nbsp;1, 2017, any 2017 Seller Medicare Advantage Plan, in each case as would adversely affect any
Conveyed Medicare Advantage Contract in any material respect; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-37- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) sell or otherwise dispose of any of the Purchased Assets; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) pledge, encumber or otherwise subject any Purchased Assets to any Lien other than Permitted Liens; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) unless otherwise expressly permitted under the terms of this Agreement, take or omit to take any action which would (i)&nbsp;adversely
affect the ability of Seller to obtain the Consents required pursuant to Section 6.01(b)&nbsp;or which would adversely affect Seller&#146;s ability to perform its covenants and agreements contained herein, in each case in any material respect, or
(ii)&nbsp;cause any Consent necessary to carry on the Existing Medicare Advantage Plans or if the Closing occurs after January&nbsp;1, 2017, the 2017 Seller Medicare Advantage Plans, to become ineffective, cancelled or terminated; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) institute or settle, any Action solely related to the Purchased Assets, or the Assumed Liabilities, except for any Actions solely related
to the Purchased Assets that arise in the ordinary course of business, which Seller may institute and/or settle without Purchaser&#146;s consent on terms consistent in all material respects with its past practice with respect to such Actions; or
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) authorize, agree or commit to do any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.02 <I>Preparation for Transfer and Transition</I>.&nbsp;From and after the date hereof until the Closing: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Seller shall, and shall cause its Affiliates to, use their best efforts to cooperate and work with Purchaser in transition planning that
will reasonably be expected to result in an effective transition and transfer of those Seller Enrollees that will after the Closing become Purchaser Enrollees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) To the extent permissible under applicable Law, and except as set forth in Section 5.10(c), Seller shall provide, or cause to be provided,
to Purchaser and/or a qualified third-party actuary of Purchaser&#146;s choice, reasonable access to information in Seller&#146;s and its Affiliates&#146; possession and in the format maintained by Seller or its applicable Affiliate that Purchaser
reasonably requires or requests for purposes of the preparation of any bid submission made to CMS until December&nbsp;31, 2019 (<I>provided</I> that nothing in this Section 5.02 shall be deemed to enlarge or otherwise modify the obligations of
Seller to provide information to Purchaser pursuant to Section 5.22 in connection with the 2018 Bids) in respect of all or any portion of the Applicable Service Area and pursuant to one or more of the Conveyed Medicare Advantage Contracts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.03 <I>Best Efforts; Novation</I>.&nbsp;(a)&nbsp;Subject to the terms and conditions of this Agreement, Purchaser and Seller shall,
and shall cause their respective Affiliates to, use best efforts to take, or cause to be taken, all actions, and to do, or cause to be done, all things, in each case necessary, proper or advisable under applicable Law to satisfy the conditions to
Closing set forth in Article 6 and consummate the transactions contemplated by this Agreement as promptly </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-38- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
as practicable after the date hereof, including (i)&nbsp;preparing and filing as promptly as practicable with any Governmental Authority or other third party all documentation to effect all
necessary, proper or advisable Filings, (ii)&nbsp;obtaining as promptly as practicable and maintaining all Consents required to be obtained from any Governmental Authority or other third party that are necessary, proper or advisable to consummate
the transactions contemplated by this Agreement, including the Required Regulatory Approvals, (iii)&nbsp;to the extent permitted by applicable Law, furnishing as promptly as practicable to one another or any Governmental Authority any information or
documentary materials reasonably requested or required in connection with obtaining and maintaining such Consents, except, in the case of either party and their respective Affiliates, as set forth in Section 5.10(c), and (iv)&nbsp;communicating and
cooperating with the other party and its Affiliates in connection with such matters.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Without limiting Section 5.03(a), as promptly as
advisable after the date hereof as reasonably determined by Seller, Seller and Purchaser shall submit advance notice to CMS of a possible change in ownership pursuant to 42 C.F.R. &#167;&nbsp;422.550(b).&nbsp;Following such advance notice to CMS,
Seller and Purchaser shall timely submit all materials requested or required by CMS and cooperate in submission of a request for CMS to approve and consent to a novation process whereby each Conveyed Medicare Advantage Contract would be split from
the applicable Existing Medicare Advantage Contract or the applicable 2017 Seller Medicare Advantage Contract, as applicable, and transferred from Seller and its Affiliates to Purchaser (or directly entered into by Purchaser with CMS, as
applicable), effective as of the Closing (such approval by CMS of either the split and transfer of each Conveyed Medicare Advantage Contract to Purchaser or Purchaser entering into each Conveyed Medicare Advantage Contract directly with CMS,
collectively, the &#147;<B>Medicare Advantage Contract Novations</B>&#148;), which materials shall be provided as promptly as practicable and shall include all of the information required pursuant to Chapter 12 of the Medicare Managed Care Manual
and any additional information required pursuant to applicable Law, as may be requested by CMS, or as is advisable to effect the Medicare Advantage Contract Novations, effective as of the Closing.&nbsp;Subject to applicable Law, each party shall
furnish (subject to the terms set forth in Section 5.10(c)), to the other party such information and assistance as the other party may reasonably request in connection with its preparation of the filing or submission of such request, and keep the
other party reasonably apprised of any communications with, and inquiries or requests for additional information from, CMS or any other Governmental Authority.&nbsp;Additionally, each party shall, to the extent practicable, provide the other party
at least one (1) Business Day&#146;s advance written notice of the time and subject matter of any material meetings or material communications with CMS relating to the transactions contemplated hereby, and the other party shall, to the extent
practicable and permitted by CMS, have the right to attend and participate in any such material meetings or material conversations.&nbsp;Additionally, each party shall be entitled to receive any materials prepared by and/or made available to the
other party in connection with such meetings or conversations and to learn of the content of such communications (subject to limitations reasonably necessary to preserve attorney-client privilege; <I>provided, however</I>, that in the event either
party shall invoke such privilege and such privilege would be preserved through a joint defense agreement entered into between Purchaser and Seller or any of its Affiliates, then Seller and Purchaser shall use their Commercially Reasonable Efforts
to enter into a mutually acceptable joint defense agreement (or similar agreement)) (it being understood and agreed that the obligations set forth in this Section 5.03(b) and Section 5.03(c) shall be Seller&#146;s only obligations with respect to
keeping Purchaser apprised of matters relating to the Humana </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-39- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Acquisition Litigation).&nbsp;Each party shall, and shall cause its Affiliates to, use their best efforts to obtain as promptly as reasonably practical, effective as of the Closing, the Medicare
Advantage Contract Novations and to satisfy all other requirements applicable to the Medicare Advantage Contract Novations pursuant to 42 C.F.R. &#167;&#167;&nbsp;422.550-552. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Except as otherwise agreed by the parties, Seller shall be entitled to control and direct the defense of the transactions contemplated
hereby before DOJ and in the Humana Acquisition Litigation and to take the lead in the scheduling of, and strategic planning for, any meetings with, and the conducting of negotiations with, DOJ or the Overseeing Court with respect to such
transactions, including in connection with the Humana Acquisition Litigation; <I>provided, however</I>, that Seller shall consult with Purchaser and shall keep Purchaser reasonably informed of all significant developments, meetings and/or
communications with respect to its dealings with DOJ and in the Humana Acquisition Litigation relating to the transactions contemplated hereby (subject to limitations reasonably necessary to preserve attorney-client privilege; <I>provided,
however</I>, that in the event Seller shall invoke such privilege and such privilege would be preserved through a joint defense agreement entered into between Purchaser and Seller or any of its Affiliates, then Seller and Purchaser shall use their
Commercially Reasonable Efforts to enter into a mutually acceptable joint defense agreement (or similar agreement)). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) Without
Seller&#146;s prior written consent, which shall not be unreasonably withheld, conditioned or delayed, Purchaser shall not, and shall cause its Affiliates not to, directly or indirectly (whether by merger, consolidation or otherwise), acquire,
purchase, lease or license (or agree to acquire, purchase, lease or license) any business, corporation, partnership, limited liability company, association or other business organization or division or part thereof, or any securities or collection
of assets, or enter into any new line of business (any such transaction, a &#147;<B>Proposed Transaction</B>&#148;), if doing so would reasonably be expected to: (i)&nbsp;impose any material delay in the obtaining of, or materially increase the risk
of not obtaining, any Consent of any Governmental Authority necessary to consummate any of the transactions contemplated hereby or the expiration or termination of any applicable waiting period; (ii)&nbsp;materially increase the risk of any
Governmental Authority entering an Order prohibiting the consummation of any of the transactions contemplated hereby; (iii)&nbsp;materially increase the risk of not being able to remove any such Order on appeal or otherwise; or (iv)&nbsp;otherwise
prevent or materially delay the consummation of any of the transactions contemplated hereby; <I>provided,</I> <I>however</I>, that nothing in this Section 5.03(d) shall prohibit Purchaser from engaging in a Proposed Transaction that exclusively
involves Medicaid assets or if the target&#146;s health insurance or health plan business is solely a Medicaid business so long as such Proposed Transaction would not cause Purchaser to be in breach of any of its representations and warranties
hereunder (in each case, as if made at the time of such Proposed Transaction, rather than as of the date of this Agreement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) In
addition, Purchaser shall, and shall cause its Affiliates to, use Commercially Reasonable Efforts, as reasonably requested by Seller and at Seller&#146;s cost and expense in the case of any reasonable out-of-pocket costs and expenses incurred by
Purchaser and its Affiliates in connection therewith, to cooperate with Seller, Humana and their respective Affiliates in connection with their efforts to defend the transactions contemplated by the Merger Agreement and this Agreement in the Humana
Acquisition Litigation, including participating in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-40- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
meetings with DOJ and the Overseeing Court, and sharing with Seller or its legal counsel, as appropriate, documents, data and other information that Seller or its legal counsel may reasonably
request related to any products or services that are the subject of the Humana Acquisition Litigation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) Notwithstanding anything to
the contrary contained herein, each party acknowledges and agrees that nothing herein shall obligate, or be construed to obligate, Seller or any of its Affiliates to, or to agree to, (i)&nbsp;sell, divest, hold separate, discontinue, limit or
otherwise dispose of any property or assets of such Person or any of its Affiliates, (ii)&nbsp;defend against any Action challenging this Agreement or the transactions contemplated hereby, (iii)&nbsp;agree to any conditions (including in any consent
decree) relating to, or changes or restrictions in, the current or future operations or ownership of such Person or any of its Affiliates or (iv)&nbsp;take any other action to satisfy the conditions set forth in Section 6.03(d).</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.04 <I>Enrollee Non-Solicitation</I><I>.</I>&nbsp;During the Restricted Period, Seller shall not, and shall not permit any of its
Affiliates to, and shall not instruct its Brokers to, directly or indirectly, solicit, induce or attempt to persuade any Purchaser Enrollee to enroll in any individual Medicare Advantage plan of Seller or any of its Affiliates in the Applicable
Service Area; <I>provided</I> that the restrictions set forth in this Section 5.04 shall not prohibit (a)&nbsp;general advertisements or similar solicitations not specifically targeted to Purchaser Enrollees, including Brokers&#146; general
marketing activities in the ordinary course of business, or (b)&nbsp;any enrollment or other activities with respect to any Purchaser Enrollees who respond to any such general advertisements, general marketing or similar solicitation.&nbsp;From the
Closing Date through the later of (A)&nbsp;December&nbsp;31, 2018 and (B)&nbsp;the second (2<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP>) anniversary of the Closing Date, Seller shall not, and shall not permit any of its Affiliates to,
directly or indirectly, use any Aetna and/or Coventry brand or substantially similar brand, name or logo for any Medicare Advantage plan of Seller or any of its Affiliates offered directly to individuals in the Applicable Service Area, with the
exception of such use in connection with (1)&nbsp;any Medicare Advantage or other plan offered by Seller or any of its Affiliates to groups or to any individual who is part of a group, (2)&nbsp;any Special Needs Plan, (3) pursuant to the
Administrative Services Agreement, (4) any Medicare Supplement plan, standalone prescription drug plan or any other plan that is not a Medicare Advantage plan offered pursuant to a Contract or (5) any Medicare Advantage or other plan offered outside
of the Applicable Service Area (and, for the avoidance of doubt, nothing herein shall prohibit or restrict in any way the use by Seller or any of its Affiliates of any Humana brand or substantially similar brand, name or logo, including for any
Medicare Advantage plan offered directly to individuals in the Applicable Service Area).</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.05 <I>Financing
Covenants</I><I>.</I>&nbsp;(a)&nbsp;If required to comply with its obligations under this Agreement (including its obligations under Section 5.03, and including to consummate the transactions contemplated hereby and satisfy regulatory capital
requirements applicable to Purchaser or any of its Affiliates related to or arising out of the consummation of the transactions contemplated hereby or the Purchased Assets), (i)&nbsp;Purchaser shall, and shall cause its Affiliates to, take, or to
cause to be taken, all such actions as may be necessary to arrange the Debt Financing on substantially the terms and conditions described in the Debt Commitment Letter, including (A)&nbsp;to negotiate and enter into the definitive agreements with
respect thereto on the terms and conditions contained in the Debt Commitment Letter (including, as necessary, the &#147;flex&#148; provisions contained in any related fee letter) by the Closing Date, and (B)&nbsp;to satisfy or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-41- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
obtain the waiver of, on a timely basis all conditions to obtaining the Debt Financing and to comply with all of Purchaser&#146;s obligations pursuant to the Debt Commitment Letter and the
definitive agreements related thereto; (ii)&nbsp;in the event that all conditions to funding the commitments contained in the Debt Commitment Letter have been satisfied, Purchaser shall cause the Financing Source to fund the Debt Financing required
to consummate the transactions contemplated by this Agreement, pay related fees and expenses and satisfy all regulatory capital requirements applicable to Purchaser related to or arising out of the consummation of the transactions contemplated
hereby or the Purchased Assets, in each case on the Closing Date (including by taking enforcement action to cause the Financing Source to provide the Debt Financing); and (iii)&nbsp;Purchaser shall not release or consent to the termination of the
commitments and obligations of the lenders under the Debt Commitment Letter nor shall Purchaser terminate the Debt Commitment Letter.&nbsp;Purchaser shall give Seller prompt notice of any material breach by any party to the Debt Commitment Letter or
the definitive agreements related thereto of which Purchaser has become aware or any termination of the Debt Commitment Letter or such definitive agreements.&nbsp;In the event that the Debt Financing is required for Purchaser to comply with its
obligations under this Agreement (including its obligations under Section 5.03, and including to consummate the transactions contemplated hereby and satisfy regulatory capital requirements applicable to Purchaser or any of its Affiliates related to
or arising out of the consummation of the transactions contemplated hereby or the Purchased Assets), and any portion of the Debt Financing becomes unavailable, Purchaser shall (A) obtain, as promptly as practicable following the occurrence of such
event, alternative debt financing for any such portion from alternative debt sources (&#147;<B>Alternative Financing</B>&#148;) in an amount that will still enable Purchaser to consummate the transactions contemplated by this Agreement and satisfy
regulatory capital requirements applicable to Purchaser or any of its Affiliates related to or arising out of the consummation of the transactions contemplated hereby or the Purchased Assets, and (B) promptly notify Seller of such unavailability and
the reason therefor.&nbsp;If obtained, Purchaser shall deliver to Seller true and complete copies of all agreements (including redacted copies of engagement and fee letters, removing only fee amounts, market &#147;flex&#148; provisions and certain
other terms (none of which concern or would adversely affect the amounts, availability, timing or conditionality of the Debt Financing), but including all fee amounts payable in connection with a termination of this Agreement) pursuant to which any
such alternative source shall have committed to provide Purchaser with Alternative Financing.&nbsp;Purchaser shall not, without Seller&#146;s prior written consent, permit any amendment or modification to, or any waiver of any provision or remedy
under, the Debt Commitment Letter or any definitive agreements related thereto unless the terms of the Debt Commitment Letter or definitive agreements related thereto, in each case as so amended, modified or waived, are substantially similar to
those in the Debt Commitment Letter or definitive agreement related thereto, prior to giving effect to such amendment, modification or waiver (other than economic terms, which shall be as good as or better for Purchaser than those in the Debt
Commitment Letter or definitive agreement relating thereto prior to giving effect to such amendment, modification or waiver); <I>provided</I> that in the case of amendments, modifications or waivers of the Debt Commitment Letter or a definitive
agreement relating thereto, the foregoing shall only apply if such amendment, modification or waiver (x) would reasonably be expected to (i)&nbsp;adversely affect the ability or likelihood of Purchaser timely consummating the transactions
contemplated by this Agreement or satisfying regulatory capital requirements applicable to Purchaser or any of its Affiliates related to or arising out of the consummation of the transactions contemplated hereby or the Purchased Assets
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-42- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or (ii)&nbsp;make the timely funding of the Debt Financing or the satisfaction of the conditions to obtaining the Debt Financing less likely to occur, (y) reduces the amount of the Debt Financing
or (z) adversely affects the ability of Purchaser to enforce its rights against other parties to the Debt Commitment Letter or the definitive agreements relating thereto.&nbsp;Purchaser shall provide Seller with prompt written notice of the receipt
of any notice or other communication from the Financing Source with respect to the Financing Source&#146;s failure or anticipated failure to fund its commitments under the Debt Commitment Letter or definitive agreement in connection
therewith.&nbsp;Upon Seller&#146;s written request, Purchaser shall provide Seller with the status of Purchaser&#146;s efforts to consummate the Debt Financing.&nbsp;Purchaser shall have the right to substitute the net cash proceeds received by
Purchaser after the date hereof and prior to the Closing Date from consummated offerings or other incurrences of long-term non-callable debt (including notes) with a maturity date on or after December 31, 2021 by Purchaser for all or any portion of
the Debt Financing by reducing commitments under the Debt Commitment Letter; <I>provided</I> that (i)&nbsp;to the extent any such debt has a special or mandatory redemption right, such right is not exercisable prior to the earlier of the
consummation of the transactions contemplated by this Agreement on the Closing Date or the termination of this Agreement, (ii)&nbsp;such offering or other incurrence of debt does not result in a breach or default under, or violation of, the Debt
Commitment Letter, (iii)&nbsp;the aggregate amount of the Debt Financing committed under the Debt Commitment Letter following such reduction, together with other cash and cash equivalents available to Purchaser, is sufficient to pay all amounts
required to be paid in connection with the transactions contemplated by this Agreement and to satisfy regulatory capital requirements applicable to Purchaser or any of its Affiliates related to or arising out of the consummation of the transactions
contemplated hereby or the Purchased Assets and (iv)&nbsp;Purchaser promptly notifies Seller of such substitution and reduction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)
Seller shall use, and shall cause its Subsidiaries and its and their respective Representatives to use, Commercially Reasonable Efforts to cooperate, on a timely basis, with Purchaser in connection with the Debt Financing (<I>provided</I> that any
cooperation shall not unreasonably interfere with the business or operations of Seller or its Subsidiaries), including (i) providing reasonable assistance in the preparation of one or more confidential information memoranda, prospectuses, offering
memoranda, private placement memoranda and other customary marketing and syndication materials reasonably requested by Purchaser or any of its Affiliates in connection with the Debt Financing; (ii) reasonably cooperating with the Financing Source or
prospective financing sources (including lenders, underwriters, initial purchasers or placement agents) for the Debt Financing (together with the arrangers and the partners, stockholders, managers, members, directors, attorneys, officers, employees,
advisors, accountants, consultants, agents, Affiliates and Representatives and successors of any of the foregoing) and their respective agents&#146; due diligence, including providing access to documentation reasonably requested by any such Person
in connection with the Debt Financing; and (iii) assisting in preparing customary rating agency presentations and causing appropriate members of Seller&#146;s management to participate in a reasonable number of sessions with rating agencies in
connection with the Debt Financing.&nbsp;Notwithstanding the foregoing, neither Seller nor any of its Affiliates shall be required (A)&nbsp;to prepare, create or provide (unless previously prepared and available) any financial information or
financial statements in respect of Seller, any of its Affiliates or the Purchased Assets in connection with any Debt Financing or (B)&nbsp;to take any action that would subject it to actual or potential Liability, to bear any cost or expense or to
pay any commitment or other similar fee or make any other payment (other than reasonable out-of-</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-43- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
pocket costs and expenses) or incur any other Liability or provide or agree to provide any indemnity in connection with the Debt Financing or any of the foregoing.&nbsp;Purchaser shall,
(1)&nbsp;promptly upon request by Seller, reimburse Seller for all reasonable and documented out-of-pocket costs and expenses (including reasonable attorneys&#146; fees) incurred by Seller in connection with the assistance of Seller contemplated by
this Section 5.05(b) and (2)&nbsp;indemnify and hold harmless the Seller and its Subsidiaries and their respective Representatives from and against any and all losses, claims, damages, liabilities, costs, reasonable attorneys&#146; fees, judgments,
fines, penalties and amounts paid in settlement provided such settlement has been entered into with Purchaser&#146;s written consent (including all interest, assessments and other charges paid or payable in connection with or in respect of any
thereof) suffered or incurred in connection with any financing or other securities offering of Purchaser or any assistance or activities provided in connection therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.06<I> Public Announcements; Confidentiality</I><I>.</I>&nbsp;(a)&nbsp;The parties agree to consult with one another before issuing
any press release, having any communication with the press (whether or not for attribution) or making any other public statement, or scheduling any press conference or conference call with investors or analysts, with respect to this Agreement or the
transactions contemplated hereby.&nbsp;Without limiting the foregoing, except for any press release or other public statement required by applicable Law (including securities laws and regulations of the Securities and Exchange Commission and any
rules or regulations applicable to the listing or quoting of the securities of either party or any of its Affiliates on any stock or securities exchange), advance notice of which shall be provided to the other party to the extent practicable, and
subject to any requirements or requests of CMS or any other Governmental Authority, (i)&nbsp;each party agrees that it shall not, and shall not permit any of its Affiliates to, issue any press release, have any communication with the press (whether
or not for attribution) or make any other public statement, or schedule any press conference or conference call with investors or analysts, in each case with respect to this Agreement or the transactions contemplated hereby, without the prior
written consent of the other party, and (ii)&nbsp;each party shall, and shall cause its Affiliates to, keep the terms of this Agreement confidential and not disclose such terms to any third party, without the prior written consent of the other
party.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) The parties agree that (i)&nbsp;from the date hereof until the Closing, each of the Confidentiality Agreement dated as of
June&nbsp;20, 2016 between Purchaser and Seller and the Clean Team Agreement dated as of June&nbsp;24, 2016 between Purchaser and Seller (together, the &#147;<B>Confidentiality Agreements</B>&#148;) shall remain in full force and effect, and
(ii)&nbsp;upon the Closing, each of the Confidentiality Agreements (but not, for the avoidance of doubt, Section 5.06(a)) shall terminate solely to the extent relating to the Purchased Assets; <I>provided </I>that, if this Agreement is terminated
prior to the Closing, then each of the Confidentiality Agreements shall continue in full force and effect in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary contained herein, subject to applicable Law and any requirements or requests of CMS, as
applicable, (i)&nbsp;each party and its Affiliates shall be permitted to make such disclosures to Governmental Authorities as are reasonably necessary to obtain the Consents of Governmental Authorities contemplated by Section 6.01(b) and Section
6.01(c), subject to the parties&#146; compliance with their obligations under Section 5.03), (ii)&nbsp;Seller and its Affiliates shall be permitted to make such disclosures to Governmental Authorities as are reasonably necessary to obtain any
Consents of Governmental </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-44- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Authorities required for the consummation of the Humana Acquisition and (iii)&nbsp;Seller and its Affiliates shall be permitted to make such disclosures with respect to this Agreement and the
transactions contemplated hereby as Seller deems appropriate to Humana or any of its Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) Following the Closing Date, neither
Seller nor any of its Affiliates or Representatives will disclose or make use of any confidential or non-public information pertaining to Purchaser or its Affiliates, the Purchased Assets (including any books, records or data), the Conveyed Medicare
Advantage Contracts, and the terms of this Agreement and the Transaction Documents, in each case, that was made available to or to which Seller or any of its Affiliates or Representatives had access to on or prior to the Closing Date, except
(a)&nbsp;to the extent that such information shall have become generally available to the public other than by breach of this Agreement by Seller or any of its Affiliates or Representatives, (b)&nbsp;to the extent that disclosure of such information
is required by applicable Law or by the rules, instruction or order of any self-regulatory organization, or Seller or any of its Affiliates or Representatives is requested or required by a Governmental Authority or in connection with any Action to
make such disclosure (but only after Purchaser, to the extent reasonably practicable under the circumstances, has been provided with reasonable notice and opportunity to take action against any such disclosure), (c)&nbsp;in connection with the
prosecution or defense of any claim or potential claim made or proposed to be made in connection with this Agreement or the agreements contemplated hereby or (d)&nbsp;in connection with the performance of any Transaction Document. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) If Purchaser determines that it is required to publicly file or otherwise disclose the Administrative Services Agreement pursuant to the
U.S. securities laws or the regulations of the Securities and Exchange Commission, (i) Purchaser and Seller shall reasonably cooperate with respect to the preparation of (including Purchaser providing Seller a reasonable opportunity to review and
comment on), and Purchaser shall file, an application with the Securities and Exchange Commission for confidential treatment of pricing information and such other information in the Administrative Services Agreement as Purchaser or Seller may
conclude is competitively sensitive or otherwise merits confidential treatment, (ii) Purchaser shall include Seller in any material correspondence (written or oral) with the Securities and Exchange Commission regarding such application for
confidential treatment, including in respect of any comment related thereto with respect to Purchaser&#146;s periodic and current reports filed with the Securities and Exchange Commission, and (iii) Purchaser and Seller shall otherwise reasonably
cooperate in connection with such application, including by using good faith efforts to agree upon the portions of the Administrative Services Agreement that will be redacted and for which Purchaser shall request confidential treatment and to
coordinate with each other with respect to any revisions to the scope of such redacted portions requested or required by the Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.07 <I>Further Assurances</I>.&nbsp;From and after the date hereof, without further consideration, including after the Closing, each
of Seller and Purchaser shall, and shall cause their respective Affiliates to, cooperate with the other party, execute and deliver such further documents and instruments (except, in the case of either party and their respective Affiliates, as set
forth in Section 5.10(c)), and do such other acts and things as Purchaser or Seller, as the case may be, may reasonably request in order to effectuate, evidence and confirm the transactions contemplated by, and the intended purposes of, this
Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-45- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.08 <I>Notice to Enrollees</I>.&nbsp;Seller shall, or shall cause its Affiliates to,
take such action as may be necessary to disseminate and mail such notices to Enrollees relating to the transactions contemplated by this Agreement as CMS requires (in a form mutually acceptable to Seller and Purchaser and in accordance with CMS
requirements), and Seller shall, or shall cause its Affiliates to, promptly provide CMS with such certifications concerning the discharge of such obligation as may reasonably be requested by CMS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.09 <I>Preauthorizations</I>.&nbsp;Purchaser hereby agrees that it shall, and shall cause its Affiliates to, honor and abide by, and
not rescind, revoke or modify, any preauthorization of coverage or services given in good faith in the ordinary course of business prior to the Closing by Seller to any Seller Enrollee that becomes a Purchaser Enrollee.&nbsp;Seller acknowledges and
agrees that any denial of a prior authorization request that occurred prior to the Closing Date, which after the Closing Date is reasonably determined to be improperly denied, shall be an Excluded Liability with respect to that portion of the claim
relating to periods from and after the Closing Date through the date of the determination that such denial of prior authorization request was improperly denied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.10 <I>Access to Information</I>.&nbsp;(a)&nbsp;From the date hereof until the Closing, Seller shall, to the extent permitted by
applicable Law, and subject to the Confidentiality Agreements, (i)&nbsp;give, and cause its Affiliates to give, Purchaser and its Representatives reasonable access to the books and records of Seller and its Affiliates relating to the Existing
Medicare Advantage Plans and, if the Closing occurs after January&nbsp;1, 2017, relating to the 2017 Seller Medicare Advantage Plans, in each case to the extent relevant to the Applicable Service Area and (ii)&nbsp;furnish, and cause its Affiliates
to furnish, to Purchaser and its Representatives such financial and operating data and other information that is in Seller&#146;s and its Affiliates&#146; possession and in the format maintained by Seller or its applicable Affiliate relating to the
Existing Medicare Advantage Plans and, if the Closing occurs after January&nbsp;1, 2017, relating to the 2017 Seller Medicare Advantage Plans, in each case as such Persons may reasonably request.&nbsp;From the date hereof until the Closing, without
Seller&#146;s prior written consent, Purchaser shall not, and shall cause its Affiliates not to, contact any Enrollees, other than in the ordinary course of Purchaser&#146;s or its Affiliates&#146; businesses, so long as any such contact does not
relate to this Agreement or the transactions contemplated hereby, and is in any event conducted in compliance with the terms of the Confidentiality Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) For the Required Period, (i)&nbsp;each party shall maintain and (subject to customary confidentiality agreements and subject to applicable
confidentiality Laws) make available to the other party on a reasonable basis, for inspection and duplication by it and its Representatives books and records in such party&#146;s or its Affiliates&#146; possession that solely relate to the Conveyed
Medicare Advantage Contracts or such party&#146;s operations related to the Purchased Assets either before or after the Closing, to the extent that such access is required (A)&nbsp;in connection with any Action, investigation, compliance with Law
purpose or matters relating to or affected by the Conveyed Medicare Advantage Contracts or such party&#146;s operations related to the Purchased Assets either before or after the Closing, including the preparation of financial reports, or
(B)&nbsp;to conclude, evidence and confirm the transactions contemplated by, and the intended purposes of, this Agreement (<I>provided</I> that in the case of the books and records included in the Purchased Assets, the parties acknowledge it is
Purchaser&#146;s obligation to maintain such books and records at its own cost), and (ii)&nbsp;neither party shall dispose of, alter or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-46- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
destroy any such books or records for the Required Period; <I>provided</I> that neither party shall be required to maintain or make available to the other party for any purpose, nor shall either
party have any other obligation pursuant to the foregoing provisions of this Section 5.10(b)&nbsp;with respect to, any policies, procedures or other proprietary materials of such party or any of its Affiliates.&nbsp;After the Required Period, each
party may destroy or otherwise dispose of any such corporate and accounting records, files, documents and correspondence, unless prior to the expiration of the Required Period the other party has given notice of its desire for a reasonable
opportunity to either take possession of such information or to make copies thereof at the requesting party&#146;s cost (subject to applicable confidentiality Laws).&nbsp;The &#147;<B>Required Period</B>&#148; shall mean (1) for patient, and
patient-related, information, 10 years following the Closing Date, and (2) for any other information or materials, seven years following the Closing Date, <I>provided</I> that if a longer period is required by applicable Law, then the Required
Period shall be such period required by applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Each party shall only be required to grant access to the other party pursuant
to the preceding clause (a) and/or (b)&nbsp;of this Section 5.10 during normal business hours in such manner as not to interfere unreasonably with the conduct of the business of such party and its Affiliates and upon at least five Business
Days&#146; advance written notice to such party.&nbsp;Notwithstanding anything to the contrary herein, nothing herein shall require (i)&nbsp;Seller or any of its Affiliates or Purchaser or any of its Affiliates to (A)&nbsp;provide information or
documents that (1)&nbsp;are competitively sensitive, (2)&nbsp;are not in such party&#146;s or its Affiliates&#146; possession, (3)&nbsp;include (x) any rebate or discount agreement or other contract relating to the provision of pharmaceutical
coverage or products that are applicable to any Existing Medicare Advantage Contract, 2017 Seller Medicare Advantage Contract or Conveyed Medicare Advantage Contract or any Excluded Assets or (y) any broker or vendor agreements or compensation
information related to unassigned Provider, Broker or vendor contracts or rates or (4)&nbsp;otherwise do not relate to the Conveyed Medicare Advantage Contracts, (B)&nbsp;convert information or documents into a different format than the format in
which such information or documents are held by such party and its Affiliates, or (C) provide the other party or its Representatives with access to (1)&nbsp;personnel records of any employee of such party or any of its Affiliates relating to
individual performance or evaluation records, medical histories or other information which, in the disclosing party&#146;s good faith opinion, is sensitive or the disclosure of which would reasonably be expected to subject such party or any of its
Affiliates to material risk of Liability, (2) information the disclosure of which, in the disclosing party&#146;s good faith opinion (x) would conflict with confidentiality obligations to which such party or any of its Affiliates is bound or (y)
would reasonably be expected to result in the forfeiture or waiver of any attorney-client or similar privilege; <I>provided</I> that, in the case of this clause (y), the disclosing party shall use Commercially Reasonable Efforts to provide the other
party, to the extent possible, with access to the relevant information in a manner that would not reasonably be expected to result in the forfeiture or waiver of any such attorney-client or similar privilege or (ii)&nbsp;either party&#146;s
independent accountants to make available to the other party or its Representatives any work papers unless and until such Person has signed a customary confidentiality and hold harmless agreement relating to such access to work papers in form and
substance reasonably acceptable to such independent accountants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) As promptly as reasonably practicable after the date hereof, subject
to Section 5.10(c), Seller shall make available to Purchaser&#146;s Representatives in the electronic data </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-47- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
room established by Seller that is known to Purchaser and Seller as the &#147;clean room&#148; and pursuant to the Confidentiality Agreements each of the Material Provider Contracts with Material
Providers that have received payments from Seller in excess of $100,000 during the period from January 1, 2015 through May 31, 2016 that was not made available to Purchaser on or prior to the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.11 <I>Broker Matters</I>.&nbsp;If, in order for Purchaser or any of its Affiliates to pay Assumed Commissions (as defined in the
form of Administrative Services Agreement attached hereto as <U>Schedule A</U>)&nbsp;to any Broker that enrolled individuals in an Existing Medicare Advantage Plan or a 2017 Seller Medicare Advantage Plan prior to the Closing, Purchaser or any of
its Affiliates is required under applicable Law to appoint such Broker as its agent for such purpose, then: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) From and after the date
hereof until the Closing, Seller shall provide Purchaser with such information with respect to such Broker as is necessary to permit Purchaser or any of its Affiliates to appoint such Broker in such capacity; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) At or prior to the Closing, Purchaser shall, or shall cause its Affiliates to, appoint such Broker in such capacity and train such Broker
to the extent required by CMS; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) At the Closing, Purchaser shall provide Seller with written evidence of such appointment and
training, in form and substance reasonably acceptable to Seller. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.12 <I>2017 Calendar Year True-Ups</I>.&nbsp;(a)&nbsp;If the
Closing occurs after January&nbsp;1, 2017, and the 2017 Split Year Medicare Advantage Contracts are the Conveyed Medicare Advantage Contracts, the parties shall take the actions provided for by Section 5.12(b) so as to ensure that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) with respect to 2017 Enrollee-Based Payments, each party receives the aggregate amount of 2017 Enrollee-Based Payments
(and, for the avoidance of doubt, no greater or lesser amount of 2017 Enrollee-Based Payments) that should have been paid to such party in accordance with CMS requirements and other applicable Law for calendar year 2017 coverage of Enrollees under
the 2017 Seller Split Year Medicare Advantage Plans, in the case of Seller, or the Purchaser Medicare Advantage Plans, in the case of Purchaser (the aggregate amount of 2017 Enrollee-Based Payments that should have been paid to each party, such
party&#146;s &#147;<B>2017 Enrollee-Based Payment Entitlement</B>&#148;); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) with respect to any 2017 Plan-Based
Adjustment, each party bears a portion of such 2017 Plan-Based Adjustment equal to (A)&nbsp;the aggregate amount of such 2017 Plan-Based Adjustment, multiplied by (B)&nbsp;a fraction, (1) the numerator of which is the sum of the number of Enrollees
during each month of calendar year 2017 in which such party offered the Medicare Advantage plan under which such 2017 Plan-Based Adjustment arises, and (2) the denominator of which is the sum of the number of Enrollees during each month of calendar
year 2017; <I>provided</I> that, for purposes of this Section 5.12, the number of Enrollees during any month of calendar year 2017 shall be as set forth in the most current membership roster for such month issued by CMS relating to Enrollees, and,
for the avoidance of doubt, shall not be based, in whole or in part, on any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-48- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
other information including any records of Seller, Purchaser or any other Person, including CMS (the portion of any 2017 Plan-Based Adjustment that each party bears hereunder, such party&#146;s
&#147;<B>2017 Plan-Based Adjustment Portion</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) If the Closing occurs after January&nbsp;1, 2017, and the 2017 Split Year
Medicare Advantage Contracts are the Conveyed Medicare Advantage Contracts: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) As promptly as practicable after
Purchaser&#146;s receipt of each CMS Report and in no event more than 30 Business Days thereafter (which period Seller shall agree to reasonably extend upon written request by Purchaser reasonably documenting the reason for such extension and the
period of such extension may not exceed an additional 30 calendar days), Purchaser shall deliver to Seller (A)&nbsp;a written statement (the <B>&#147;</B><B>Purchaser True-Up Statement</B>&#148;) setting forth Purchaser&#146;s calculation of
(1)&nbsp;each party&#146;s 2017 Enrollee-Based Payment Entitlement and/or each party&#146;s 2017 Plan-Based Adjustment Portion, as applicable, relating to such CMS Report, and (2)&nbsp;the net amount payable by either Purchaser or Seller to the
other party as a result of such calculation so as to ensure that each party receives or bears its 2017 Enrollee-Based Payment Entitlement and/or 2017 Plan-Based Adjustment Portion, as applicable, relating to such CMS Report, taking into account, in
the case of each party&#146;s 2017 Enrollee-Based Entitlement, the aggregate amount of 2017 Enrollee-Based Payments that such party actually received for calendar year 2017, including any adjustment to or additional payment actually received with
respect to any such payment for calendar year 2017 (such net amount, the &#147;<B>True-Up Amount</B>&#148; relating to such CMS Report), and (B)&nbsp;a copy of each applicable CMS Report. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) If Purchaser fails to timely deliver any Purchaser True-Up Statement in accordance with Section 5.12(b)(i), Purchaser
shall still be required to deliver to Seller the applicable CMS Report(s) in accordance with Section 5.12(b)(i), and if any CMS Report is not so delivered, Purchaser hereby authorizes Seller to request such report directly from CMS and authorizes
CMS to deliver such report directly to Seller.&nbsp;In such event: (A)&nbsp;upon receipt of any CMS Report from Purchaser or CMS, as applicable, Seller shall be entitled to calculate each party&#146;s 2017 Enrollee-Based Payment Entitlement and/or
2017 Plan-Based Adjustment Portion, as applicable, relating to such CMS Report(s); and (B)&nbsp;Seller shall deliver to Purchaser (1)&nbsp;a written statement (the &#147;<B>Seller True-Up Statement</B>&#148;) setting forth Seller&#146;s calculation
of (x)&nbsp;each party&#146;s 2017 Enrollee-Based Payment Entitlement and/or each party&#146;s 2017 Plan-Based Adjustment Portion, as applicable, and (y)&nbsp;the True-Up Amount, in each case relating to such CMS Report(s), and (2)&nbsp;a copy of
each applicable CMS Report.&nbsp;Purchaser shall be deemed to have agreed with the True-Up Amount and all other items and amounts in each Seller True-Up Statement, and each such item and amount shall be final and binding upon Purchaser and Seller
for all purposes of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) If Purchaser timely delivers a Purchaser True-Up Statement and the applicable
CMS Report(s) in accordance with Section 5.12(b)(i), and Seller disagrees with Purchaser&#146;s calculation of either party&#146;s 2017 Enrollee-Based Payment Entitlement or 2017 Plan-Based Adjustment Portion, as applicable, relating to such CMS
Report(s) as set forth in such Purchaser True-Up Statement, Seller may, within 30 Business Days after receipt of such Purchaser True-Up Statement, deliver a notice (a &#147;<B>Notice of True-Up </B> </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-49- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
<B>Disagreement</B>&#148;) to Purchaser disagreeing with either party&#146;s 2017 Enrollee-Based Payment Entitlement and/or 2017 Plan-Based Adjustment Portion, as applicable, as set forth in such
Purchaser True-Up Statement, and specifying Seller&#146;s calculation of (A)&nbsp;each party&#146;s 2017 Enrollee-Based Payment Entitlement and/or 2017 Plan-Based Adjustment Portion, as applicable, and (B)&nbsp;the True-Up Amount, in each case
relating to such CMS Report(s).&nbsp;If Seller does not timely deliver a Notice of True-Up Disagreement following receipt of a Purchaser True-Up Statement, (1)&nbsp;Seller shall be deemed to have agreed with the True-Up Amount and all other items
and amounts contained in such Purchaser True-Up Statement; and (2)&nbsp;each such item and amount shall be final and binding upon Purchaser and Seller for all purposes of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) If Seller timely delivers a Notice of True-Up Disagreement with respect to a Purchaser True-Up Statement, Purchaser and
Seller shall, during the 30 Business Days after delivery of such notice, use their respective Commercially Reasonable Efforts to reach agreement on the disputed matters in order to determine (A)&nbsp;each party&#146;s 2017 Enrollee-Based Payment
Entitlement and/or 2017 Plan-Based Adjustment Portion, as applicable, relating to the applicable CMS Report(s), each of which amounts shall not be greater than the greatest value for such amount claimed by either party or less than the smallest
value for such amount claimed by either party, in each case as set forth in the applicable Purchaser True-Up Statement or the applicable Notice of True-Up Disagreement, as applicable, and (B)&nbsp;the True-Up Amount relating to the applicable CMS
Report(s).&nbsp;If Purchaser and Seller reach agreement as to the True-Up Amount relating to any CMS Report during such 30 Business Day period, such True-Up Amount and each other item and amount relating to the calculation thereof that is agreed
upon by the parties in connection with their agreement as to such True-Up Amount shall be final and binding upon Purchaser and Seller for all purposes of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) If Purchaser and Seller are unable to reach agreement as to either party&#146;s 2017 Enrollee-Based Payment Entitlement or
2017 Plan-Based Adjustment Portion, as applicable, relating to a CMS Report during such 30 Business Day period, either party may thereafter cause an independent accounting firm of nationally recognized standing reasonably satisfactory to Purchaser
and Seller (the &#147;<B>Accounting Referee</B>&#148;), to promptly review this Agreement and the disputed matters for the purpose of calculating each party&#146;s 2017 Enrollee-Based Payment Entitlement and/or 2017 Plan-Based Adjustment Portion, as
applicable, relating to such CMS Report.&nbsp;If the parties submit the dispute to an Accounting Referee, then in making such calculation, the Accounting Referee shall (A)&nbsp;be bound by the terms of this Agreement, including the definitions of
2017 Enrollee-Based Payment, 2017 Enrollee-Based Payment Entitlement, 2017 Plan-Based Adjustment, 2017 Plan-Based Adjustment Portion, True-Up Amount and the other terms of this Section 5.12, (B)&nbsp;consider only the disputed matters and
(C)&nbsp;not assign a value to any disputed item greater than the greatest value for such item claimed by either party or less than the smallest value for such item claimed by either party, in each case as set forth in the applicable Purchaser
True-Up Statement or the applicable Notice of True-Up Disagreement, as applicable.&nbsp;The Accounting Referee&#146;s determination of any disputed matter shall be based solely on written materials, presentations and arguments submitted and/or made
by Purchaser and Seller (i.e., shall not be based on an independent review).&nbsp;The Accounting Referee shall deliver to Purchaser and Seller, as promptly as practicable, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-50- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
a written report setting forth (1) its calculation of the disputed matters and each party&#146;s 2017 Enrollee-Based Payment Entitlement and/or 2017 Plan-Based Adjustment Portion, as applicable,
relating to such CMS Report, each of which amounts shall not be greater than the greatest value for such amount claimed by either party or less than the smallest value for such amount claimed by either party, in each case as set forth in the
applicable Purchaser True-Up Statement or the applicable Notice of True-Up Disagreement, as applicable, and (2) the True-Up Amount relating to such CMS Report.&nbsp;Such Accounting Referee&#146;s report shall be final and binding upon Purchaser and
Seller for all purposes of this Agreement.&nbsp;The fees and expenses of the Accounting Referee for each report shall be allocated between Purchaser, on the one hand, and Seller, on the other hand, based upon the percentage which the portion of the
aggregate dollar value of the items set forth in the Notice of True-Up Disagreement not awarded to Purchaser and Seller bears to the amount actually contested by such party.&nbsp;For example, if Seller claims that the appropriate adjustments are
$1,000 greater than the amount determined by Purchaser and if the Accounting Referee ultimately resolves such items by awarding to Seller $300 of the $1,000 contested, then the fees, costs and expenses of the Accounting Referee will be allocated
thirty percent (30%) (i.e., 300 &divide; 1,000) to Purchaser and seventy percent (70%) (i.e., 700 &divide; 1,000) to Seller.</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) Within five Business Days after the True-Up Amount relating to any CMS Report has become final and binding upon Purchaser
and Seller pursuant to Section 5.12(b)(ii), Section 5.12(b)(iii), Section 5.12(b)(iv)&nbsp;or Section 5.12(b)(v), as applicable, Purchaser or Seller, as applicable, shall pay to the other party such True-Up Amount by wire transfer of immediately
available funds to an account specified by the receiving party. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) Each of Seller and Purchaser agrees that it shall,
and agrees at its expense to cause its independent accountants to, cooperate and assist in the calculation of each party&#146;s 2017 Enrollee-Based Payment Entitlement and 2017 Plan-Based Adjustment Portion, as applicable, relating to any CMS
Report, and in the conduct of the reviews referred to in this Section 5.12(b), including making available, to the extent reasonably requested, books, records, work papers and personnel in accordance with Section 5.10(c). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) For the avoidance of doubt, (A)&nbsp;each party acknowledges and agrees that amounts received under any Conveyed
Medicare Advantage Contracts or the 2017 Seller Medicare Advantage Contracts may fall within the scope of this Section 5.12 if and to the extent that such amounts constitute 2017 Enrollee-Based Payments or 2017 Plan-Based Adjustments, and any such
amounts shall be allocated between the parties in accordance with this Section 5.12 notwithstanding the fact that such amounts also constitute Purchased Assets or Excluded Assets, and (B)&nbsp;each party acknowledges and agrees (on behalf of itself
and each of its Respective Indemnified Persons) that neither party nor any of its Respective Indemnified Persons shall have any right or remedy against the other party or any of its Respective Indemnified Persons for any matter or claim relating to
any report or other communication issued by CMS after December&nbsp;31, 2018, regardless of whether such report or other communication contains a determination by CMS of (1) any adjustment to or additional payment with respect to any 2017
Enrollee-Based Payments or (2) any 2017 Plan-Based Adjustment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-51- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary contained herein, Purchaser and Seller agree that,
in connection with any calculation used as the basis for any 2017 Enrollee-Based Payment or 2017 Plan-Based Adjustment, Purchaser and Seller shall, and shall cause each of their respective Affiliates to, perform such calculation in good faith and
consistent with their respective practices used for such calculations for their other similar businesses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.13 <I>Mail and
Communications</I>.&nbsp;Each party shall promptly deliver to the other party any mail or other communications relating to the Purchased Assets that is intended for the other party and that is received by such party or any of its Affiliates
following the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.14 <I>Notices of Certain Events</I>.&nbsp;(a)&nbsp;Each of Purchaser and Seller shall promptly notify
the other party of any of the following if such party has knowledge thereof: (i)&nbsp;any written notice or other written communication from any Person alleging that the consent of such Person is or may be required in connection with the
transactions contemplated hereby; (ii)&nbsp;any written or material oral notice or other material communication from any Governmental Authority in connection with the transactions contemplated hereby; and (iii)&nbsp;the commencement of any Action or
investigation that, if pending on the date of this Agreement, would have been required to have been disclosed pursuant to Section 3.06, in the case of Seller, or Section 4.05, in the case of Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to the contrary herein, a party&#146;s good faith failure to comply with this Section 5.14 shall not provide the
other party the right not to effect the transactions contemplated by this Agreement, except, in each case, to the extent that any other provision of this Agreement independently provides such right. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.15 <I>Seller Marks</I>.&nbsp;From and after the Closing, except as otherwise set forth in the Transitional Trademark License
Agreement, Purchaser shall not, and shall cause its Affiliates not to, (a)&nbsp;use or reference any trademarks, service marks, domain names, logos or names owned by Seller or any of its Affiliates (including the AETNA and/or COVENTRY name or marks)
or any mark confusingly similar thereto (collectively, the &#147;<B>Seller Marks</B>&#148;), (b)&nbsp;hold themselves out as having any affiliation, either expressly or by implication, with Seller or any of its Affiliates or (c)&nbsp;challenge the
ownership, validity or enforceability of any of the Seller Marks. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.16 <I>Tax Matters</I>.&nbsp;(a)&nbsp;Purchaser and Seller
agree to furnish or cause to be furnished to each other, subject to the limitations set forth in Section 5.10(c), upon request, as promptly as practicable, such information and assistance relating to the Purchased Assets (including access to books
and records) as is reasonably necessary for the filing of all Tax Returns, the making of any election relating to Taxes, the preparation for any audit by any Taxing Authority, and the prosecution or defense of any claim, suit or proceeding relating
to any Tax.&nbsp;Purchaser and Seller shall retain all books and records with respect to Taxes pertaining to the Purchased Assets for a period of at least six years following the Closing Date.&nbsp;On or after the end of such period, each party
shall use Commercially Reasonable Efforts to provide the other party with at least 10 days prior written notice before destroying any such books and records, during which period the party receiving such notice can elect to take possession, at its
own expense, of such books and records.&nbsp;Seller and Purchaser shall cooperate with each other in the conduct of any audit or other proceeding relating to Taxes involving the Purchased Assets. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-52- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Any real property taxes, personal property taxes and similar <I>ad valorem</I> obligations
levied with respect to the Purchased Assets for a taxable period which includes (but does not begin on) the Closing Date (collectively, the &#147;<B>Apportioned Obligations</B>&#148;) shall be apportioned between Seller and Purchaser based on the
number of days of such taxable period included in the Pre-Closing Tax Period and the number of days of such taxable period in the Post-Closing Tax Period.&nbsp;Seller shall be liable for the proportionate amount of such taxes that is attributable to
the Pre-Closing Tax Period, and Purchaser shall be liable for the proportionate amount of such taxes that is attributable to the Post-Closing Tax Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) All excise, sales, use, value added, registration stamp, recording, documentary, conveyancing, franchise, property, transfer, gains and
similar Taxes, levies, charges and fees incurred in connection with the transactions contemplated by this Agreement (collectively, &#147;<B>Transfer Taxes</B>&#148;) shall be borne equally by Purchaser and Seller.&nbsp;Purchaser and Seller shall
cooperate in providing each other with any appropriate resale exemption certifications and other similar documentation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) Apportioned
Obligations and Transfer Taxes shall be timely paid, and all applicable filings, reports and returns shall be filed, as provided by applicable Law.&nbsp;The paying party shall be entitled to reimbursement from the non-paying party in accordance with
Section 5.16(b) or Section 5.16(c), as the case may be.&nbsp;Upon payment of any such Apportioned Obligation or Transfer Tax, the paying party shall present a statement to the non-paying party setting forth the amount of reimbursement to which the
paying party is entitled under Section 5.16(b) or Section 5.16(c), as the case may be, together with such supporting evidence as is reasonably necessary to calculate the amount to be reimbursed.&nbsp;The non-paying party shall make such
reimbursement promptly but in no event later than 10 days after the presentation of such statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.17 <I>2016 Marketing
Matters</I>.&nbsp;(a)&nbsp;For purposes of this Agreement, the following terms have the following meanings: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)
&#147;<B>Lead Generation Budget</B>&#148; means the amount set forth on Section 5.17(a) of the Seller Disclosure Schedules in the aggregate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) &#147;<B>Pre-Closing Lead Generation Budget</B>&#148; means an amount equal to (i)&nbsp;the amount of the Lead Generation
Budget, multiplied by (ii)&nbsp;a fraction, (A)&nbsp;the numerator of which is the number of days from the date hereof until the earlier of the Closing Date and January&nbsp;1, 2017, and (B)&nbsp;the denominator of which is the number of days from
the date hereof until January&nbsp;1, 2017. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) &#147;<B>Post-Closing Lead Generation Budget</B>&#148; means an amount
equal to (i)&nbsp;the amount of the Lead Generation Budget, multiplied by (ii)&nbsp;a fraction, (A)&nbsp;the numerator of which is the number of days from the Closing Date until January&nbsp;1, 2017 (if any), and (B)&nbsp;the denominator of which is
the number of days from the date hereof until January&nbsp;1, 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) From the date hereof until the earlier of the Closing Date and
January&nbsp;1, 2017, Seller shall, or shall cause its Affiliates to, use Commercially Reasonable Efforts to spend </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-53- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
at least the Pre-Closing Lead Generation Budget on direct sales lead generation with respect to the Conveyed Medicare Advantage Contracts.&nbsp;Subject to applicable Law, Seller shall, and shall
cause its Affiliates to, use Commercially Reasonable Efforts to spend the Pre-Closing Lead Generation Budget in accordance with a written plan to be provided by Purchaser to Seller, subject to Seller&#146;s prior written approval, such approval not
to be unreasonably withheld, delayed or conditioned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) If the Closing occurs prior to January&nbsp;1, 2017, Seller shall pay or cause
to be paid to Purchaser an amount equal to the Post-Closing Lead Generation Budget at the Closing (which amount may be netted against and reduce the amount of the Closing Payment, if mutually agreed by the parties). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) If the Closing occurs after January&nbsp;1, 2017, from and after January&nbsp;1, 2017 until the Closing, Seller will conduct marketing
activities with respect to the 2017 Seller Medicare Advantage Plans in the ordinary course of business consistent with past practice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.18 <I>2017 Marketing Matters</I>.&nbsp;(a) For purposes of this Agreement, the following terms have the following meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) &#147;<B>2017 Lead Generation</B><B> Budget</B>&#148; means an amount equal to the product of (A)&nbsp;the number of new
Seller Enrollees as of the first date that is on or after March 1, 2017 as shown on the monthly membership report issued by CMS in April 2017 and (B)&nbsp;Seller&#146;s 2016 average cost per sale for direct channels. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) &#147;<B>Pre-Closing 2017 Lead Generation Budget</B>&#148; means an amount equal to (i) the amount of the 2017 Lead
Generation Budget, multiplied by (ii) a fraction, (A)&nbsp;the numerator of which is the number of days from September&nbsp;1, 2017 until the earlier of the Closing Date and January&nbsp;1, 2018 (if any), and (B)&nbsp;the denominator of which is the
number of days from September&nbsp;1, 2017 until January&nbsp;1, 2018. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) &#147;<B>Post-Closing 2017 Lead Generation
Budget</B>&#148; means an amount equal to (i) the amount of the 2017 Lead Generation Budget, multiplied by (ii) a fraction, (A)&nbsp;the numerator of which is the number of days from the Closing Date until January&nbsp;1, 2018 (if any), and
(B)&nbsp;the denominator of which is the number of days from September&nbsp;1, 2017 until January&nbsp;1, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) If the Closing has
not occurred by September&nbsp;1, 2017, then from September&nbsp;1, 2017 until the earlier of the Closing Date and January&nbsp;1, 2018, Seller shall, or shall cause its Affiliates to, use Commercially Reasonable Efforts to spend at least the
Pre-Closing 2017 Lead Generation Budget on direct sales lead generation with respect to the Conveyed Medicare Advantage Contracts.&nbsp;Subject to applicable Law, Seller shall, and shall cause its Affiliates to, use Commercially Reasonable Efforts
to spend the Pre-Closing 2017 Lead Generation Budget in accordance with a written plan to be provided by Purchaser to Seller, subject to Seller&#146;s prior written approval, such approval not to be unreasonably withheld, delayed or conditioned.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) If the Closing occurs after September&nbsp;1, 2017 and prior to January&nbsp;1, 2018, Seller shall pay or cause to be paid to
Purchaser an amount equal to the Post-Closing 2017 Lead Generation Budget at the Closing (which amount may be netted against and reduce the amount of the Closing Payment, if mutually agreed by the parties). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-54- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.19 <I>Exclusivity</I>.&nbsp;Between the date of this Agreement and the earlier to occur
of the termination of this Agreement pursuant to Article 8 and the Closing Date, Seller shall not, directly or indirectly (including indirectly through its Representatives), (a)&nbsp;solicit, initiate, knowingly encourage or induce or take any other
action to in any way knowingly facilitate any inquiries or the making of any proposal that constitutes or would reasonably be expected to lead to (including by way of furnishing information or assistance) a Competing Transaction, (b)&nbsp;engage in
or otherwise participate in any negotiations or discussions with any Person (other than any Governmental Authority) concerning, provide any information to, or cooperate in any way with, any Person relating to, any Competing Transaction or
(c)&nbsp;agree to, approve or recommend any contract (written or oral), agreement in principle, letter of intent, term sheet or other similar instrument relating to any Competing Transaction.&nbsp;Seller shall immediately cease and cause to be
terminated any existing activities, discussions or negotiations with any parties conducted heretofore with respect to any of the foregoing (other than any such discussions with any Governmental Authority) and shall use its Commercially Reasonable
Efforts to cause any such party in possession of confidential information about Seller that was furnished by or on behalf of Seller in connection with the sale process conducted by Seller prior to the date hereof with respect to the Purchased Assets
to return or destroy all such information.&nbsp;Seller acknowledges and agrees that any remedy at law for breach of the foregoing covenant may be inadequate and, in addition to any other relief which may be available, Purchaser shall be entitled to
seek temporary and permanent injunctive relief without the necessity of proving actual damages, posting bond or providing surety, and without regard to the adequacy of any remedy at Law.&nbsp;Seller represents and warrants that, as of the date
hereof, (x) it is not engaged in discussions or negotiations with any party other than Purchaser or any Governmental Authority with respect to any of the foregoing, (y) there is no stand-by or back-up contract (written or oral), agreement or other
understanding with respect to the sale of the Purchased Assets, and (z) it has terminated all discussions with third parties (other than any Governmental Authorities) with respect to such proposed matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.20 <I>Purchase Option</I>.&nbsp;(a)&nbsp;In consideration of the transactions contemplated hereby, if after the date hereof Seller
or any of its Affiliates are required to, or otherwise determine to, divest individual Medicare Advantage plan Contracts in addition to the Conveyed Medicare Advantage Contracts (the portion of such Contracts covering the applicable geographies to
be divested, the &#147;<B>Additional Contracts</B>&#148;) in connection with the Humana Acquisition and prior to the closing of the Humana Acquisition, Purchaser shall have the exclusive irrevocable option (the &#147;<B>Option</B>&#148;) to
purchase, free and clear of any Liens except Permitted Liens, the Additional Contracts on terms substantially identical to those set forth in this Agreement at a purchase price calculated on a per-Enrollee basis of the amount per Enrollee set forth
on Section 5.20(a) of the Seller Disclosure Schedules, to be adjusted proportionally based on deviation in premium revenue and medical benefit ratio for such Additional Contracts as compared to the Conveyed Medicare Advantage Contracts and such
other metrics as the parties shall mutually agree upon.&nbsp;Seller shall provide prompt notice in writing to Purchaser of its intention to divest such Additional Contracts and Purchaser shall have the right to irrevocably exercise the Option with
respect to all (but not less than all) of the Additional Contracts within 15 days of receipt of such notice by providing irrevocable written notice of such election to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-55- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Seller; <I>provided, however</I>, that if Purchaser shall notify Seller in writing within such 15-day period that it is diligently and in good faith pursuing financing sources to enable it to
exercise the Option, then Purchaser shall have up to a total (including the initial 15 days) of 30 days to provide such notice of election to Seller (such 15-day or 30-day period, the &#147;<B>Option Exercise Period</B>&#148;). Purchaser
acknowledges and agrees that it will exercise the Option and acquire the Additional Contracts if, in Purchaser&#146;s good faith and reasonable judgment, (i) the acquisition of the Additional Contracts pursuant to this Section 5.20, and (ii) the
acquisition of the Purchased Assets pursuant to this Agreement, considered together and as a whole, are commercially reasonable.&nbsp;If Purchaser exercises the Option during the Option Exercise Period (including any extension of the Option Exercise
Period pursuant to Section 5.20(b) below), Purchaser and Seller will enter into an amendment to this Agreement or an agreement on substantially similar terms as this Agreement promptly after such exercise providing for Purchaser&#146;s purchase of
the Additional Contracts.&nbsp;If Purchaser does not exercise the Option within the Option Exercise Period (including any extension of the Option Exercise Period pursuant to Section 5.20(b) below), Seller shall be free to sell, divest or otherwise
transfer the Additional Contracts to one or more Persons without restriction thereafter and this Option shall thereafter terminate.&nbsp;Notwithstanding the foregoing, Purchaser agrees that all of Purchaser&#146;s rights under this Section 5.20
(including, for the avoidance of doubt, the grant of the Option to Purchaser) shall terminate on the earlier to occur of (1) the closing of the Humana Acquisition and (2) the termination of this Agreement pursuant to Article 8.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to the contrary in Section 5.20(a), if Seller reasonably and in good faith determines that Purchaser&#146;s
purchase of the Additional Contracts pursuant to the Option is not reasonably likely to be consummated in a timely manner in accordance with the terms set forth in this Agreement, including Section 5.20, taking into account, among other things, any
governmental or other Consent requirements for (or potential governmental challenges to) such purchase and the likelihood that such Consents will be obtained (or such challenges overcome) in a timely manner, Seller shall promptly notify Purchaser in
writing of such determination, which notice shall set forth in reasonable detail Seller&#146;s concerns underlying such determination, and Purchaser shall have 10 days after receipt of such notice to reasonably respond to the issues raised by
Seller.&nbsp;If after such 10-day period, Purchaser is unable to reasonably address Seller&#146;s concerns as determined in Seller&#146;s reasonable good faith judgment, then Seller shall not be required to offer the Additional Contracts to
Purchaser pursuant to the Option, and Purchaser shall not have the right to purchase the Additional Contracts pursuant to the Option.&nbsp;Alternatively, if during such 10-day period, Purchaser is able to reasonably address Seller&#146;s concerns as
determined in Seller&#146;s reasonable good faith judgment, then the Option Exercise Period shall be extended for such additional period of time (up to 10 days) for Purchaser and Seller to resolve any issues raised by Seller under this Section
5.20(b).</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.21 <I>Humana Purchase Agreement</I>.&nbsp;Without Seller&#146;s prior written consent, Purchaser shall not, and shall
cause its Affiliates not to, amend, waive, alter or otherwise modify the Humana APA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5.22 <I>2018 Bids</I>.&nbsp;(a) From the
date hereof until the Closing Date, subject to applicable Law, Seller shall, and shall cause its Affiliates to, provide Purchaser with copies of all business and financial books, records and data maintained by or on behalf of Seller and its
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-56- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Affiliates that are required to prepare each of the bids to be submitted to CMS with respect to the entry into any Contract split from and replacing any 2017 Seller Medicare Advantage Contract
pursuant to which any Medicare Advantage plans will be offered directly to individuals in the Applicable Service Area during calendar year 2018 (each, a &#147;<B>2018 Bid</B>&#148;, and such books, records and data, collectively, the &#147;<B>2018
Bid Information</B>&#148;); <I>provided</I> that, notwithstanding the foregoing: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) with respect to any 2018 Bid
Information relating to any county in the Applicable Service Area in which Purchaser or any of its Affiliates offers or is planning to offer Medicare Advantage plans directly to individuals, such 2018 Bid Information shall not be provided to
Purchaser and shall instead be provided to a third-party consultant designated by Purchaser, subject to the prior written consent of Seller, not to be unreasonably withheld, delayed or conditioned (such consultant, the &#147;<B>Reviewing
Consultant</B>&#148;), and the Reviewing Consultant may not share any 2018 Bid Information or any notes, summaries, analyses or compilations derived, in whole or in part, from any 2018 Bid Information, with Purchaser, any of its Affiliates or any of
their respective Representatives prior to the Closing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(ii) with respect to any 2018 Bid Information provided to
Purchaser, Purchaser shall ensure that such 2018 Bid Information is provided or otherwise accessible only to those of Purchaser&#146;s and its Affiliates&#146; employees who are responsible for preparing Purchaser&#146;s and its Affiliates&#146;
2018 Bids, and such employees may not share any 2018 Bid Information or any notes, summaries, analyses or compilations derived, in whole or in part, from any 2018 Bid Information, with any other employees or other Representatives of Purchaser or any
of its Affiliates prior to the Closing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(iii) Seller acknowledges and agrees that, notwithstanding Section
5.10(c)(i)(A)(3), the 2018 Bid Information shall include business and financial books, records and data maintained by or on behalf of Seller and its Affiliates of the types referred to in Section 5.10(c)(i)(A)(3) (in either aggregated or, if
required, unaggregated), to the extent that such books, records and data are required to prepare the 2018 Bids (the books, records and data referred to in this clause (iii), collectively, &#147;<B>Sensitive 2018 Bid Information</B>&#148;); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(iv) Seller shall, or shall cause its Affiliates to, provide the 2018 Bid Information to Purchaser or the Reviewing Consultant,
as applicable, pursuant to this Section 5.22(a) promptly after the 2018 Bid Information becomes available to Seller&#146;s and its Affiliates&#146; own employees who are responsible for preparing Seller&#146;s and its Affiliates&#146; 2018 Bids.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Purchaser shall, and shall cause its Affiliates and Representatives (including, if applicable, the Reviewing Consultant) to, (i) keep
the 2018 Bid Information confidential, (ii) use the 2018 Bid Information solely for the purpose of preparing the 2018 Bids and (iii) return or destroy (A) the Sensitive 2018 Bid Information, including any notes, summaries, analyses and compilations
derived, in whole or in part, from the Sensitive 2018 Bid Information, promptly after the earlier of (1) the submission of the 2018 Bids to CMS, regardless of whether Seller and its Affiliates, or Purchaser and its Affiliates, submit their
respective 2018 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-57- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Bids to CMS pursuant to Section 5.22(c), and (2) the termination of this Agreement in accordance with its terms and (B) all other 2018 Bid Information, including any notes, summaries, analyses
and compilations derived, in whole or in part, from such 2018 Bid Information, promptly after any request by Seller to do so following the earlier of (1) the submission of Seller&#146;s and its Affiliates&#146; 2018 Bids to CMS, if Seller and its
Affiliates submit the 2018 Bids pursuant to Section 5.22(c), and (2) the termination of this Agreement in accordance with its terms.&nbsp;Purchaser shall be liable to Seller for any breach of Sections 5.22(a) or 5.22(b) by any of its Affiliates or
Representatives (including, if applicable the Reviewing Consultant). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Seller and its Affiliates, on the one hand, and Purchaser and
its Affiliates, on the other hand, shall prepare their own respective 2018 Bids.&nbsp;If the Closing occurs after June 1, 2017, Seller shall, and shall cause its Affiliates to, submit their respective 2018 Bids to CMS when due.&nbsp;If the Closing
occurs on or before June 1, 2017, Purchaser shall, and shall cause its Affiliates to, submit their respective 2018 Bids to CMS when due. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) Each party shall, and shall cause its Affiliates to, prepare their respective 2018 Bids in good faith and in compliance with applicable
Laws.&nbsp;Seller shall, and shall cause its Affiliates to, prepare their respective 2018 Bids in the ordinary course of business consistent with Seller&#146;s and its Affiliates&#146; practices for the preparation of bids with respect to the entry
into Contracts pursuant to which Medicare Advantage plans will be offered directly to individuals outside of the Applicable Service Area for calendar year 2018, and Seller shall cause its and its Affiliates&#146; respective 2018 Bids to be for
individual Medicare Advantage plans for calendar year 2018 that in each case have a plan design that is capable of being supported by Purchaser&#146;s and its Affiliates&#146; existing systems and vendor agreements.&nbsp;Unless Purchaser shall have
terminated the Administrative Services Agreement in accordance with its terms with respect to calendar year 2018 prior to the submission of the 2018 Bids to CMS, Purchaser shall cause its and its Affiliates&#146; respective 2018 Bids to be for
individual Medicare Advantage plans for calendar year 2018 that in each case have a plan design that is capable of being supported by Seller&#146;s and its Affiliates&#146; existing systems and vendor agreements.&nbsp;Seller shall ensure that none
of its or its Affiliates&#146; 2018 Bids are prepared by employees of Seller or any of its Affiliates who are responsible for preparing Humana&#146;s individual Medicare Advantage bids. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 6 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONDITIONS TO CLOSING
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 6.01 <I>Conditions to Purchaser&#146;s and Seller&#146;s Obligations</I><I>.</I>&nbsp;The obligations of Purchaser and Seller to
consummate the Closing are subject to the satisfaction or, to the extent permissible, waiver in writing by Purchaser and Seller in their sole discretion, prior to or at the Closing, of each of the following conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <I>No Legal Prohibition.</I><I>&nbsp;</I>No Law shall be in effect that enjoins, prevents or prohibits the consummation of the Closing.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <I>Notifications and Consents</I>.&nbsp;The Consents of any Governmental Authority, or expiration of any other waiting or
notification periods imposed by any Law or Governmental Authority or associated with any Filing, in each case described in Section 6.01(b) of the Seller Disclosure Schedules shall have been obtained or occurred, as the case may be&nbsp;(each such
Consent or expiration of a waiting period referred to in this Section 6.01(b), and each of the Medicare Advantage Contract Novations, a &#147;<B>Required Regulatory Approval</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-58- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <I>Medicare Advantage Contract Novations</I>.&nbsp;Each of the Medicare Advantage Contract
Novations shall have been obtained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <I>Other Asset Purchase Agreement</I>.&nbsp;The &#147;Closing&#148; of the transactions under and
as defined in Purchaser&#146;s Asset Purchase Agreement with Humana dated as of the date hereof relating to Purchaser&#146;s acquisition of assets divested by Humana in connection with the Humana Acquisition (the &#147;<B>Humana APA</B>&#148;) shall
have been consummated in accordance with the terms of such agreement prior to, or shall be consummated substantially contemporaneously with, the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section 6.02 <I>Conditions to Purchaser&#146;s Obligation</I><I>.</I>&nbsp;The obligation of Purchaser to consummate the Closing is subject to
the satisfaction or, to the extent permissible, waiver in writing by Purchaser in its sole discretion, prior to or at the Closing, of each of the following conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <I>Accuracy of Representations and Warranties</I>.&nbsp;All of the Seller Fundamental Representations shall be true and correct in all
material respects at and as of the Closing, as if made at and as of such time (except for any such representations and warranties that are made at or as of a specific date or time, which representations and warranties shall be true and correct in
all material respects only at and as of such specific date or time); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <I>Compliance with Agreement</I>.&nbsp;Seller shall have
performed in all material respects all agreements and covenants contained in this Agreement that are required to be performed by it prior to or at the Closing, or shall have cured any failure to perform in all material respects all such agreements
and covenants prior to or at the Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <I>Release of Liens</I>.&nbsp;Purchaser shall have received evidence reasonably
satisfactory to it that all Liens on any Purchased Assets (other than Permitted Liens) have been released. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <I>CMS
Sanctions</I>.&nbsp;(i)&nbsp;CMS shall not have imposed any sanction involving suspension of marketing, enrollment and/or payment (it being understood and agreed that the imposition of a civil monetary penalty that does not involve the suspension of
payment will not be included in this clause (i)) under any Existing Medicare Advantage Contract with respect to any Existing Medicare Advantage Plan, (ii)&nbsp;other than in connection with the terms of this Agreement, CMS shall not have terminated
any Existing Medicare Advantage Contract with respect to any Existing Medicare Advantage Plan, and (iii)&nbsp;neither Seller nor any of its Affiliates shall have suspended enrollment or marketing under any Existing Medicare Advantage Contract with
respect to any Existing Medicare Advantage Plan (each of the items in clauses (i), (ii)&nbsp;and (iii)&nbsp;of this Section 6.02(d), a &#147;<B>CMS Sanction</B>&#148;), in each case which CMS Sanction, individually or in the aggregate with any and
all other CMS Sanctions, has, or would reasonably be expected to have, a material adverse effect on Seller&#146;s ability to provide the services under the Administrative Services Agreement (it being understood and agreed that, among other things,
the impact (and the reasonably expected impact) of any remediation or other offsetting actions taken </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-59- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by Seller or any of its Affiliates, shall be taken into account in determining if such CMS Sanction, individually or in the aggregate with any and all other CMS Sanctions, has, or would
reasonably be expected to have, a material adverse effect on the Seller&#146;s ability to provide the services under the Administrative Services Agreement); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) <I>Star Rating</I>.&nbsp;Purchaser shall have received reasonably adequate assurances from CMS that the Medicare star rating relating to
each Conveyed Medicare Advantage Contract immediately following the effective time of the Medicare Advantage Contract Novations shall be no less than the star rating of the applicable Existing Medicare Advantage Contract or 2017 Seller Medicare
Advantage Contract, as applicable, from which such Contract was split as measured immediately prior to the Closing; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) <I>Seller
Deliveries at Closing</I>.&nbsp;Seller shall have delivered to Purchaser the following, dated the Closing Date, and duly executed by authorized officers of Seller or its Affiliates, as applicable: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) (A)&nbsp;a certificate of an officer of Seller certifying and including the following: the resolutions of the Board of
Directors (or an equivalent governing body) authorizing the execution, delivery and performance of this Agreement, the Transaction Documents, and the transactions contemplated hereby and thereby; and (B)&nbsp;each of the conditions specified in
Section 6.02(a), Section 6.02(b) and Section 6.02(d)&nbsp;are satisfied; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) unless Purchaser is entering into the
Conveyed Medicare Advantage Contracts directly with CMS, the Novation Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the Administrative Services
Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) the Transitional Trademark License Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) the Assignment and Assumption Agreement; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) the FIRPTA Certificate, duly executed by Seller<I>.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 6.03 <I>Conditions to Seller&#146;s Obligation</I><I>.</I>&nbsp;The obligation of Seller to consummate the Closing is subject to the
satisfaction or, to the extent permissible, waiver in writing by Seller in its sole discretion, prior to or at the Closing, of each of the following conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <I>Accuracy of Representations and Warranties</I>.&nbsp;All of the Purchaser Fundamental Representations shall be true and correct in all
material respects at and as of the Closing, as if made at and as of such time (except for any such representations and warranties that are made at or as of a specific date or time, which representations and warranties shall be true and correct in
all material respects only at and as of such specific date or time); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <I>Compliance with Agreement</I>.&nbsp;Purchaser shall have
performed in all material respects all agreements and covenants contained in this Agreement that are required to be performed by it prior to or at the Closing, or shall have cured any failure to perform in all material respects all such agreements
and covenants prior to or at the Closing; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-60- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <I>Purchaser Deliveries at Closing</I>.&nbsp;Purchaser shall have delivered to Seller the
following, dated the Closing Date, and duly executed by authorized officers of Purchaser or its Affiliates, as applicable: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) a certificate of an officer of Purchaser certifying and including the following: (A)&nbsp;the resolutions of the Board of
Directors authorizing the execution, delivery and performance of this Agreement, the Transaction Documents, and the transactions contemplated hereby and thereby; and (B)&nbsp;a certificate to the effect that each of the conditions specified in
Section 6.03(a)&nbsp;and Section 6.03(b)&nbsp;are satisfied; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) unless Purchaser is entering into the Conveyed Medicare
Advantage Contracts directly with CMS, the Novation Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the Administrative Services Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) the Transitional Trademark License Agreement; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) the Assignment and Assumption Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <I>Humana Acquisition</I>.&nbsp;(i)&nbsp;The Humana Acquisition shall have been consummated in accordance with the Merger Agreement prior
to, or shall be so consummated substantially contemporaneously with, the Closing, and (ii)&nbsp;none of Seller, Humana or any of their respective Affiliates shall have received notice from any Governmental Authority that such Governmental Authority
will, and no provision of any applicable Law shall, (A)&nbsp;require Seller or any of its Affiliates to sell, divest, hold separate, discontinue, limit or otherwise dispose of any material portion of Humana&#146;s Medicare Advantage business in the
Applicable Service Area or (B)&nbsp;place any material limitation on Seller&#146;s or any of its Affiliates&#146; continued operation or ownership of Humana&#146;s Medicare Advantage business in the Applicable Service Area or any portion thereof.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 6.04 <I>Frustration of Conditions</I><I>.</I>&nbsp;Neither Purchaser nor Seller shall, and each shall cause its Affiliates not
to, take any action that would, or would reasonably be expected to, result in any condition set forth in this Article 6 not being satisfied. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 7 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INDEMNIFICATION AND
REMEDIES </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 7.01 <I>Survival</I>.&nbsp;The representations and warranties of the parties contained in this Agreement shall survive
the Closing until, and shall terminate on, the fifteen (15)-month &#147;anniversary&#148; of the Closing Date; <I>provided</I> that the Seller Fundamental Representations, the Purchaser Fundamental Representations and the representations of Seller
contained in Section 3.16 (Taxes) (&#147;<B>Tax Representations</B>&#148;) shall survive the Closing indefinitely or until the latest date permitted by applicable Law; <I>provided</I><I>, further</I>, that the representations of Seller contained in
Section 3.09 (Compliance with Applicable Laws), Section 3.11 (Material Provider Contracts) and Section 3.12 (Seller Enrollees) (collectively, the &#147;<B>Extended Representations</B>&#148;) shall survive the Closing until the third (3<SUP
STYLE="font-size:85%; vertical-align:top">rd</SUP>) anniversary of the Closing Date.&nbsp;The covenants and agreements of the parties contained in this Agreement that are to be performed prior to the Closing shall survive the Closing only until, and
shall terminate on, the first anniversary of the Closing Date, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-61- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
except for such covenants and agreements as contemplated to survive the Closing for a longer period, which shall survive the Closing indefinitely except as otherwise provided
herein.&nbsp;Notwithstanding anything to the contrary above, any and all claims arising out of or related to actual and intentional fraud or Willful Breach shall survive the Closing indefinitely.&nbsp;Notwithstanding the preceding sentences of this
Section 7.01, any breach of representation, warranty, covenant or agreement in respect of which indemnity may be sought under this Agreement shall survive the time at which it would otherwise terminate pursuant to such sentences if notice of the
breach thereof giving rise to such right of indemnity shall have been given in accordance with Section 7.04 or Section 7.05, as applicable, to the party against whom such indemnity may be sought prior to such time, which notice shall include the
specific Section or Sections hereof that the party giving such notice claims to have been breached and the Section or Sections hereof pursuant to which the party giving notice claims to be entitled to indemnification hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 7.02 <I>Indemnification by Seller</I>.&nbsp;(a)&nbsp;Subject to the limitations set forth in this Article 7, from and after the
Closing, Seller hereby agrees to indemnify Purchaser, its Affiliates, their respective officers, directors and employees and their respective successors and assigns (collectively, the &#147;<B>Purchaser Indemnified Persons</B>&#148;) against, and to
hold each of them harmless from, any and all damages, losses, costs, expenses, fines, penalties and interest ((x) including reasonable and documented out-of-pocket expenses of investigation and reasonable and documented out-of-pocket attorneys&#146;
fees and expenses in connection with any Direct Claim or Third-Party Claim, but (y) excluding (i)&nbsp;punitive, exemplary or speculative damages and (ii)&nbsp;special, indirect or consequential damages, except, in the case of this clause (ii), to
the extent such damages were as of the date of this Agreement the reasonably foreseeable consequence of the relevant breach (other than, in the case of this clause (y), any such damages actually paid to a third party in respect of a Third-Party
Claim), and (z) including damages arising out of or relating to actual and intentional fraud or Willful Breach) (collectively, &#147;<B>Damages</B>&#148;) to the extent actually suffered by the Purchaser Indemnified Persons and arising out of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) any misrepresentation or breach of warranty made by Seller in this Agreement (&#147;<B>Seller Warranty Breaches</B>&#148;);
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) any breach of covenant or agreement made or to be performed by Seller in this Agreement; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) any Excluded Liability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) With respect to indemnification by Seller for Seller Warranty Breaches, other than Seller Warranty Breaches in respect of Seller
Fundamental Representations or Tax Representations or the Extended Representations or as a result of actual and intentional fraud or Willful Breach, (i)&nbsp;Seller shall not be liable for any such individual Seller Warranty Breach unless the
Damages with respect thereto exceed $20,000 (the &#147;<B>De Minimis Amount</B>&#148;, and any such Seller Warranty Breach, a &#147;<B>Qualifying Seller Warranty Breach</B>&#148;), (ii)&nbsp;Seller shall not be liable for any Damages with respect to
any Qualifying Seller Warranty Breaches unless and until the aggregate amount of Damages with respect to all Qualifying Seller Warranty Breaches exceeds one percent (1%) of the Purchase Price, as adjusted hereunder (the
&#147;<B>Threshold</B>&#148;), in which case Seller shall be liable for all Damages with respect to all Qualifying Seller Warranty </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-62- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Breaches from the first dollar, and (iii)&nbsp;Seller&#146;s maximum liability for all Qualifying Seller Warranty Breaches shall not exceed fifteen percent (15%) of the Purchase Price, as
adjusted hereunder (the &#147;<B>Cap</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) With respect to indemnification by Seller for all Seller Warranty Breaches,
including Seller Warranty Breaches in respect of Seller Fundamental Representations, Tax Representations and Extended Representations, but excluding any Seller Warranty Breaches arising from actual and intentional fraud or Willful Breach,
Seller&#146;s maximum aggregate liability shall be limited to the Purchase Price, as adjusted hereunder (the &#147;<B>Aggregate Cap</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) With respect to indemnification by Seller for any Seller Warranty Breach in respect of Tax Representations, Seller shall not be liable for
any Damages resulting from or relating to any Tax with respect to a Post-Closing Tax Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 7.03 <I>Indemnification by
Purchaser</I>.&nbsp;(a)&nbsp;Subject to the limitations set forth in this Article 7, from and after the Closing, Purchaser hereby agrees to indemnify Seller, its Affiliates, their respective officers, directors and employees and their respective
successors and assigns (collectively, the &#147;<B>Seller Indemnified Persons</B>&#148;) against, and to hold each of them harmless from, any and all Damages to the extent actually suffered by the Seller Indemnified Persons and arising out of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) any misrepresentation or breach of warranty made by Purchaser in this Agreement (&#147;<B>Purchaser Warranty
Breaches</B>&#148;); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) any breach of covenant or agreement made or to be performed by Purchaser in this Agreement; or
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) any Assumed Liability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) With respect to indemnification by Purchaser for Purchaser Warranty Breaches, other than Purchaser Warranty Breaches in respect of
Purchaser Fundamental Representations, (i)&nbsp;Purchaser shall not be liable for any such Purchaser Warranty Breach unless the Damages with respect thereto exceed the De Minimis Amount (any such Purchaser Warranty Breach, a &#147;<B>Qualifying
Purchaser Warranty Breach</B>&#148;), (ii)&nbsp;Purchaser shall not be liable for any Damages with respect to any Qualifying Purchaser Warranty Breaches unless and until the aggregate amount of Damages with respect to all Qualifying Purchaser
Warranty Breaches exceeds the Threshold, in which case Purchaser shall be liable for all Damages with respect to all Qualifying Purchaser Warranty Breaches from the first dollar, and (iii)&nbsp;Purchaser&#146;s maximum liability for all Qualifying
Purchaser Warranty Breaches shall not exceed the Cap. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) With respect to indemnification by Purchaser for all Purchaser Warranty
Breaches, including Purchaser Warranty Breaches in respect of Purchaser Fundamental Representations, Purchaser&#146;s maximum aggregate liability shall be limited to the Aggregate Cap. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 7.04 <I>Third-Party Claim Procedures</I><I>.</I>&nbsp;(a)&nbsp;The party seeking indemnification under Section 7.02(a) or 7.03(a) (the
&#147;<B>Indemnified Party</B>&#148;) agrees to give prompt notice in writing to the party against whom indemnity is to be sought (the &#147;<B>Indemnifying Party</B>&#148;) of the assertion of any claim or the commencement of any Action by any
third party (a &#147;<B>Third-Party </B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-63- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<B>Claim</B>&#148;) in respect of which indemnity may be sought under such Section.&nbsp;Such notice shall set forth in reasonable detail the facts and circumstances of such Third-Party Claim and
the basis for indemnification in respect thereof, including the specific Section or Sections hereof that the Indemnified Party claims to have been breached (taking into account the information then available to the Indemnified Party) and the Section
or Sections hereof pursuant to which the Indemnified Party claims to be entitled to indemnification hereunder.&nbsp;The failure of the Indemnified Party to so notify the Indemnifying Party shall not relieve the Indemnifying Party of its obligations
hereunder, except to the extent such failure shall have prejudiced the Indemnifying Party.&nbsp;Following delivery of the initial notice with respect to a Third-Party Claim, the Indemnified Party shall deliver to the Indemnifying Party, as promptly
as reasonably practicable after the Indemnified Party&#146;s receipt thereof, copies of all written notices and other documents (including any court papers) received by the Indemnified Party relating to such Third-Party Claim, and the Indemnified
Party shall provide the Indemnifying Party with such other information with respect to such Third-Party Claim as the Indemnifying Party may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) The Indemnifying Party shall be entitled to participate in the defense of any Third-Party Claim and, subject to the limitations set forth
in this Section 7.04(b), shall be entitled to control and appoint lead counsel of the Indemnifying Party&#146;s choice for such defense, in each case at the Indemnifying Party&#146;s own expense, if it gives notice of its intention to do so to the
Indemnified Party within 30 days after receipt of the initial notice with respect to such Third-Party Claim from the Indemnified Party pursuant to Section 7.04(a); <I>provided</I> that, if such Third-Party Claim relates to or arises out of any
criminal enforcement action against the Indemnified Party or seeks as its primary remedy equitable or injunctive relief against the Indemnified Party, then the Indemnified Party shall be entitled to control the defense of such Third-Party Claim and
appoint lead counsel of the Indemnified Party&#146;s choice for such defense (so long as such counsel is reasonably acceptable to the Indemnifying Party), in each case at the Indemnifying Party&#146;s expense, if the Indemnified Party gives notice
of its intention to do so to the Indemnifying Party within 30 days after the Indemnified Party becomes aware that either of the above circumstances exists with respect to such Third-Party Claim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) If the Indemnifying Party shall assume the control of the defense of any Third-Party Claim in accordance with the provisions of this
Section 7.04, (i)&nbsp;the Indemnifying Party shall obtain the prior written consent of the Indemnified Party (which consent shall not be unreasonably withheld, delayed or conditioned) before entering into any settlement of such Third-Party Claim,
if the settlement (1) does not release the Indemnified Party and its Affiliates from all liabilities and obligations with respect to such Third-Party Claim or (2) imposes injunctive or other equitable relief on the Indemnified Party or any of its
Affiliates that limits the operation of the business of any of such Persons and (ii)&nbsp;the Indemnified Party shall be entitled to participate in the defense of any Third-Party Claim and to employ separate counsel of its choice and at its own
expense.&nbsp;The Indemnified Party shall not settle any Third-Party Claim without the prior written consent of the Indemnifying Party (which consent shall not be unreasonably withheld, conditioned or delayed). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) Each party shall cooperate, and cause its Affiliates to cooperate, in the defense or prosecution of any Third-Party Claim, and shall
furnish or cause to be furnished such records, information and testimony, and attend such conferences, discovery proceedings, hearings, trials or appeals, as may be reasonably requested in connection therewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-64- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 7.05 <I>Direct Claim Procedures</I><I>.</I>&nbsp;If an Indemnified Party has a claim for
indemnity under Section 7.02(a) or 7.03(a) against the Indemnifying Party that does not involve a Third-Party Claim (a &#147;<B>Direct Claim</B>&#148;), the Indemnified Party agrees to give prompt notice thereof in writing to the Indemnifying
Party.&nbsp;Such notice shall set forth in reasonable detail the facts and circumstances of such Direct Claim and the basis for indemnification in respect thereof, including the specific Section or Sections hereof that the Indemnified Party claims
to have been breached (taking into account the information then available to the Indemnified Party) and the Section or Sections hereof pursuant to which the Indemnified Party claims to be entitled to indemnification hereunder.&nbsp;The failure of
the Indemnified Party to so notify the Indemnifying Party shall not relieve the Indemnifying Party of its obligations hereunder, except to the extent such failure shall have prejudiced the Indemnifying Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 7.06 <I>Calculation of Damages</I><I>.</I>&nbsp;(a)&nbsp;The amount of any Damages payable under Section 7.02(a) or 7.03(a), as
applicable, by the Indemnifying Party shall be decreased by any (i)&nbsp;amounts actually recovered by the Indemnified Party under applicable insurance policies or from any other Person alleged to be responsible therefor and (ii)&nbsp;Tax benefit
actually realized by the Indemnified Party (in cash or as a reduction in Taxes otherwise due) arising from the incurrence or payment of such Damages.&nbsp;If the Indemnified Party receives any amounts under applicable insurance policies, or from any
other Person alleged to be responsible for any Damages, after the Indemnifying Party makes an indemnification payment in respect of such Damages, then the Indemnified Party shall promptly (and in any event within 10 Business Days) reimburse the
Indemnifying Party for any payment made or expense incurred by such Indemnifying Party in connection with providing such indemnification payment up to the amount received by the Indemnified Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) The Indemnifying Party shall not be liable under Section 7.02(a) or 7.03(a), as applicable, for any Damages relating to any matter to the
extent that the Indemnified Party or any of its Affiliates has recovered for such Damages under another provision of this Agreement or any of the other Transaction Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Each Indemnified Party shall use its respective Commercially Reasonable Efforts to mitigate in accordance with applicable Law any Damages
for which such Indemnified Party may seek indemnification under this Agreement; <I>provided</I> that any Damages incurred by an Indemnified Party in connection with efforts to mitigate any Damages pursuant to this Section 7.06 shall constitute
Damages incurred by such Indemnified Party for which such Indemnified Party shall be indemnified pursuant to this Article 7. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) Each
Indemnified Party shall use Commercially Reasonable Efforts to collect any amounts available under applicable insurance policies, or from any other Person alleged to be responsible, for or with respect to any Damages payable by the Indemnifying
Party under Section 7.02(a) or 7.03(a), as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 7.07 <I>Assignment of Claims</I><I>.</I>&nbsp;If the Indemnified Party
receives any payment from an Indemnifying Party in respect of any Damages pursuant to Section 7.02(a) or 7.03(a), as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-65- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable, and the Indemnified Party could have recovered all or a part of such Damages from a third party based on the underlying claim asserted by the Indemnified Party against the
Indemnifying Party, the Indemnified Party hereby assigns such of its rights to proceed against such third party as are necessary to permit the Indemnifying Party to recover from such third party the amount of such payment; <I>provided</I> that such
assignment would not reasonably be expected to have a material and adverse effect on the business, affairs, customer, Enrollee, Provider or supplier relationships or prospects of the business of such Indemnified Party.&nbsp;Notwithstanding the
foregoing, an Indemnifying Party&#146;s right to seek coverage from any subrogation with respect to insurance carriers shall not be subject to the proviso in the immediately preceding sentence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 7.08 <I>Exclusive Remedy</I><I>.</I>&nbsp;From and after the Closing, except (a)&nbsp;as expressly provided in Section 2.09 (Purchase
Price Adjustment), Section 2.10 (Additional Adjustment to Purchase Price), Section 5.12 (2017 Calendar Year True-Ups), Section 5.16 (Tax Matters) or the other Transaction Documents or (b)&nbsp;with respect to (i)&nbsp;actual and intentional fraud by
either party with respect to its representations and warranties expressly contained herein, and (ii)&nbsp;equitable relief pursuant to Section 9.12, each party acknowledges and agrees (in the case of Purchaser, on behalf of itself and each of the
other Purchaser Indemnified Persons, and in the case of Seller, on behalf of itself and each of the other Seller Indemnified Persons (in each case, such party&#146;s &#147;<B>Respective Indemnified Persons</B>&#148;)) that the sole and exclusive
remedy of such party and its Respective Indemnified Persons against the other party or its Respective Indemnified Persons for any matter or claim relating to the Purchased Assets, the Assumed Liabilities, the Excluded Liabilities, the Existing
Medicare Advantage Plans, the 2017 Seller Medicare Advantage Plans, Purchaser&#146;s Medicare Advantage Plans, the Existing Medicare Advantage Contracts, the 2017 Seller Medicare Advantage Contracts, this Agreement, the subject matter hereof or the
transactions contemplated hereby (including any claim for breach of contract and misrepresentation or breach of warranty under this Agreement) shall be as provided by this Article 7. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 7.09 <I>Purchase Price Adjustment</I><I>.</I>&nbsp;To the extent permitted by applicable Law, any amount paid under this Article 7
shall be treated as an adjustment to the Purchase Price paid hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 7.10 <I>Additional Indemnity
Provisions</I><I>.</I>&nbsp;The indemnification rights of the parties hereunder shall be subject to the following terms and conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding anything to the contrary contained herein, for purposes of determining whether there has been a breach of representation
or warranty resulting in a claim for indemnification hereunder (but not for purposes of determining the amount of Damages), each representation and warranty contained in this Agreement shall be read without regard and without giving effect to any
&#147;materiality&#148; or &#147;material adverse effect&#148; standard or qualification contained in such representation or warranty (as if such standard or qualification was deleted from such representation and warranty). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Each party acknowledges that any rights to indemnification of the other party or its Respective Indemnified Persons for breach of the
representations, warranties, covenants and obligations of the first such party contained in this Agreement, and the rights and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-66- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
remedies that may be exercised by the other party hereunder, are part of the basis of the bargain contemplated by this Agreement, and neither party&#146;s rights to indemnification under this
Agreement shall be limited, waived or otherwise affected by virtue of (and each party shall be deemed to have relied on the express representations and warranties of the other party set forth in this Agreement notwithstanding) any knowledge on the
part of such party or any of its Affiliates or Representatives, of any inaccuracy of any such representation or warranty of the other party set forth in this Agreement, regardless of whether such knowledge was obtained through such party&#146;s own
investigation or otherwise (including disclosure by the other party or any of its Affiliates or Representatives), and regardless of whether such knowledge was obtained before or after the execution and delivery of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 8 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TERMINATION </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 8.01 <I>Grounds for Termination</I><I>.</I>&nbsp;This Agreement may be terminated at any time prior to the Closing: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) by mutual written agreement of Seller and Purchaser; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) by Seller or Purchaser if the Closing has not occurred on or before December&nbsp;31, 2016 (as such date may be extended pursuant to the
following provisos, the &#147;<B>End Date</B>&#148;); <I>provided</I> that the End Date shall be extended to and including August&nbsp;31, 2017, if Seller notifies Purchaser on or before December&nbsp;31, 2016 of its election to extend the End Date
to August&nbsp;31, 2017; and <I>provided, further</I>, that the End Date shall be extended to and including January 3, 2018, if (i) the Humana Acquisition Litigation has been finally and non-appealably resolved (including by settlement), or has been
resolved and such resolution has not yet been appealed, in each case on or before August&nbsp;31, 2017 and (ii) Seller notifies Purchaser on or before August&nbsp;31, 2017 of its election to extend the End Date to January 3, 2018; <I>provided,
however</I>, that the right to terminate this Agreement pursuant to this Section 8.01(b) shall not be available to any party whose breach of any provision of this Agreement results in the failure of the Closing to have occurred by such time; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) by Seller or Purchaser if (i)&nbsp;there shall be any applicable Law in the United States of America or any of its territories that
enjoins, prevents or prohibits the consummation of the Closing and, if such Law is an Order, such Order shall have become final and non-appealable, or (ii)&nbsp;any Required Regulatory Approval shall have been finally and non-appealably denied by
the applicable Governmental Authority; <I>provided</I> that the right to terminate this Agreement pursuant to this Section 8.01(c)&nbsp;shall not be available to any party that has failed to perform its obligations under Section 5.03 in any material
respect; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) by Seller or Purchaser if the Merger Agreement shall have been terminated in accordance with its terms; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) by Purchaser if a breach of any representation or warranty or failure to perform any covenant or agreement on the part of Seller set forth
in this Agreement shall have occurred that would cause any condition set forth in Section 6.02(a) or Section 6.02(b) not to be satisfied, and such breach or failure to perform (i)&nbsp;is incapable of being cured or (ii)&nbsp;has not been
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-67- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cured by Seller within 45 days following written notice to Seller from Purchaser of such breach or failure to perform, but only so long as Purchaser is not then in breach of its representations,
warranties, covenants or agreements set forth in this Agreement, which breach by Purchaser would cause any condition set forth in Section 6.03(a) or Section 6.03(b) not to be satisfied; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) by Seller if a breach of any representation or warranty or failure to perform any covenant or agreement on the part of Purchaser set forth
in this Agreement shall have occurred that would cause any condition set forth in Section 6.03(a) or Section 6.03(b) not to be satisfied, and such breach or failure to perform (i)&nbsp;is incapable of being cured or (ii)&nbsp;has not been cured by
Purchaser within 45 days following written notice to Purchaser from Seller of such breach or failure to perform, but only so long as Seller is not then in breach of its representations, warranties, covenants or agreements set forth in this
Agreement, which breach by Seller would cause any condition set forth in Section 6.02(a) or Section 6.02(b) not to be satisfied; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) by
Seller if Seller, Humana or any of their respective Affiliates shall have received notice from any Governmental Authority that such Governmental Authority will, or any provision of any applicable Law shall, (i)&nbsp;require Seller or any of its
Affiliates to sell, divest, hold separate, discontinue, limit or otherwise dispose of a material portion of Humana&#146;s Medicare Advantage business in the Applicable Service Area or (ii)&nbsp;place any material limitation on Seller&#146;s or any
of its Affiliates&#146; continued operation or ownership of Humana&#146;s Medicare Advantage business in the Applicable Service Area or any portion thereof; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(h) by Seller if (i) DOJ or the Overseeing Court shall have specifically notified in writing Seller or Purchaser (or their respective
Affiliates) that Purchaser is not an acceptable acquirer, (ii) the Overseeing Court shall have notified in writing Seller or Purchaser (or their respective Affiliates) that the transactions contemplated by this Agreement are not an acceptable remedy
(and the parties have not within 15 days after such notification by the Overseeing Court agreed upon changes to the terms hereof that would render the transactions contemplated by this Agreement an acceptable remedy) or (iii) the Humana Acquisition
Litigation shall have been finally and non-appealably resolved (including by settlement), or shall have been resolved and such resolution shall not yet have been appealed, and such resolution does not require Seller to divest individual Medicare
Advantage plan Contracts in any of the counties included in the Applicable Service Area; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) by Seller if CMS has imposed or proposed in
writing to impose sanctions on Purchaser or any of its Affiliates, including with respect to (i)&nbsp;eligibility to participate in government healthcare programs, (ii)&nbsp;suspension of marketing, enrollment and/or payment under any Medicare
Advantage contract or Medicare Part D contract to which Purchaser or any of its Affiliates is a party or (iii)&nbsp;termination of any Medicare Advantage contract or Medicare Part D contract to which Purchaser or any of its Affiliates is a party, in
each case above, that would reasonably be expected to have the effect of preventing or materially impairing or materially delaying Purchaser&#146;s consummation of any of the transactions contemplated by this Agreement; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(j) by Seller or Purchaser if the Humana APA shall have been terminated in accordance with its terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-68- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The party desiring to terminate this Agreement pursuant to Section 8.01(b), Section 8.01(c), Section 8.01(d),
Section 8.01(e), Section 8.01(f), Section 8.01(g), Section 8.01(h), Section 8.01(i) or Section 8.01(j) shall give notice of such termination to the other party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 8.02 <I>Effect of Termination</I><I>.</I>&nbsp;If this Agreement is terminated as permitted by Section 8.01, this Agreement shall
forthwith become null and void, and such termination shall be without Liability of either party or their respective Affiliates (or their respective Representatives or equityholders) to the other party, except as provided in Section 8.03(a);
<I>provided</I> that, subject to Section 8.03(b), if such termination shall result from the intentional failure of either party to (a)&nbsp;fulfill a condition to the performance of the obligations of the other party or (b)&nbsp;perform any covenant
or agreement of such party contained herein, such intentionally failing party shall be fully liable for any and all Damages or other Liability incurred or suffered by the other party as a result of such failure.&nbsp;The provisions of this Section
8.02, Section 8.03, the last sentence of Section 5.05(b), Section 5.22(b), Article 9 (other than Section 9.12) and, for the avoidance of doubt, each of the Confidentiality Agreements shall survive any termination hereof pursuant to Section 8.01.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 8.03 <I>Applicable Termination Fee</I>.&nbsp;(a)(i) If this Agreement is terminated&nbsp;on or prior to December 31, 2016 (A) by
Seller pursuant to Section 8.01(b), Section 8.01(d), Section 8.01(g) or Section 8.01(h) (in each case, other than in the event that the circumstances giving rise to such right to termination were proximately caused by Purchaser&#146;s material
breach of this Agreement) or (B) by either party under Section 8.01(c)(i) as a result of an Order relating to the Humana Acquisition Litigation (other than in the event that the circumstances giving rise to such right to termination were proximately
caused by Purchaser&#146;s material breach of this Agreement) or Section 8.01(j) (but only if termination pursuant to this provision is in connection with termination of the Humana APA as a result of an Applicable Termination (as defined
thereunder)) (each of the terminations described in clauses (A) and (B) above, an &#147;<B>Applicable Termination</B>&#148;), then Seller shall pay or cause to be paid to Purchaser a fee in the amount of (1) the Applicable Portion of Fifty Million
Dollars ($50,000,000), plus (2) the Applicable Portion of Purchaser&#146;s Transaction Costs; (ii) if this Agreement is terminated on or after January 1, 2017 and prior to July 1, 2017 pursuant to an Applicable Termination, then Seller shall pay or
cause to be paid to Purchaser a fee in the amount of (1) the Applicable Portion of Seventy-Five Million Dollars ($75,000,000), plus (2) the Applicable Portion of Purchaser&#146;s Transaction Costs; and (iii) if this Agreement is terminated on or
after July 1, 2017 pursuant to an Applicable Termination, then Seller shall pay or cause to be paid to Purchaser a fee in the amount of (1) the Applicable Portion of One Hundred Million Dollars ($100,000,000), plus (2) the Applicable Portion of
Purchaser&#146;s Transaction Costs (the amount referred to in the foregoing clause (i), (ii) or (iii), as applicable, the &#147;<B>Applicable Termination Fee</B>&#148;) as promptly as reasonably practicable (and in any event within five Business
Days following such termination) by wire transfer of immediately available funds to an account designated in writing by Purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)
The parties agree and understand that in no event shall Seller be required to pay or cause to be paid the Applicable Termination Fee on more than one occasion, and in no event shall Purchaser be entitled to receive an amount greater than the
Applicable Termination Fee pursuant to this Agreement.&nbsp;Notwithstanding anything to the contrary in this Agreement, (i) if Purchaser receives the Applicable Termination Fee from Seller pursuant to this Section 8.03, such payment shall be the
sole and exclusive remedy of Purchaser and its Respective </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-69- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Indemnified Persons against Seller and its Respective Indemnified Persons and their respective former, current or future partners, stockholders, managers, members, Affiliates and Representatives
relating to or arising out of this Agreement or the transactions contemplated hereby and none of Seller or its Respective Indemnified Persons shall have any further Liability relating to or arising out of this Agreement or the transactions
contemplated hereby, and (ii) if Purchaser or any of its Respective Indemnified Persons receives any payments from Seller or any of its Respective Indemnified Persons in respect of any breach of this Agreement and thereafter Purchaser receives the
Applicable Termination Fee pursuant to this Section 8.03, the amount of the Applicable Termination Fee shall be reduced by the aggregate amount of such payments made by Seller and its Respective Indemnified Persons in respect of any such
breach.&nbsp;The parties acknowledge that the agreements contained in this Section 8.03 are an integral part of the transactions contemplated hereby, and that, without these agreements, the parties would not enter into this Agreement and that any
amounts payable pursuant to this Section 8.03 do not constitute a penalty.&nbsp;Accordingly, if Seller fails to promptly pay any amount due pursuant to this Section 8.03, Seller shall also pay any reasonable and documented out-of-pocket costs and
expenses (including reasonable and documented out-of-pocket legal fees and expenses) incurred by Purchaser in connection with a legal action to enforce this Agreement that results in a judgment for such amount against Seller failing to promptly pay
such amount.&nbsp;Any amount not paid when due pursuant to this Section 8.03 shall bear interest from the date such amount is due until the date paid at a rate equal to the prime rate as published in <I>The Wall Street Journal, Eastern Edition</I>
in effect on the date of such payment. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 9 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">MISCELLANEOUS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 9.01
<I>Notices</I>.&nbsp;All notices, requests and other communications to any party hereunder shall be in writing (including facsimile transmission and, if permitted below, electronic mail (&#147;<B>e-mail</B>&#148;) transmission), and shall be given,
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="86%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="78%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">If to Seller, to:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aetna Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">151 Farmington Avenue, RC6A</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hartford, Connecticut 06156</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;General Counsel</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Facsimile: (860) 273-8340</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">with a copy (which shall not constitute notice) to:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Davis Polk &amp; Wardwell LLP</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">450 Lexington
Avenue</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10017</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;H. Oliver
Smith</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Harold Birnbaum</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Facsimile:&nbsp;(212) 701-5800</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">E-Mail:&nbsp;oliver.smith@davispolk.com</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">harold.birnbaum@davispolk.com</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-70- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="86%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="78%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">If to Purchaser, to:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Molina Healthcare, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">200 Oceangate, Suite
100</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Long Beach, California 90802</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;Jeff Barlow,
Chief Legal Officer &amp; Burt Park, Sr. Assistant General Counsel</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Facsimile:&nbsp;(916) 646-4572</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email:&nbsp;jeff.barlow@molinahealthcare.com</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">and
burt.park@molinahealthcare.com</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">with a copy (which shall not constitute notice) to:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sheppard Mullin Richter &amp; Hampton, LLP</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1901
Avenue of the Stars #1600</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Century City, CA 90067</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;Eric Klein, Esq. &amp; Aytan Dahukey, Esq.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Facsimile:&nbsp;(310) 228-3906</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email:&nbsp;eklein@sheppardmullin.com</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">and
adahukey@sheppardmullin.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address, facsimile number or email as such party may hereafter specify for the purpose by notice to the other
party.&nbsp;All such notices, requests and other communications shall be deemed received on the date of receipt by the recipient thereof if received prior to 5:00 p.m. on a Business Day in the place of receipt.&nbsp;Otherwise, any such notice,
request or communication shall be deemed to have been received on the next succeeding Business Day in the place of receipt. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 9.02
<I>Amendments and Waivers</I><I>.</I>&nbsp;(a)&nbsp;Except as provided in Section 2.12, any provision of this Agreement may be amended or waived if, but only if, such amendment or waiver is in writing and is signed, in the case of an amendment, by
each party or, in the case of a waiver, by the party against whom the waiver is to be effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) No failure or delay by any party in
exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege.&nbsp;Except
as set forth in Section 7.08, the rights and remedies provided in this Agreement shall be cumulative and not exclusive of any rights or remedies provided by applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 9.03 <I>Expenses</I>.&nbsp;Except as otherwise provided in this Agreement, all costs and expenses incurred in connection with this
Agreement shall be paid by the party incurring such cost or expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 9.04 <I>Disclosure Schedule References</I><I>.</I>&nbsp;The
parties agree that any reference in a particular Section of the Disclosure Schedules shall be deemed to be an exception to (or, as applicable, a disclosure for purposes of) (a)&nbsp;the representations and warranties (or covenants, as applicable) of
Seller that are contained in the corresponding Section of this Agreement and (b)&nbsp;any other representations and warranties (or covenants, as applicable) of Seller that are contained in this Agreement to which such reference is relevant or
applicable on its face.&nbsp;The inclusion of any information in the Disclosure Schedules shall not be deemed to be an admission </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-71- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or acknowledgment, in and of itself, that such information is required by the terms hereof to be disclosed, is material, has resulted in or would result in a material adverse effect or is outside
the ordinary course of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 9.05 <I>Binding Effect; Benefit; Assignment</I><I>.</I>&nbsp;(a)&nbsp;Except for the rights of
the Financing Source set forth in Section 9.13 (of which the Financing Source is the intended third party beneficiary), the provisions of this Agreement shall be binding upon and shall inure solely to the benefit of the parties, except that each of
the Purchaser Indemnified Persons and Seller Indemnified Persons that is entitled to indemnification pursuant to Section 7.02(a) or Section 7.03(a), as applicable, and is not a party to this Agreement, shall be an express third-party beneficiary of
this Agreement to the extent provided by such Sections. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) No party may assign, delegate or otherwise transfer any of its rights or
obligations under this Agreement without the prior written consent of the other party, and any purported assignment, delegation or other transfer in violation of the terms of this Section 9.05(b)&nbsp;shall be null and void <I>ab initio</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 9.06 <I>Governing Law</I><I>.</I>&nbsp;This Agreement shall be governed by and construed and enforced in accordance with the Laws of
the State of Delaware, without regard to the conflicts of law rules of such state. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 9.07
<I>Jurisdiction/Venue</I><I>.</I>&nbsp;Each of the parties (a)&nbsp;irrevocably consents to the service of the summons and complaint and any other process in any Action relating to the transactions contemplated hereby, on behalf of itself or its
property or its Respective Indemnified Persons, in accordance with Section 9.01 or in such other manner as may be permitted by applicable Law, and nothing in this Section 9.07 shall affect the right of any party to serve legal process in any other
manner permitted by applicable Law, (b)&nbsp;irrevocably and unconditionally consents and submits itself and its property in any Action to the exclusive general jurisdiction of the Delaware Court of Chancery and any state appellate court therefrom
within the State of Delaware (or, only if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any federal court within the State of Delaware) in the event any dispute arises out of this Agreement or the
transactions contemplated hereby, or for recognition and enforcement of any judgment in respect thereof, (c)&nbsp;agrees that it shall not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court,
(d)&nbsp;agrees that any Action arising in connection with this Agreement or the transactions contemplated hereby shall be brought, tried and determined only in the Delaware Court of Chancery (or, only if the Delaware Court of Chancery declines to
accept jurisdiction over a particular matter, any federal court within the State of Delaware), (e)&nbsp;waives any objection that it may now or hereafter have to the venue of any such Action in any such court or that such Action was brought in an
inconvenient court and agrees not to plead or claim the same and (f)&nbsp;agrees that it shall not bring any Action relating to this Agreement or the transactions contemplated hereby in any court other than the aforesaid courts.&nbsp;Each party
agrees that a final judgment in any Action in such court as provided above shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 9.08 <I>WAIVER OF JURY TRIAL</I>.&nbsp;EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-72- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF
ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.&nbsp;EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (a)&nbsp;NO REPRESENTATIVE OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR
OTHERWISE, THAT THE OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (b)&nbsp;EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (c)&nbsp;EACH PARTY MAKES THIS WAIVER VOLUNTARILY AND
(d)&nbsp;EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS Section 9.08. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 9.09 <I>Counterparts; Effectiveness</I><I>.</I>&nbsp;This Agreement may be signed in any number of counterparts, including by
facsimile or by e-mail with .pdf attachments, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.&nbsp;This Agreement shall become effective when each party shall have
received a counterpart hereof signed and delivered (by electronic communication, facsimile or otherwise) by the other party.&nbsp;Until and unless each party has received a counterpart hereof signed by the other party, this Agreement shall have no
effect and no party shall have any right or obligation hereunder (whether by virtue of any other oral or written agreement or other communication). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 9.10 <I>Entire Agreement</I>.&nbsp;This Agreement, the other Transaction Documents and the Confidentiality Agreements constitute the
entire agreement between the parties and their respective Affiliates with respect to the subject matter thereof and supersede all prior agreements and understandings, both oral and written, between the parties and their respective Affiliates with
respect to the subject matter hereof and thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 9.11 <I>Severability</I>.&nbsp;If any term, provision, covenant or restriction
of this Agreement is held by a court of competent jurisdiction or other Governmental Authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and
effect and shall in no way be affected, impaired or invalidated so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to either party.&nbsp;Upon such a determination, the
parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner in order that the transactions contemplated hereby be consummated as originally
contemplated to the fullest extent possible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 9.12 <I>Specific Performance</I>.&nbsp;The parties acknowledge and agree that
irreparable harm would occur and that the parties would not have any adequate remedy at law (a)&nbsp;for any breach of the provisions of this Agreement or (b)&nbsp;in the event that any of the provisions of this Agreement were not performed in
accordance with their specific terms.&nbsp;It is accordingly agreed that, except where this Agreement is properly terminated in accordance with Section 8.01, the parties shall be entitled to an injunction or injunctions to prevent breaches of this
Agreement and to specifically enforce the terms and provisions of this Agreement, without proof of actual damages, and each party further agrees to waive any requirement for the securing or posting of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-73- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any bond in connection with such remedy.&nbsp;The parties further agree that (i)&nbsp;by seeking the remedies provided for in this Section 9.12, a party shall not in any respect waive its right
to seek any other form of relief that may be available to a party under this Agreement, including, subject to Section 8.02, monetary damages in the event that this Agreement has been terminated or in the event that the remedies provided for in this
Section 9.12 are not available or otherwise are not granted and (ii)&nbsp;nothing contained in this Section 9.12 shall require any party to institute any Action for (or limit any party&#146;s right to institute any Action for) specific performance
under this Section 9.12 before exercising any termination right under Section 8.01 (and pursuing damages after such termination) nor shall the commencement of any Action pursuant to this Section 9.12 or anything contained in this Section 9.12
restrict or limit any party&#146;s right to terminate this Agreement in accordance with the terms of Section 8.01 or pursue any other remedies under this Agreement that may be available then or thereafter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 9.13 <I>Waiver of Claims</I>.&nbsp;Notwithstanding anything to the contrary contained herein, Seller (on behalf of itself and any of
its Affiliates, directors, officers, employees, agents and representatives) hereby waives any rights or claims against the Financing Source or its Representatives (which for the avoidance of doubt shall exclude Purchaser and its Affiliates) in
connection with this Agreement or the Debt Commitment Letter (whether in law, equity, tort, contract or otherwise) or in respect of any oral or written representations made or alleged to be made by a Financing Source in connection herewith or
therewith and Seller (on behalf of itself and any of its Affiliates, directors, officers, employees, agents and representatives) agrees not to commence any action or proceeding against the Financing Source or its Representatives (which for the
avoidance of doubt shall exclude Purchaser and its Affiliates) in connection with this Agreement or the Debt Commitment Letter.&nbsp;In furtherance and not in limitation of the foregoing waiver, it is acknowledged and agreed that neither the
Financing Source nor its Representatives shall have any liability for any claims or damages to Seller in connection with this Agreement or the Debt Commitment Letter or the transactions contemplated hereby or thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Remainder of page intentionally left blank; signature pages follow] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-74- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>PURCHASER:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>SELLER:</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">MOLINA HEALTHCARE, INC.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">AETNA INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John C. Molina</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bjorn B. Thaler</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name:&nbsp;John C. Molina</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Title: Chief
Financial Officer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name:&nbsp;Bjorn B. Thaler</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Title:&nbsp;Vice&nbsp;President,&nbsp;Corporate&nbsp;Development</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Signature Page </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
